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Integration of miRNA and mRNA 
expression profiles reveals 
microRNA-regulated networks 
during muscle wasting in cardiac 
cachexia
Leonardo N. Moraes1, Geysson J. Fernandez1, Ivan J. Vechetti-Júnior1, Paula P. Freire1, 
Rodrigo W. A. Souza1, Rolando A. R. Villacis2,3, Silvia R. Rogatto4, Patricia P. Reis5, Maeli Dal-
Pai-Silva1 & Robson F. Carvalho1
Cardiac cachexia (CC) is a common complication of heart failure (HF) associated with muscle wasting 
and poor patient prognosis. Although different mechanisms have been proposed to explain muscle 
wasting during CC, its pathogenesis is still not understood. Here, we described an integrative analysis 
between miRNA and mRNA expression profiles of muscle wasting during CC. Global gene expression 
profiling identified 1,281 genes and 19 miRNAs differentially expressed in muscle wasting during CC. 
Several of these deregulated genes are known or putative targets of the altered miRNAs, including 
miR-29a-3p, miR-29b-3p, miR-210-5p, miR-214, and miR-489. Gene ontology analysis on integrative 
mRNA/miRNA expression profiling data revealed miRNA interactions affecting genes that regulate 
extra-cellular matrix (ECM) organization, proteasome protein degradation, citric acid cycle and 
respiratory electron transport. We further identified 11 miRNAs, including miR-29a-3p and miR-29b-3p, 
which target 21 transcripts encoding the collagen proteins related to ECM organization. Integrative 
miRNA and mRNA global expression data allowed us to identify miRNA target genes involved in 
skeletal muscle wasting in CC. Our functional experiments in C2C12 cells confirmed that miR-29b down-
regulates collagen genes and contributes to muscle cell atrophy. Collectively, our results suggest that 
key ECM-associated miRNAs and their target genes may contribute to CC in HF.
Heart failure (HF) is a major public health problem affecting millions of patients worldwide. As the most growing 
cardiovascular problem, HF affects about 2% of the Western population, with the prevalence increasing sharply 
from 1% in 40-year-old individuals to 10% above the age of 70 years1. It is the most common cause of hospitaliza-
tion with a poor prognosis similar to diseases such as cancer1–3. Cachexia associated with HF, or cardiac cachexia 
(CC), is a complex metabolic syndrome defined by a weight loss of > 6% over 6 months that accompanies HF in 
up to 50% of severe cases, being an independent factor of poor prognosis4, 5.
The awareness of CC has increased over the last two decades6, and several skeletal muscle alterations have 
been described in patients and animals with this condition; these include atrophy (wasting), shift from slow to fast 
fibers, decreased oxidative capacity, and increased fatigability7–11. Considering the overall complexity of skeletal 
muscle function regulatory mechanisms, processes that lead to progressive muscle wasting, ultimately resulting in 
CC, are likely due to deregulation of signaling networks. Previous examinations of large scale mRNA expression 
in human and rodent skeletal muscle atrophy have generated insights on the molecular changes underlying the 
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loss of skeletal muscle mass in different conditions such as unloading, immobilization, glucocorticoid treatment, 
diabetes, sarcopenia, starvation, and denervation12–17 and revealed new biomarkers of cancer cachexia18, 19.
Despite the pathophysiological stimuli for muscle wasting, different types of muscle atrophy may also share 
common transcriptional programs activated in systemic diseases20. Such complexity illustrates the need to apply 
a global approach to analyzing the molecular changes that occur during wasting in CC. Although global gene 
expression alterations are informative, the identification of microRNAs (miRNAs) has opened up a new field of 
investigation to understand molecular regulatory gene expression mechanisms in skeletal muscle diseases21–24. 
Comprehensive miRNA expression profiling has revealed that miRNA expression changes are associated with 
wasting conditions such as primary muscular disorders, dexamethasone-induced atrophy, fasting, denervation, 
diabetes, and cancer cachexia23–26. However, to our knowledge, no other study has examined the role of miRNAs 
in skeletal muscle wasting during HF and CC. Therefore, our goal was to perform an integrative, global miRNA 
and mRNA expression profiling analysis in soleus muscle of rats with CC to unravel novel regulatory networks 
and molecular pathways involved in muscle wasting. Studies such as this will provide the basis to understand the 
molecular regulatory mechanisms modulated by miRNAs in CC. Our data may be useful for future development 
of novel therapeutic approaches for preventing and treating muscle wasting in CC.
Results
Monocrotaline (MCT) treatment induces cardiac hypertrophy and failure. As expected, all rats 
that received intraperitoneal MCT injection developed right ventricular hypertrophy and failure (CC group) 
compared to control rats injected with saline (CT group) (Table 1). After 30 days of MCT injection, CC group 
exhibited signs of HF that included strong tachypnea, lack of spontaneous activity, piloerection and cold extrem-
ities before sacrifice. These animals also showed HF at post-mortem, confirmed by atrium and right ventricular 
hypertrophies, pleural and pericardial effusions, and presence of lung and liver congestion. No alterations were 
found in the control rats. Heart weight was increased in CC compared to CT, as demonstrated by right ventricle 
weight (RVW), atrium weight (ATW), and by the indexes of cardiac hypertrophy [left ventricle weight (LVW)/
body weight (BW), RVW/BW, and ATW/BW]. LVW was decreased in CC compared to CT; however, the LVW/
BW index was increased in CC.
MCT-treated rats develop CC associated with muscle wasting and fiber-type changes. Our 
findings are consistent with previous reports showing skeletal myopathy in HF (reviewed elsewhere27). 
MCT-treated rats develop CC associated with a significant reduction in whole BW (Table 1) and muscle fiber 
cross-sectional area (CSA; taken as an index of muscle atrophy) (Fig. 1A), confirming that these animals were also 
cachectic. The histochemical reaction of myofibrillar ATPase (m-ATPase) revealed a significant reduction in fiber 
CSA of all muscle-fiber types (I, II and Ic/IIc) in CC rats (Fig. 1A,B). These structural abnormality characteristics 
of skeletal myopathy related to CC also included qualitative changes in the content of muscular fibers second-
ary with a slow to fast transition in myofibrillar properties (Fig. 1C,D). Expression of the atrogenes Fbxo32 and 
Trim63 was increased in CC compared to CT; however, the expression of the myogenic regulatory factor Myod1 
was decreased (Fig. 1E). Additionally, gene expression analysis demonstrated reduced slow TnnI1 transcript levels 
despite no activation in the expression of fast TnnI2 or TnnT3 mRNAs in CC group (Fig. 1E).
Skeletal myopathy in cardiac cachexia is associated with transcriptome changes in key reg-
ulatory pathways. In order to understand the transcriptomic changes associated with skeletal myopa-
thy in CC, we performed a global mRNAs expression profiling analysis that identified 1,281 deregulated genes 
(p ≤ 0.01 and fold change ≥ 1.5), of which 538 and 743 were up- or down-regulated, respectively (Supplementary 
Table S1). Microarray data are available in Gene Expression Omnibus GSE72701, and the mRNA differentially 
expressed in CC are provided in the supplementary material. In most cases, a functional class was assigned to 
these 1,281 regulated genes using the Gene Set Enrichment Analysis (Supplementary Table S2). The top over- and 
under-expressed genes were selected and ranked by a combination of p-value < 0.05 and fold change ≥ 5, and are 
listed in Supplementary Tables S3 and S4, respectively.
CT CC P value
BW (g) 344.6 ± 17.5 255 ± 13.7 0.0022
LVW (g) 0.69 ± 0.03 0.60 ± 0.06 0.0152
LVW/BW (mg/g) 1.99 ± 0.17 2.35 ± 0.21 0.0260
RVW (g) 0.20 ± 0.03 0.49 ± 0.04 0.0022
RVW/BW (mg/g) 0.58 ± 0.06 1.94 ± 0.23 0.0022
ATW (g) 0.10 ± 0.01 0.19 ± 0.03 0.0022
ATW/BW (mg/g) 0.28 ± 0.03 0.76 ± 0.11 0.0022
Liver W/D 3.09 ± 0.04 3.53 ± 0.13 0.0002
Lung W/D 4.61 ± 0.19 4.98 ± 0.22 0.0219
Table 1. Anatomic data of CT and CC groups. Values are mean ± SD; n: number of animals; CT: control group 
(n = 6); CC: cardiac cachexia group (n = 6); BW: body weight; LVW: left ventricle weight; RVW: right ventricle 
weight; ATW: atrium weight; W/D, wet-to-dry weight. P value of the statistical significance difference between 
the groups.
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To determine the biological and functional implications of gene expression changes in muscle wasting during 
CC, we performed functional enrichment of the differentially expressed genes. This analysis showed that 30 path-
ways were clustered in biological processes important to skeletal myopathy in HF, which included structural genes 
(e.g., collagen biosynthesis, regulation of myotubes differentiation, extra-cellular matrix organization, and mus-
cle contraction), metabolic processes, cell death and proteolysis, and muscle growth and differentiation (Fig. 2). 
Other relevant processes enriched in our dataset included cytokine signaling, ion regulation and angiogenesis 
(Fig. 2).
To gain further insight into individual pathways, we also analyzed the over- and under-expressed genes in 
each pathway (Fig. 2). Notably, this analysis showed that all deregulated genes related to collagen biosynthesis 
were down regulated. The large majority of the deregulated genes related to cell proteolytic systems and cell death 
pathways were up regulated (Fig. 2).
Figure 1. Monocrotaline-treated rats develop right heart failure and cardiac cachexia associated with muscle 
wasting and fiber-type changes. Representative cross-sections of soleus muscles showing fiber-type distribution 
using myofibrillar adenosine triphosphatase (m-ATPase) reaction after pre-incubation at pH 4.3, from control 
(CT) and cardiac cachexia (CC) groups (A). CC decreases cross-sectional area (CSA; µm2) of fiber-types I, Ic/
IIc, and IIa (B), induces a slow-to-fast switch in fiber types composition (C), and changes the relative myosin 
heavy chain (MyHC) isoform percentage (%) in soleus muscle (D). Expression of atrogenes (Fbxo32 and 
Trim63), Myod, and slow and fast (Tnni1, Tnni2, and Tnnt3) myofiber genes in soleus muscle of CC compared 
to their levels of expression in CT (set at a value of 0), as detected by real-time PCR. Y-axis represents log2-fold 
change. The expression of each transcript was normalized by the expression of Ppib, B2m, and Ppia. (E) Data are 
expressed as mean ± SD; n = 6 per group. *p < 0.05; **p < 0.001: statistical significance versus CT group.
www.nature.com/scientificreports/
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miRNAs associated with skeletal myopathy in cardiac cachexia. To identify miRNAs as gene 
expression regulators in skeletal myopathy during CC, we performed a comparative miRNA expression profiling 
analysis. Eighteen of 373 miRNAs were differentially expressed in muscle wasting during CC compared to con-
trols (13 upregulated and 5 downregulated) (Fig. 3 and Supplementary Table S5).
Figure 2. Gene-term enrichment analysis of differentially expressed genes in soleus muscle of cardiac cachexia 
rats to identify top canonical pathways. Each vertical colored bars (y-axis) represent a major module; horizontal 
bars represent the percentage of genes presented in the data set compared to the total number of genes in 
each pathway. Fraction of DE genes in each pathway (up/down, red/blue; respectively) are shown in x-axis. 
Additional information in Supplementary Table S2.
Figure 3. Identification of differentially expressed miRNAs in soleus muscle of cardiac cachexia group (CC) 
compared to their level of expression in control group (CT; set at a value of 0), as detected by low-density 
miRNA arrays. Y-axis represents log2-fold change. The dashed line indicates fold change value of 1.5. The 
expression of each miRNA was normalized by the expression of the small RNAs snoRNA135, Y1, U87, and 
MammU6. Data are expressed as mean ± SD; n = 6 per group. *p < 0.05: statistical significance versus CT 
group.
www.nature.com/scientificreports/
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Integrative analyses of miRNA and mRNA expression profiles identified signaling pathways 
enriched with predicted miRNA targets. Since miRNAs regulate gene expression by both mRNA degra-
dation and translational repression mechanisms, and miRNA-mRNA regulatory networks are complex, we used 
a parallel miRNA-mRNA expression profile approach as previously described28–30 to increase the accuracy of our 
in silico mRNA target prediction used to identify potential mRNA targets of the differentially expressed miRNAs. 
A dataset of 1,281 genes generated from our mRNA microarray data with predicted and experimentally validated 
targets were paired to 18 differentially expressed miRNAs in CC. These miRNA–target relationships were pre-
dicted by at least four target prediction algorithms. To avoid target multiplicity, we constructed the miRNA tar-
get–gene network using differentially expressed genes identified by cDNA microarrays, considering that mRNA 
and miRNA expression levels should be inversely correlated if one regulates the other. We detected the next 
topology: 222 deregulations between 18 miRNAs and 177 target genes; the number and the overlap among these 
predicted targets for each miRNA are represented in Fig. 4.
Interestingly, the miRNAs miR-29a-3p and miR-29b-3p showed the higher number of overlapping targets 
mRNAs, including many transcripts that encode proteins related to extracellular matrix (ECM) (Supplementary 
Table S6). Moreover, we found that 95% of the deregulated miRNAs has at least 2 targets genes and that 10 
deregulated miRNAs have at least 10 targets genes (Supplementary Table S7). Indeed, we have found that the 
transcripts Fbxw7, Dnmt3a, and Ppic are co-deregulated by 3 or more miRNAs; including miR-29a-3p and miR-
29b-3p (Supplementary Table S8). As also shown in Fig. 4, most miRNA/mRNAs deregulations are connected, 
and generate a large connecting network. These results indicate an implicated combination of target multiplicity 
and miRNA cooperativeness during muscle wasting in CC.
Based on miRNA-target deregulated network analysis described above, we identified enriched pathways for tar-
get genes deregulated by differentially expressed miRNAs. As shown in the Fig. 5 and Supplementary Tables S4, 5 
pathways were enriched. Statistical comparisons revealed miRNA interactions affecting genes regulating ECM 
organization (P = 9.2E-5), proteasome protein degradation (P = 3.2E-5), citric acid cycle and respiratory electron 
Figure 4. Two distinct sub-networks miRNA-mRNA deregulated in cardiac cachexia. We identified 222 
deregulations between 18 miRNAs and 177 target genes. The solid lines connecting molecules represent 
miRNA-mRNA interaction. Node size represents number of targets for each miRNA, edge width denotes 
overlap between miRNAs measured by the Jaccard coefficient (JC), and nodes are colored based on the log2 fold 
change of the differential expression of the miRNA. The interaction network showed two smaller deregulated 
subnetworks that are clearly separate: one with 8 up-regulated miRNAs (in red) and the other with 4 down-
regulated miRNAs (in green) and each miRNA has multiple targets.
Figure 5. Gene-term enrichment analysis of mRNAs regulated by miRNAs in cardiac cachexia. Top canonical 
pathways affected in cardiac cachexia. Bars represent percentage of genes altered by miRNAs present in the data 
set compared to the total number of genes present in each selected pathway. In front of each bar is indicated the 
number of altered miRNAs in the pathway. Each color represents a major module.
www.nature.com/scientificreports/
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transport (P = 5.6E-4), JNK cascade (P = 3.4E-4) and cellular response to TGF-β (P = 7.8E-3). Interestingly, this 
analysis also revealed 11 miRNAs, including miR-29a-3p and miR-29b-3p, which target 21 transcripts encod-
ing proteins related to ECM, comprising the collagens Col1a1, Col1a2, Col22a1, Col3a1, Col5a1, and Col6a2 
(Supplementary Table S4).
To elucidate the functions of these complex interactions between mRNAs and miRNAs in the ECM network, 
we further examined probable miRNA-mRNA interactions. The complexity of the miRNA-mRNA interactome 
of muscle wasting in CC is demonstrated by a regulatory network displaying predicted and validated interac-
tions between deregulated miRNAs and target mRNAs that are enriched, considering physical and pathway 
protein-protein interactions using Cytoscape database (Fig. 6). This analysis further confirmed the importance 
of miR-29 family members and their interaction with ECM protein coding transcripts. Our data highlight, for 
the first time, a set of miRNAs that targets transcripts that encode ECM organization proteins in muscle wasting 
during CC.
Extracellular matrix remodeling in cardiac cachexia. The high degree of consistency in the pathway 
enrichment analyses clearly suggests that CC induces coherent interactions between the miRNAs and mRNAs 
involved in ECM. The ECM remodeling was confirmed by changes in both collagen gene (Fig. 7A) and protein 
expression (Fig. 7B,C). Corroborating these data, the cross-sectional analysis of the soleus muscle stained by 
Picrosirius technique demonstrated a relative decrease of collagen content in the ECM (Fig. 7D,E). Next, we 
asked whether miR-29b mediates the repression of Col1a1 and Col3a1 expression with a functional consequence 
in muscle cells atrophy. To test this, we transfected a synthetic miR-29b mimic into C2C12 myoblasts that were 
further fully differentiated in myotubes. C2C12 myotubes transfected with miR-29b mimic had a significant 
reduction in myotubes area (Fig. 8A and B), total protein concentration (Fig. 8C), number of myotubes (three 
or more nucleus/cells; Fig. 8D), and Myh7 and Myh2 expression (Fig. 8E). The miR-29b overexpression also 
repressed Col1a1 and Col3a1transcript levels (Fig. 8E).
Discussion
To the best of our knowledge, ours is the first study performing an integrated global miRNA and mRNA expres-
sion profiling in muscle of rats with CC to unravel novel regulatory networks and molecular pathways involved 
in muscle wasting. Our results highlight miRNA-regulated gene networks involved in skeletal muscle wasting in 
CC. Specifically, our results suggest that key ECM-associated miRNAs and their target genes may contribute to 
CC in HF.
Structural abnormality characteristics of skeletal myopathy have been described in CC11, 31, 32; however, tran-
scriptome profile changes associated with CC remain widely unknown. We have produced a global transcriptome 
catalogue of muscle wasting in CC that identified 1,281 differentially expressed genes, of which 538 and 743 
were up- or down-regulated, respectively. Among these, we selected the top 23 deregulated genes (p-value < 0.05 
and fold change ≥ 5); from which, 8 genes were up regulated. These most highly expressed genes revealed the 
metallothioneins (Mt1m, Mt1, and Mt2a), which are significantly increased in human skeletal muscle after 48 h 
immobilization33; these metallothioneins have also been shown to mediate protective adaptations in soleus mus-
cle following disuse mediated by spinal cord injury34 and oxidative stress protection in a mouse model of dystro-
phinopathy35. It is also noteworthy that Cyp2e1, which has been shown to impair GLUT4 gene expression and 
function in muscle cells36, had the highest fold change (46.6X) among the upregulated genes. In addition, 15 genes 
were downregulated, including mRNAs encoding ECM (Col1a1, Col3a1, and Mfap4), neuromuscular junction 
(Ky and Rab3a), IGF-1 pathway (Dok5 and Igfbp5), and myoblast proliferation proteins (Mlf1, Nrep, and Sfrp4); 
these findings are consistent with muscle fiber regeneration and ECM remodeling.
Figure 6. Complexity of the miRNA-mRNA interactome network in rat soleus muscles with cardiac cachexia. 
The regulatory network displays predicted and validated interactions between miRNAs (rectangle) and mRNAs 
(elliptic) deregulated from TLDA and microarray experiments generated by using a fold-change cutoff <1.5, 
P < 0.05 and enrichment with physical and pathway protein-protein interaction by Cytoscape database.
www.nature.com/scientificreports/
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Category analysis of the differentially expressed genes showed up-regulation of genes for catabolism (e.g., 
ubiquitin-proteasome, p53 signaling pathway, autophagy, and apoptosis) and the suppression of structural genes 
(e.g., collagen biosynthesis, regulation of myotubes differentiation, ECM organization, and muscle contraction). 
Our results are consistent with a previous meta-analysis on gene expression signatures pertaining to different 
types of muscle atrophy37. These authors described six functional pathways that occupy central positions in the 
molecular network obtained by the integration of atrophy transcriptome and interaction data. Similar to our 
study, pathway analysis of different types of muscle atrophy transcriptome indicated that deregulated genes in 
atrophy conditions are mainly involved in ECM reorganization, cytoskeleton organization, cytokines signaling, 
and apoptosis pathways37. Our results are also in agreement with a previous transcriptome analysis of skeletal 
muscle wasting performed in a transgenic mouse model of HF and CC raised by sustained activation of Met 
Tyrosine Kinase in the heart38. These authors identified 107 differentially expressed genes (fold change > 1.7) in 
CC, and the functional categories and pathways in which these differentially expressed genes were classified pre-
sented some shared core molecular mechanisms with our CC model. These include genes associated with muscle 
metabolism, growth, protein synthesis, and inflammation.
Undoubtedly, the formation, maintenance, and physiological and pathophysiological responses of skeletal 
muscles, with all their complex regulatory circuits, are subject to regulation by miRNAs. To our knowledge, ours 
is the first study that analyzed genome-wide profiling of miRNA expression during muscle wasting in CC. Using 
this analysis, we identified 18 altered miRNAs; 13 were upregulated and 5 downregulated. Previous studies have 
also reported alterations of global miRNA expression in muscle atrophy in primary muscle disorders23, diabe-
tes24, denervation24, dexamethasone-induced atrophy25, fasting24 and cancer cachexia24. The comparison of our 
CC miRNA profile with these previous studies did not reveal any similar miRNA profile but instead identified 
a specific subset of CC miRNAs. This is in line with the work by Soares et al., 201439 who did not find a com-
mon signature of miRNAs in different atrophic models (starvation, denervation, diabetes, and cancer cachexia). 
Previously, several miRNAs have also been implicated in pathological cardiac hypertrophy and HF in humans 
and in mouse models of heart disease (reviewed elsewhere40). In this sense, our findings in the skeletal muscle are 
somewhat similar to what has been found in cardiac muscle in which miRNAs add an additional layer of regula-
tion in muscle remodeling during HF.
Among the regulated skeletal muscle miRNAs in CC, we identified two upregulated miRNAs (miR-337-5p 
and miR434-3p,) that are located in the same cluster (<10 kb) and have very similar fold change values (1.98 
and 1.94, respectively). Also notable, we identified miR-29b-3p, miR-29a-3p, miR-210-3p, miR-214, and miR-
489, which had been previously reported as involved in the regulation of myogenesis41–45. Specifically, high level 
of miR-29 is important for driving myogenic differentiation, and loss of miR-29 promotes transdifferentiation 
Figure 7. Decreased collagen in the extracellular matrix in the soleus muscle of rats with cardiac cachexia. 
Analysis of type I collagen gene expression by real-time PCR (in log 2) normalized by Ppib, B2m, and Ppia 
(A). Western blot of collagen I and III normalized by β-actin (B,C). Soleus muscle cross-sections stained 
with Sirius red and analyzed in microscope under light polarized (D). Mean gray scale level of Picrosirius 
red stained collagen fibers in the soleus muscle expressed as a percent of the mean gray scale level of collagen 
in the endomysium (E). Data are expressed as mean ± SD; n = 6 per group. *p < 0.05; **p < 0.01: statistical 
significance versus CT group.
www.nature.com/scientificreports/
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of myoblasts into myofibroblasts by targeting extracellular molecules including collagens46, 47. In fact, previous 
studies have demonstrated the miR-29 family as a “master fibromiRNA” regulator of the liver, lung, skin, kidney, 
heart, and skeletal muscles fibrosis48–55. Multiple transcripts encoding standard ECM proteins such as collagens, 
fibrillins and elastin have been implicated as miR-29 family direct targets49–53. In C2C12 muscle cells, the stable 
over-expression of miR-29 down-regulates ECM and cell adhesion genes46. Most recently, Galimov et al., 201643 
used next generation RNA sequencing from miR‐29a knockout myoblasts to identified members of the basement 
membrane as the most abundant miR‐29a targets. This same study also showed that miR-29 can initiate muscle 
cell senescence leading to aging-induced atrophy by suppressing the expression of several mediators of cell prolif-
eration and muscle growth. Furthermore, in vivo studies have shown that intramuscular injection of miR-29 into 
dystrophic limb muscles down-regulated collagen and elastin mRNA expression53, whereas the systemic delivery 
of miR-29 mimics led to significant improvement of dystrophic diaphragm muscle by reducing existing fibrosis 
and increasing regeneration47. Thus, the upregulation of the miRNAs miR-29b-3p and miR-29a-3p in our model 
of CC suggest that they may have an important role in ECM remodeling in this condition.
In order to reduce the complexity of predicted miRNA-mRNA interactions identified by in silico prediction, 
and to increase the list of miRNAs targets likely associated with muscle wasting in CC, we applied an integrated 
and simultaneous mRNA and miRNA analysis. This strategy enabled us to identify biologically relevant and 
experimentally validated miRNA target genes and provided a comprehensive picture of molecular networks regu-
lated by the identified miRNAs. Specifically, this analysis identified mRNAs and miRNAs that play pivotal roles in 
Figure 8. miR-29b promotes muscle atrophy and reduces collagens expression. Immunofluorescence of 
C2C12 myotubes transfected with miR-29b-3p-mimic stained with antibodies specific to myosin heavy chain 
Myh2 (red). Nuclei stained with DAPI (blue) (A). Quantitative analyses of myotubes area (B). Total protein 
concentration in C2C12 myotubes measured by the Bradford assay (C). Number of total myotubes nuclei (three 
or more nucleus/cells) (D). mRNA levels of Col1a1, Col3a1, Myh7, and Myh2 in myotubes after miR-29b-
mimic transfection compared to their levels of expression in CT, as detected by real-time PCR. The expression 
of each transcript was normalized by the expression of Ppia and Ppib (E). Data represent the average of three 
independent experiments and are expressed as mean ± SD. *p < 0.05; **p < 0.001: statistical significance versus 
CT group.
www.nature.com/scientificreports/
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modulating diverse important biological processes in the skeletal muscle such as proteasome protein degradation 
(P = 3.2E-5), citric acid cycle and respiratory electron transport (P = 5.6E-4), JNK cascade (P = 3.4E-4), cellular 
response to TGF-β (P = 7.8E-3) and, especially, ECM organization (P = 9.2E-5). Our results showed that, com-
bined with metabolic alterations, different degradation systems and ECM remodeling are key events that likely 
contribute to skeletal muscle wasting in CC.
Several mechanisms have been proposed to explain the reduced tolerance to exercise during cardiac failure, 
focusing largely on muscle fibers intracellular alterations. The data obtained in our model, right ventricular pres-
sure overload, described in details mRNAs and miRNAs alterations that may contribute to alterations in muscle 
endomysium during CC. These results were further confirmed by a dramatic decrease in collagen deposition, 
demonstrating an actively remodeling of the ECM during skeletal muscle wasting in CC. These results differ from 
Filippatos et al., 200356 who found increased fibrosis in quadriceps muscle of HF patients with CC. Other few 
studies have analyzed the changes in the skeletal muscle ECM in CC; these alterations mainly involve enhanced 
metalloproteinase (MMP) activity and collagen content56–58. Interestingly, our data agree with recent studies that 
showed thickening of endomysium and downregulation of several ECM gene transcripts in muscle wasting in 
cancer cachexia59, 60. Considering the isolated effect of miR-29b in C2C12 myotubes, our functional experiments 
also corroborate with previous studies in C2C12 cells demonstrating that miR-29b has an anti-fibrogenic effect 
by down-regulating collagen genes46, 47 and contributes to muscle atrophy61.
To summarize, we have discovered deregulated miRNAs and their target mRNAs in CC that modulate impor-
tant biological processes in the skeletal muscle, such as proteasome protein degradation, citric acid cycle and 
respiratory electron transport, JNK cascade, cellular response to TGF-β and, importantly, ECM organization. In 
addition, our data showed that 11 miRNAs, including miR-29a-3p and miR-29b-3p, target 21 transcripts encod-
ing proteins related to ECM, comprising the collagens Col1a1, Col1a2, Col22a1, Col3a1, Col5a1, and Col6a2. 
Furthermore, the up-regulated miR-29a-3p and miR-29b-3p had the higher number of overlapping targets 
mRNAs, including target transcripts that encode ECM proteins. Herein, our integrative miRNA and mRNA anal-
ysis highlight miRNA candidates to regulate genes that may contribute to the cachectic state observed in HF.
Methods
Cardiac cachexia model. Right HF was experimentally induced in 6 male Wistar rats, 250–300 g of body 
weight, by a single intra-peritoneal (ip, 60 mg/kg) injection of monocrotaline (MCT, Sigma-Aldrich, Germany), 
following the procedure described by Gary-Bobo et al., 201062. MCT is a pyrrolizidine alkaloid that induces 
pulmonary vascular disease with severe right ventricle hypertrophy and failure63. The monocrotaline-induced 
pulmonary hypertension experimental model was used since CC is associated with right ventricular failure64. 
Moreover, this model stands out with rapidly progressive right HF and CC65, thus allowing an enhanced sensi-
tivity of detection due to larger magnitude of change in a short time frame65. Six controls rats (CT group) were 
injected with saline and were given the same quantity of food as consumed on the previous day by the rats in the 
treatment group (CC).
CC and CT rats were studied 30 days after MCT administration when the HF group had developed overt 
HF. Upon anesthesia with intraperitoneal sodium pentobarbital (50 mg/Kg), animals were euthanized and body 
weight (BW) was evaluated. Soleus muscles were excised, immediately frozen in liquid nitrogen, and stored at 
−80 °C. Left ventricle weight (LVW), right ventricle weight (RVW), and atrium weight (ATW) normalized by 
body weight (BW) were used as indexes of heart hypertrophy. Fragments of liver and lung were weighed before 
and after drying sessions (65 °C for 72 h) to evaluate wet/dry weight ratios. All experiments were carried out in 
accordance with the Guide of the Institute of Biosciences, UNESP, Botucatu, SP, Brazil. The protocol was approved 
by the Institute of Biosciences, UNESP, Botucatu, SP, Brazil (Protocol # 201).
Histochemical and morphometric procedures. Soleus histological sections (12 µm thick) from CC 
(n = 6) and CT (n = 6) were obtained in a cryostat JUNG CM1800 (Leica, Germany) at −24 °C to determine mus-
cle fiber-type frequency and cross-sectional area (CSA), using myofibrillar adenosine triphosphatase (m-ATPase) 
histochemistry after pre-incubation at pH 4.35. Muscle fiber types were classified as Types I, Ic/IIc, and IIa. Fiber 
CSA for each fiber type, and fiber-type frequencies were determined using Image Analysis System Software 
(Leica, Germany). At least 200 fibers at different points of soleus muscle were measured and their frequency was 
expressed as the number of fibers per type against the total number of fibers measured.
Electrophoretic analysis of myosin heavy chain. Myosin heavy chain (MyHC) isoform analysis was 
performed by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) in triplicate. Twelve 
histological sections (12 µm thick) of CC (n = 6) and CT (n = 6) were collected from each whole muscle sample. 
The gels were stained with Coomassie Blue and used to identify the MyHC isoforms (MHC I and MyHC IIa) 
according to their molecular weight. The gels were photographed and densitometry analysis was performed using 
ImageMaster VDS Software v. 3.0 (GE, USA) to determine relative MyHC isoform content.
RNA preparations. Total RNA was isolated using TRIzol reagent (Life Technologies, USA) as described 
by the manufacturer. Total RNA was solubilized in nuclease free-water and treated to eliminate genomic DNA 
contamination with DNA-free kit (Life Technologies, USA) as described by the manufacturer. Total RNA quan-
tity was determined by the A 260 nm/A 280 nm and A 260 nm/A 230 nm ratios (acceptable when both ratios 
were > 1.8). RNA Integrity was ensured by obtaining a RNA Integrity Number - RIN > 8 with Agilent 2100 
Bioanalyzer (Agilent Technologies, Germany).
Expression profiling of miRNAs and reference genes. miRNA and mRNA was reverse transcribed 
using the Megaplex RT Primers Pools A and B and High Capacity RNA-to-cDNA master mix (Life Technologies, 
USA), respectively. Global miRNA profiling of CC (n = 6) and CT (n = 6) samples was performed with the 
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TaqMan® Array Rodent MicroRNA Cards A and B v3.0 (Life Technologies, USA) for 373 mature miRNAs in rats. 
The expression profiling of 16 mRNAs commonly used as references genes were evaluated by using the TaqMan® 
assays Low Density Array Endogenous Control Panel (Life Technologies, USA) to determine the most stable 
reference genes. miRNA and mRNAs quantitative PCR (qPCR) analyses were performed as described by the 
manufacturer and run on the ViiA™ 7 Real-Time PCR System. Finally, raw data from each card set was retrieved 
and imported into Expression Suite Software v1.0.3 (Life Technologies, USA). The small RNAs snoRNA135, Y1, 
U87, and MammU6 were selected as reference control genes to normalize the miRNA data and genes B2m, Ppia, 
and Ppib to further normalize mRNA data based on geNorm calculations66. Relative quantification of miRNA 
expression was evaluated using the comparative quantification method67. Cutoffs for significant changes were a 
fold-change > 1.5 and a p-value ≤ 0.05.
Quantitative analyses of gene expression by real-time reverse transcription polymerase chain 
reaction (RT-qPCR). RT-qPCR was carried out with GoTaq® qPCR Master Mix (Promega, USA), using 
specifics primers (Supplementary Table S9) and cDNA of each sample of CC (n = 6) and CT (n = 6) groups. 
Reactions were set up in a total volume of 20 µL and performed in the ABI Prism 7300 real-time PCR system 
(Life Technologies, USA) as described by the manufacturer. Relative quantification of mRNA expression by SYBR 
green I were assessed by using REST software 2009 v2.0.13, using the pair-wise fixed randomization test with 
10,000 permutations68, with PCR efficiencies calculated by linear regression from fluorescence increase in the 
exponential phase in the program LinRegPCR v11.169. Cutoffs for significant changes were a fold-change > 1.5 
and a p-value ≤ 0.05.
Global gene expression profiling analysis. Gene expression profiling of CC (n = 3) and CT (n = 3) 
groups was performed using the Rat Gene 1.0 ST Array platform (Affymetrix, USA) that covers 17,061 RefSeq 
transcripts, according to the manufacturer’s instructions. The Ambion WT Expression Kit (Life Technologies, 
Carlsbad, CA, USA) was used to cDNA synthesis and cRNA amplification, while the fragmentation and labeling 
procedures were performed with the Affymetrix GeneChip WT Terminal Labeling Kit. Arrays hybridization, 
washing and scanning were carried on the Affymetrix GeneChip Hybridization Oven 645, Fluidic Station 450 and 
Scanner 3000 7 G, respectively. Quality control and probe set summarization to attain gene-level signal data was 
provided by Affymetrix Expression Console software. Data analysis was performed with the R language (v.2.13.0). 
Background correction and quartile data normalization were applied using RMA (Robust Multi-array Average) 
algorithm70. The limma Bioconductor package71 was used to identify differential expressed genes (DEG). Cutoffs 
for significant changes were a fold-change > 1.5 and a p-value ≤ 0.05.
Western Blot analysis. Protein levels of soleus muscle of CC and CT samples were analyzed by Western 
blotting using antibodies specific for collagen I (1:100) (sc-25974, Santa Cruz) and collagen III (1:5000) (ab6310, 
Abcam). Protein levels were normalized by the endogenous β-actin (1:1000) (sc-81178, Santa Cruz). Muscle 
protein was extracted using Tris-Triton buffer (10 mM Tris pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 
1% Triton X-100, 10% glycerol, 0.1% SDS, 0.5% deoxycholate) containing Protease Inhibitor Cocktail (Sigma- 
Aldrich, USA) and quantified by the Bradford method72. Samples were separated on a polyacrylamide gel and 
then transferred to a nitrocellulose membrane. After blockage, membranes were incubated with the primary 
antibody. Membrane was washed with TBS-T and incubated with secondary peroxidase-conjugated antibody 
(1:2500). Super Signal® West Pico Chemiluminescent Substrate (Pierce Protein Research Products, Rockford, 
USA) was used to detect bound antibodies.
Pathway and gene ontology enrichment analysis. To further understand the biological relevance of 
differential expressed genes, we performed functional enrichment analysis in the context of the Gene Ontology 
(GO) categories, Kyoto Encyclopedia of Genes and Genomes (KEGG) and Reactome databases. A p-value cut-off 
of 0.001 was used to identify enriched processes. A kappa score was calculated to reflect the relationships between 
the terms based on the similarity of their associated genes, PSIQUIC web services with the threshold set at 0.3. 
was used to provide a comprehensive view on the relevant pathways using experimental and in silico data from 
gene networks, protein–protein interactions, and functional interactions73, 74. Networks were visualized and ana-
lyzed with Cytoscape75.
miRNA – target gene network. Candidate miRNA–target relationships were assessed by at least four tar-
get prediction algorithms (union set) extracted from: mirDB, TargetScan 5.1 (conservation and non-conservation 
sites) (www.targetscan.com), DIANA-microT-CDS v576, miRWalK v2.077, and miRanda78. Additionally, we used 
validated targets deposited in miRTarBase79, miRecords80, and miRwalK81. To avoid target multiplicity, we con-
structed miRNA target–gene networks considering differentially expressed genes identified by cDNA microarray 
experimental data.
Determination of collagen content. Collagen content in soleus muscle was determined using Picrosirius 
red staining. Briefly, transverse cryosections (12 μm thick) of all samples were placed on the same slide to mini-
mize staining differences; sections were incubated with saturated picric acid solution followed by Picrosirius red 
(0.1% Sirius red in saturated picric acid) for 3 min., dehydrated and mounted in Permount. Eight color pictures 
per sample were captured using the microscope with polarized light (400X magnification). Light intensity and 
filters alignment parameters used were the same for all samples. Quantitative analysis of endomysium collagen 
type I staining intensity was determined by measuring the grayscale with the Image Analysis System Software 
(Leica, Germany). The gray values were normalized by mean fiber area.
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Oligonucleotides and transfection. The miR-29b-3p mimic and the respective negative control were 
complexed with Opti-MEM reduced serum medium (Thermo Fisher Scientific, USA) before transfection. C2C12 
myoblasts transfections were performed, when the cells were at approximately 80% confluent, with RNAiMAX 
lipofectamine (Thermo Fisher Scientific, USA) combined with 30 nM of each oligonucleotide for 15 h. Myoblasts 
were switched to medium containing 2% horse serum to induce differentiation into myotubes. Myotube area, total 
protein concentration, number of myotubes, and gene expression were analyzed after 5 days of differentiation.
Immunostaining. C2C12 myotubes cultured in 6-well plates were fixed in 4% paraformaldehyde for 15 min, 
washed with PBS and 0.1% TritonX-100 (Sigma, USA), and blocked with 3% BSA, 1% glycine, 8% fetal bovine 
serum in PBS and 0.1% TritonX-100 for 1 h at room temperature. Subsequently, the cells were incubated with pri-
mary (Myh) antibodies overnight at 4 °C and, after washing, the cells were incubated with secondary antibodies 
for 1 h at room temperature and counterstained with DAPI. All images were acquired at room temperature by 
scanning confocal microscope TCS SP5 (Leica Microsystems, UK). Myotubes area and number of nuclei were 
measured by ImageJ software (National Institutes of Health, USA).
Statistical analysis. Data were expressed as mean ± standard deviation (SD). Statistical analysis was per-
formed using the GraphPad Prisma software v 6.07 (GraphPad Software, Inc., USA). For all statistical analyses not 
described elsewhere, we used an unpaired, Mann Whitney test. Statistical significance was considered achieved 
when the p-value was <0.05.
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Table Supplementary 1 mRNA differentially expressed in cardiac cachexia
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ENSRNOG00000012458 5.63 0.0010 49.57
Mt1m metallothionein 1M ENSRNOG00000028841 3.03 0.0082 8.18
Fah fumarylacetoacetate hydrolase ENSRNOG00000013223 2.95 0.0023 7.74
Mt1 metallothionein 1 ENSRNOG00000025764 2.89 0.0042 7.42
Mt1 metallothionein 1 ENSRNOG00000038047 2.84 0.0037 7.17
Pbld1 phenazine biosynthesis-like protein domain containing 1 ENSRNOG00000000386 2.80 0.0061 6.99
Cdkn1a cyclin-dependent kinase inhibitor 1A ENSRNOG00000000521 2.65 0.0131 6.29
Serpine1 serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 ENSRNOG00000001414 2.46 0.0172 5.51
Mt2A metallothionein 2A ENSRNOG00000043098 2.41 0.0067 5.31
Lox lysyl oxidase ENSRNOG00000014426 2.28 0.0197 4.86
Slc7a8 solute carrier family 7 (amino acid transporter light chain, L system), member 8 ENSRNOG00000014311 2.17 0.0055 4.51
Stc1 stanniocalcin 1 ENSRNOG00000015075 2.04 0.0019 4.12
Acer2 alkaline ceramidase 2 ENSRNOG00000007637 2.04 0.0025 4.10
Galnt15 polypeptide N-acetylgalactosaminyltransferase 15 ENSRNOG00000019718 2.01 0.0028 4.04
Sdc4 syndecan 4 ENSRNOG00000014297 1.98 0.0023 3.96
Fam49a family with sequence similarity 49, member A ENSRNOG00000005836 1.98 0.0342 3.94
Tmem140 transmembrane protein 140 ENSRNOG00000026965 1.96 0.0080 3.89
Pnpla7 patatin-like phospholipase domain-containing protein 7-like ENSRNOG00000008190 1.94 0.0039 3.83
Arntl aryl hydrocarbon receptor nuclear translocator-like ENSRNOG00000014448 1.93 0.0142 3.82
Alas2 aminolevulinate, delta-, synthase 2 ENSRNOG00000000167 1.93 0.0420 3.81
Fkbp5 FK506 binding protein 5 ENSRNOG00000022523 1.87 0.0023 3.65
Apold1 apolipoprotein L domain containing 1 ENSRNOG00000007830 1.87 0.0043 3.65
Hpd 4-hydroxyphenylpyruvate dioxygenase ENSRNOG00000001338 1.86 0.0267 3.64
Sat1 spermidine/spermine N1-acetyl transferase 1 ENSRNOG00000003809 1.85 0.0066 3.62
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Adamts9 ADAM metallopeptidase with thrombospondin type 1 motif, 9 ENSRNOG00000023257 1.85 0.0023 3.60
Ctsl cathepsin L ENSRNOG00000018566 1.84 0.0017 3.59
Mical2 microtubule associated monooxygenase, calponin and LIM domain containing 2 ENSRNOG00000016244 1.82 0.0100 3.54
Nfil3 nuclear factor, interleukin 3 regulated ENSRNOG00000011668 1.81 0.0072 3.51
Eif4ebp1 eukaryotic translation initiation factor 4E binding protein 1 ENSRNOG00000012582 1.80 0.0023 3.49
Igfbp3 insulin-like growth factor binding protein 3 ENSRNOG00000008645 1.80 0.0030 3.49
Tgif1 TGFB-induced factor homeobox 1 ENSRNOG00000015906 1.80 0.0021 3.49
Tmem252 transmembrane protein 252 ENSRNOG00000025476 1.79 0.0054 3.47
Zfand2a zinc finger, AN1-type domain 2A ENSRNOG00000032917 1.78 0.0096 3.44
Gabarapl1 GABA(A) receptor-associated protein like 1 ENSRNOG00000008498 1.74 0.0023 3.33
Porf1 preoptic regulatory factor 1 ENSRNOG00000003891 1.73 0.0432 3.31
Spsb1 splA/ryanodine receptor domain and SOCS box containing 1 ENSRNOG00000017212 1.70 0.0142 3.26
Tp53inp1 tumor protein p53 inducible nuclear protein 1 ENSRNOG00000007964 1.69 0.0118 3.22
Ampd3 adenosine monophosphate deaminase 3 ENSRNOG00000018262 1.66 0.0042 3.17
Fam107a family with sequence similarity 107, member A ENSRNOG00000033261 1.66 0.0019 3.16
Nr4a1 nuclear receptor subfamily 4, group A, member 1 ENSRNOG00000007607 1.66 0.0240 3.15
Bcl2l1-ps1 Bcl2-like 1, pseudogene 1 ENSRNOG00000018503 1.66 0.0062 3.15
Abhd2 abhydrolase domain containing 2 ENSRNOG00000017120 1.64 0.0151 3.12
RGD621098 similar to RIKEN cDNA D230025D16Rik ENSRNOG00000014668 1.64 0.0077 3.12
Sgk1 serum/glucocorticoid regulated kinase 1 ENSRNOG00000011815 1.63 0.0035 3.10
Slc4a1 solute carrier family 4 (anion exchanger), member 1 ENSRNOG00000020951 1.62 0.0154 3.08
Gadd45b growth arrest and DNA-damage-inducible, beta ENSRNOG00000019822 1.60 0.0082 3.04
Uck2 uridine-cytidine kinase 2 ENSRNOG00000003917 1.59 0.0363 3.02
Atp13a3 ATPase type 13A3 ENSRNOG00000001724 1.58 0.0257 3.00
Dapk1 death associated protein kinase 1 ENSRNOG00000018198 1.58 0.0142 2.99
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Cpm carboxypeptidase M ENSRNOG00000034134 1.58 0.0249 2.98
Id1 inhibitor of DNA binding 1 ENSRNOG00000021750 1.57 0.0066 2.97
Gstm2 glutathione S-transferase mu 2 ENSRNOG00000019094 1.57 0.0436 2.96
Lgals3 lectin, galactoside-binding, soluble, 3 ENSRNOG00000010645 1.57 0.0214 2.96
Edn1 endothelin 1 ENSRNOG00000014361 1.56 0.0027 2.96
Btg2 BTG family, member 2 ENSRNOG00000003300 1.56 0.0030 2.95
Golm1 golgi membrane protein 1 ENSRNOG00000018400 1.56 0.0023 2.95
Tmem63c transmembrane protein 63c ENSRNOG00000011334 1.56 0.0163 2.94
Fgl2 fibrinogen-like 2 ENSRNOG00000012881 1.55 0.0056 2.94
Ahnak2 AHNAK nucleoprotein 2 ENSRNOG00000028545 1.55 0.0238 2.93
Sqrdl sulfide quinone reductase-like (yeast) ENSRNOG00000000172 1.53 0.0018 2.90
Rorc RAR-related orphan receptor C ENSRNOG00000020836 1.53 0.0082 2.89
Sik1 salt-inducible kinase 1 ENSRNOG00000001189 1.53 0.0179 2.88
Slc44a3 solute carrier family 44, member 3 ENSRNOG00000011723 1.53 0.0162 2.88
Arnt2 aryl hydrocarbon receptor nuclear translocator 2 ENSRNOG00000013017 1.52 0.0105 2.86
Oas1k 2 ' -5 ' oligoadenylate synthetase 1K ENSRNOG00000033220 1.51 0.0142 2.86
Tcp11l2 t-complex 11, testis-specific-like 2 ENSRNOG00000007587 1.51 0.0053 2.85
Oser1 oxidative stress responsive serine-rich 1 ENSRNOG00000008297 1.51 0.0055 2.85
Nos1 nitric oxide synthase 1, neuronal ENSRNOG00000001130 1.50 0.0434 2.83
Vwf von Willebrand factor ENSRNOG00000019689 1.49 0.0061 2.81
Ndrg1 N-myc downstream regulated 1 ENSRNOG00000007393 1.49 0.0035 2.81
Abra actin-binding Rho activating protein ENSRNOG00000007999 1.46 0.0088 2.76
Nek10 NIMA-related kinase 10 ENSRNOG00000005883 1.46 0.0450 2.75
Gpr157 G protein-coupled receptor 157 ENSRNOG00000017528 1.46 0.0042 2.74
Csrnp1 cysteine-serine-rich nuclear protein 1 ENSRNOG00000033433 1.45 0.0021 2.73
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Clec2d C-type lectin domain family 2 member D-like 1 ENSRNOG00000007866 1.44 0.0197 2.71
Rbm3 RNA binding motif (RNP1, RRM) protein 3 ENSRNOG00000005387 1.44 0.0023 2.71
Bcl2l1 Bcl2-like 1 ENSRNOG00000007946 1.44 0.0105 2.70
Pi4k2a phosphatidylinositol 4-kinase type 2 alpha ENSRNOG00000014675 1.44 0.0034 2.70
Rps27 ribosomal protein S27 ENSRNOG00000016961 1.41 0.0182 2.67
Myc myelocytomatosis oncogene ENSRNOG00000004500 1.41 0.0023 2.66
LOC689064 beta globin minor gene ENSRNOG00000031230 1.40 0.0381 2.65
Cblb Cbl proto-oncogene B, E3 ubiquitin protein ligase ENSRNOG00000001982 1.40 0.0156 2.64
Foxo1 forkhead box O1 ENSRNOG00000013397 1.40 0.0154 2.64
Fam214a family with sequence similarity 214, member A ENSRNOG00000008150 1.39 0.0248 2.63
Pdk4 pyruvate dehydrogenase kinase, isozyme 4 ENSRNOG00000009565 1.39 0.0096 2.61
Ell elongation factor RNA polymerase II ENSRNOG00000019824 1.38 0.0090 2.61
Arid5a AT rich interactive domain 5A (Mrf1 like) ENSRNOG00000015382 1.38 0.0441 2.61
Sh3rf2 SH3 domain containing ring finger 2 ENSRNOG00000018780 1.38 0.0178 2.60
Ednrb endothelin receptor type B ENSRNOG00000010997 1.37 0.0319 2.58
Junb jun B proto-oncogene ENSRNOG00000042838 1.35 0.0224 2.55
Mreg melanoregulin ENSRNOG00000015774 1.34 0.0180 2.54
Osmr oncostatin M receptor ENSRNOG00000033192 1.33 0.0047 2.51
Gnrh1 gonadotropin-releasing hormone 1 (luteinizing-releasing hormone) ENSRNOG00000013441 1.32 0.0498 2.49
Lgals5 lectin, galactose binding, soluble 5 ENSRNOG00000012557 1.32 0.0209 2.49
Cds2 CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2 ENSRNOG00000021265 1.31 0.0077 2.49
Ppp1r15a protein phosphatase 1, regulatory subunit 15A ENSRNOG00000020938 1.31 0.0045 2.48
Map3k6 mitogen-activated protein kinase kinase kinase 6 ENSRNOG00000008936 1.31 0.0133 2.48
Phlda1 pleckstrin homology-like domain, family A, member 1 ENSRNOG00000004019 1.30 0.0379 2.45
Ngp neutrophilic granule protein ENSRNOG00000024330 1.29 0.0088 2.45
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Gpr56 G protein-coupled receptor 56 ENSRNOG00000014963 1.29 0.0043 2.45
Slc30a2 solute carrier family 30 (zinc transporter), member 2 ENSRNOG00000016650 1.29 0.0131 2.45
Bmx BMX non-receptor tyrosine kinase ENSRNOG00000003705 1.29 0.0043 2.44
Pik3c2a phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 alpha ENSRNOG00000020479 1.28 0.0068 2.42
Map1lc3b microtubule-associated protein 1 light chain 3 beta-like ENSRNOG00000017905 1.27 0.0047 2.42
Colq collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase ENSRNOG00000019615 1.27 0.0047 2.42
Ogfrl1 opioid growth factor receptor-like 1 ENSRNOG00000014142 1.27 0.0370 2.41
Per1 period circadian clock 1 ENSRNOG00000007387 1.26 0.0113 2.40
Mafk v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K ENSRNOG00000001277 1.26 0.0038 2.39
Unc5b unc-5 homolog B (C. elegans) ENSRNOG00000000567 1.25 0.0027 2.38
Tspan5 tetraspanin 5 ENSRNOG00000015913 1.25 0.0037 2.38
Ciart circadian associated repressor of transcription ENSRNOG00000042717 1.24 0.0376 2.37
Slco2a1 solute carrier organic anion transporter family, member 2a1 ENSRNOG00000009005 1.24 0.0354 2.36
Cdo1 cysteine dioxygenase type 1 ENSRNOG00000000158 1.22 0.0495 2.34
Fos FBJ osteosarcoma oncogene ENSRNOG00000008015 1.22 0.0220 2.33
Slc25a33 solute carrier family 25 (pyrimidine nucleotide carrier), member 33 ENSRNOG00000016949 1.22 0.0118 2.33
Ube2v1 ubiquitin-conjugating enzyme E2 variant 1 ENSRNOG00000025580 1.21 0.0155 2.32
Slc7a6 solute carrier family 7 (amino acid transporter light chain, y+L system), member 6 ENSRNOG00000019943 1.21 0.0030 2.32
Rhbdf2 rhomboid 5 homolog 2 (Drosophila) ENSRNOG00000011459 1.21 0.0299 2.31
Cep85l centrosomal protein 85-like ENSRNOG00000000414 1.20 0.0360 2.29
Plat plasminogen activator, tissue ENSRNOG00000019018 1.20 0.0149 2.29
Gpihbp1 glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 ENSRNOG00000007475 1.20 0.0179 2.29
Hmox1 heme oxygenase (decycling) 1 ENSRNOG00000014117 1.19 0.0278 2.28
Cd24 CD24 molecule ENSRNOG00000000321 1.19 0.0318 2.28
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ninj1 ninjurin 1 ENSRNOG00000016587 1.19 0.0411 2.28
LOC100910104 xin actin-binding repeat-containing protein 1-like ENSRNOG00000037085 1.18 0.0054 2.27
Tmco4 transmembrane and coiled-coil domains 4 ENSRNOG00000017401 1.17 0.0136 2.26
Rpl22l1 ribosomal protein L22 like 1 ENSRNOG00000011817 1.17 0.0113 2.25
Ube4b ubiquitination factor E4B ENSRNOG00000014986 1.17 0.0179 2.24
Tinagl1 tubulointerstitial nephritis antigen-like 1 ENSRNOG00000013179 1.16 0.0027 2.23
Otulin OTU deubiquitinase with linear linkage specificity ENSRNOG00000012017 1.16 0.0216 2.23
PVR poliovirus receptor ENSRNOG00000019202 1.15 0.0342 2.21
Klf15 Kruppel-like factor 15 ENSRNOG00000017808 1.14 0.0183 2.21
Il18 interleukin 18 ENSRNOG00000009848 1.14 0.0434 2.21
Rpl22l2 ribosomal protein L22-like 2 ENSRNOG00000029173 1.14 0.0066 2.20
LOC685727 similar to neuron navigator 3 ENSRNOG00000042773 1.13 0.0186 2.19
Atp6v1h ATPase, H+ transporting, lysosomal V1 subunit H ENSRNOG00000030862 1.13 0.0081 2.19
Ppan peter pan homolog (Drosophila) ENSRNOG00000020608 1.13 0.0104 2.19
Lss lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) ENSRNOG00000001267 1.13 0.0271 2.19
Rhbdd1 rhomboid domain containing 1 ENSRNOG00000014620 1.13 0.0220 2.18
Bach1 BTB and CNC homology 1, basic leucine zipper transcription factor 1 ENSRNOG00000001582 1.12 0.0155 2.18
Gpnmb glycoprotein (transmembrane) nmb ENSRNOG00000008816 1.12 0.0084 2.17
Tcea1 transcription elongation factor A (SII) 1 ENSRNOG00000022323 1.12 0.0096 2.17
Gnl3 guanine nucleotide binding protein-like 3 (nucleolar) ENSRNOG00000028461 1.11 0.0068 2.16
Pgpep1l pyroglutamyl-peptidase I-like ENSRNOG00000014402 1.10 0.0063 2.15
Cirbp cold inducible RNA binding protein ENSRNOG00000015999 1.10 0.0089 2.15
Chi3l1 chitinase 3-like 1 (cartilage glycoprotein-39) ENSRNOG00000003312 1.10 0.0457 2.14
Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a ENSRNOG00000003546 1.09 0.0131 2.14
Hgs hepatocyte growth factor-regulated tyrosine kinase substrate ENSRNOG00000036696 1.09 0.0066 2.13
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Enc1 ectodermal-neural cortex 1 ENSRNOG00000016541 1.09 0.0233 2.12
Pkmyt1 protein kinase, membrane associated tyrosine/threonine 1 ENSRNOG00000003657 1.09 0.0042 2.12
Spon2 spondin 2, extracellular matrix protein ENSRNOG00000006033 1.08 0.0479 2.12
Cyr61 cysteine-rich, angiogenic inducer, 61 ENSRNOG00000014350 1.08 0.0281 2.12
Fam117b family with sequence similarity 117, member B ENSRNOG00000022066 1.08 0.0066 2.11
Pla1a phospholipase A1 member A ENSRNOG00000027252 1.08 0.0221 2.11
Runx1 runt-related transcription factor 1 ENSRNOG00000001704 1.07 0.0290 2.10
Sfmbt1 Scm-like with four mbt domains 1 ENSRNOG00000016645 1.07 0.0068 2.10
Pcna proliferating cell nuclear antigen ENSRNOG00000021264 1.07 0.0066 2.10
Tmem38b transmembrane protein 38B ENSRNOG00000028063 1.07 0.0151 2.10
Nupr1 nuclear protein, transcriptional regulator, 1 ENSRNOG00000019206 1.06 0.0184 2.09
Gnl2 guanine nucleotide binding protein-like 2 (nucleolar) ENSRNOG00000009430 1.06 0.0246 2.09
Psmd8 proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 ENSRNOG00000037580 1.06 0.0118 2.08
Usp28 ubiquitin specific peptidase 28 ENSRNOG00000007325 1.05 0.0381 2.07
Sesn1 sestrin 1 ENSRNOG00000000302 1.05 0.0291 2.07
Tbc1d15 TBC1 domain family, member 15 ENSRNOG00000003889 1.05 0.0178 2.07
Sox18 SRY (sex determining region Y)-box 18 ENSRNOG00000016248 1.05 0.0096 2.07
Gfpt2 glutamine-fructose-6-phosphate transaminase 2 ENSRNOG00000002810 1.04 0.0342 2.06
Glis3 GLIS family zinc finger 3 ENSRNOG00000014768 1.04 0.0286 2.06
Rnf139 ring finger protein 139 ENSRNOG00000008987 1.04 0.0066 2.06
LOC688922 similar to Insulin-induced gene 1 protein (INSIG-1) ENSRNOG00000027445 1.04 0.0352 2.06
Mecom MDS1 and EVI1 complex locus ENSRNOG00000012645 1.03 0.0213 2.04
Zfp143 zinc finger protein 143 ENSRNOG00000010087 1.03 0.0252 2.04
Chn2 chimerin 2 ENSRNOG00000009411 1.03 0.0415 2.04
Adm adrenomedullin ENSRNOG00000027030 1.03 0.0184 2.04
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Chka choline kinase alpha ENSRNOG00000016791 1.03 0.0261 2.04
Hey1 hes-related family bHLH transcription factor with YRPW motif 1 ENSRNOG00000011593 1.02 0.0051 2.03
Ubc ubiquitin C ENSRNOG00000028756 1.02 0.0127 2.03
Olr1 oxidized low density lipoprotein (lectin-like) receptor 1 ENSRNOG00000008375 1.01 0.0172 2.02
Bcl2l11 BCL2-like 11 (apoptosis facilitator) ENSRNOG00000016551 1.01 0.0039 2.02
Klhl18 kelch-like family member 18 ENSRNOG00000020880 1.01 0.0238 2.02
Arl4a ADP-ribosylation factor-like 4A ENSRNOG00000004282 1.01 0.0101 2.02
Utp15 UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) ENSRNOG00000016591 1.01 0.0128 2.01
Zbtb10 zinc finger and BTB domain containing 10 ENSRNOG00000011319 1.01 0.0077 2.01
Slc2a3 solute carrier family 2 (facilitated glucose transporter), member 3 ENSRNOG00000008376 1.01 0.0179 2.01
Cd63 Cd63 molecule ENSRNOG00000007650 1.01 0.0149 2.01
Fam219a family with sequence similarity 219, member A ENSRNOG00000039559 1.00 0.0082 2.00
Taf1d TATA box binding protein (Tbp)-associated factor, RNA polymerase I, D ENSRNOG00000010921 1.00 0.0163 2.00
Tex10 testis expressed 10 ENSRNOG00000008618 1.00 0.0489 2.00
Sorbs1 sorbin and SH3 domain containing 1 ENSRNOG00000015658 1.00 0.0162 2.00
Acsl4 acyl-CoA synthetase long-chain family member 4 ENSRNOG00000019180 1.00 0.0209 2.00
H6pd hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) ENSRNOG00000017523 1.00 0.0251 2.00
Wdr62 WD repeat domain 62 ENSRNOG00000020807 0.99 0.0253 1.99
Fbxo32 F-box protein 32 ENSRNOG00000006738 0.99 0.0120 1.99
Angpt2 angiopoietin 2 ENSRNOG00000016696 0.99 0.0292 1.99
Fnip2 folliculin interacting protein 2 ENSRNOG00000027833 0.99 0.0172 1.99
Dsg4 desmoglein 4 ENSRNOG00000022364 0.99 0.0481 1.99
Rbp7 retinol binding protein 7, cellular ENSRNOG00000015850 0.99 0.0114 1.98
RGD1564428 similar to FLJ32921 protein ENSRNOG00000018721 0.99 0.0088 1.98
Utp18 UTP18 small subunit (SSU) processome component homolog (yeast) ENSRNOG00000002644 0.99 0.0072 1.98
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ckap4 cytoskeleton-associated protein 4 ENSRNOG00000008016 0.99 0.0178 1.98
Cp ceruloplasmin (ferroxidase) ENSRNOG00000011913 0.99 0.0337 1.98
Il4r interleukin 4 receptor ENSRNOG00000015441 0.98 0.0225 1.98
Chrnb3 cholinergic receptor, nicotinic, beta 3 (neuronal) ENSRNOG00000012448 0.98 0.0071 1.98
H3f3b H3 histone, family 3B ENSRNOG00000006532 0.98 0.0083 1.98
Arhgap10 Rho GTPase activating protein 10 ENSRNOG00000013152 0.98 0.0233 1.98
Ubxn8 UBX domain protein 8 ENSRNOG00000015109 0.98 0.0233 1.97
Actr1b ARP1 actin-related protein 1 homolog B, centractin beta (yeast) ENSRNOG00000016789 0.98 0.0477 1.97
Mall mal, T-cell differentiation protein-like ENSRNOG00000015599 0.98 0.0150 1.97
Mmp14 matrix metallopeptidase 14 (membrane-inserted) ENSRNOG00000010947 0.97 0.0360 1.96
Cir1 corepressor interacting with RBPJ, 1 ENSRNOG00000018719 0.97 0.0151 1.96
Ccl2 chemokine (C-C motif) ligand 2 ENSRNOG00000007159 0.97 0.0279 1.96
Psmd11 proteasome (prosome, macropain) 26S subunit, non-ATPase, 11 ENSRNOG00000005538 0.97 0.0187 1.96
Fv1 Friend virus susceptibility 1 ENSRNOG00000019132 0.97 0.0054 1.95
Slc7a5 solute carrier family 7 (amino acid transporter light chain, L system), member 5 ENSRNOG00000018824 0.96 0.0465 1.95
Pcnx pecanex homolog (Drosophila) ENSRNOG00000007459 0.96 0.0068 1.94
Klf4 Kruppel-like factor 4 (gut) ENSRNOG00000016299 0.95 0.0178 1.94
S100a9 S100 calcium binding protein A9 ENSRNOG00000011483 0.95 0.0238 1.93
Lgmn legumain ENSRNOG00000007089 0.94 0.0297 1.92
Whamm WAS protein homolog associated with actin, golgi membranes and microtubules ENSRNOG00000028113 0.94 0.0179 1.92
Rad18 RAD18 homolog (S. cerevisiae) ENSRNOG00000005907 0.94 0.0322 1.91
Adrm1 adhesion regulating molecule 1 ENSRNOG00000006991 0.94 0.0142 1.91
Psmc4 proteasome (prosome, macropain) 26S subunit, ATPase, 4 ENSRNOG00000018994 0.93 0.0230 1.91
Pnrc1 proline-rich nuclear receptor coactivator 1 ENSRNOG00000007793 0.93 0.0066 1.91
Arhgap28 Rho GTPase activating protein 28 ENSRNOG00000017065 0.93 0.0118 1.91
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Litaf lipopolysaccharide-induced TNF factor ENSRNOG00000002520 0.93 0.0445 1.91
Dll4 delta-like 4 (Drosophila) ENSRNOG00000014011 0.93 0.0067 1.91
Zfp36l2 zinc finger protein 36, C3H1 type-like 2-like ENSRNOG00000005067 0.93 0.0159 1.91
Creb3 cAMP responsive element binding protein 3 ENSRNOG00000016452 0.93 0.0374 1.90
Riok3 RIO kinase 3 ENSRNOG00000023376 0.93 0.0084 1.90
Fam134b family with sequence similarity 134, member B ENSRNOG00000010589 0.93 0.0142 1.90
Kctd9 potassium channel tetramerization domain containing 9 ENSRNOG00000012951 0.92 0.0233 1.90
Creg1 cellular repressor of E1A-stimulated genes 1 ENSRNOG00000003291 0.92 0.0450 1.90
Ftl1 ferritin light chain 1 ENSRNOG00000020843 0.92 0.0072 1.89
Dido1 death inducer-obliterator 1 ENSRNOG00000009936 0.91 0.0215 1.88
Tsnaxip1 translin-associated factor X interacting protein 1 ENSRNOG00000018954 0.91 0.0294 1.88
Osbpl8 oxysterol binding protein-like 8 ENSRNOG00000026962 0.91 0.0338 1.87
Usp53 ubiquitin specific peptidase 53 ENSRNOG00000014660 0.90 0.0085 1.87
Smad7 SMAD family member 7 ENSRNOG00000018359 0.90 0.0394 1.87
Phip pleckstrin homology domain interacting protein ENSRNOG00000008652 0.90 0.0073 1.87
Pnpla2 patatin-like phospholipase domain containing 2 ENSRNOG00000018736 0.90 0.0133 1.87
Lrrc8c leucine rich repeat containing 8 family, member C ENSRNOG00000002122 0.90 0.0142 1.86
Agfg2 ArfGAP with FG repeats 2 ENSRNOG00000001404 0.90 0.0290 1.86
Rgs3 regulator of G-protein signaling 3 ENSRNOG00000024501 0.90 0.0132 1.86
Lrrc30 leucine rich repeat containing 30 ENSRNOG00000030389 0.89 0.0181 1.86
Srgap1 SLIT-ROBO Rho GTPase activating protein 1 ENSRNOG00000004603 0.89 0.0179 1.86
Adarb1 adenosine deaminase, RNA-specific, B1 ENSRNOG00000001227 0.89 0.0286 1.86
Ccnl1 cyclin L1 ENSRNOG00000011586 0.89 0.0292 1.86
Tbc1d17 TBC1 domain family, member 17 ENSRNOG00000020191 0.89 0.0271 1.86
Mustn1 musculoskeletal, embryonic nuclear protein 1 ENSRNOG00000017369 0.89 0.0275 1.86
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Nedd9 neural precursor cell expressed, developmentally down-regulated 9 ENSRNOG00000014548 0.89 0.0209 1.85
Utp11l UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast) ENSRNOG00000007174 0.89 0.0485 1.85
Bid BH3 interacting domain death agonist ENSRNOG00000012439 0.88 0.0238 1.85
Hoga1 4-hydroxy-2-oxoglutarate aldolase 1 ENSRNOG00000029501 0.88 0.0212 1.85
Klf10 Kruppel-like factor 10 ENSRNOG00000006118 0.88 0.0197 1.84
Ift57 intraflagellar transport 57 ENSRNOG00000001958 0.88 0.0329 1.84
Pcsk5 proprotein convertase subtilisin/kexin type 5 ENSRNOG00000012036 0.88 0.0209 1.84
Clec12b C-type lectin domain family 12, member B ENSRNOG00000037070 0.87 0.0367 1.83
Ginm1 glycoprotein integral membrane 1 ENSRNOG00000015239 0.87 0.0102 1.83
Lin54 lin-54 DREAM MuvB core complex component ENSRNOG00000002203 0.87 0.0149 1.83
Pmm1 phosphomannomutase 1 ENSRNOG00000005358 0.87 0.0414 1.83
RGD1566239 similar to RIKEN cDNA 2810428I15 ENSRNOG00000019990 0.87 0.0090 1.82
Zdhhc18 zinc finger, DHHC-type containing 18 ENSRNOG00000007021 0.87 0.0475 1.82
Cmip c-Maf-inducing protein ENSRNOG00000013178 0.86 0.0224 1.82
Gcnt2 glucosaminyl (N-acetyl) transferase 2, I-branching enzyme ENSRNOG00000023778 0.86 0.0101 1.82
Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha ENSRNOG00000007390 0.86 0.0146 1.82
Dnajb9 DnaJ (Hsp40) homolog, subfamily B, member 9 ENSRNOG00000004006 0.86 0.0085 1.82
Pim3 Pim-3 proto-oncogene, serine/threonine kinase ENSRNOG00000029698 0.86 0.0253 1.82
Ftl1l1 ferritin light chain 1-like 1 ENSRNOG00000034150 0.86 0.0113 1.82
Nob1 NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) ENSRNOG00000021890 0.86 0.0100 1.81
Pdlim3 PDZ and LIM domain 3 ENSRNOG00000012658 0.85 0.0398 1.81
Cyp4f4 cytochrome P450, family 4, subfamily f, polypeptide 4 ENSRNOG00000032895 0.85 0.0197 1.80
Zc3h12a zinc finger CCCH type containing 12A ENSRNOG00000009131 0.85 0.0130 1.80
LOC102548013 uncharacterized LOC102548013 ENSRNOG00000023089 0.85 0.0122 1.80
Furin furin (paired basic amino acid cleaving enzyme) ENSRNOG00000011352 0.85 0.0151 1.80
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Spryd7 SPRY domain containing 7 ENSRNOG00000015095 0.84 0.0125 1.79
Mtss1 metastasis suppressor 1 ENSRNOG00000009001 0.84 0.0473 1.79
Gtpbp4 GTP binding protein 4 ENSRNOG00000016217 0.84 0.0133 1.79
Eif1 eukaryotic translation initiation factor 1 ENSRNOG00000033765 0.84 0.0238 1.79
Pappa pregnancy-associated plasma protein A ENSRNOG00000033527 0.83 0.0246 1.78
Nrarp Notch-regulated ankyrin repeat protein ENSRNOG00000009354 0.83 0.0092 1.78
Kpna1 karyopherin alpha 1 ENSRNOG00000000399 0.83 0.0432 1.78
Gpr4 G protein-coupled receptor 4 ENSRNOG00000016362 0.83 0.0494 1.78
Fam102b family with sequence similarity 102, member B ENSRNOG00000027540 0.83 0.0323 1.78
LOC499746 similar to hypothetical gene supported by AK097565; BC033939 ENSRNOG00000010002 0.83 0.0178 1.78
Npap60 nuclear pore associated protein ENSRNOG00000013423 0.83 0.0342 1.77
Ftl1 ferritin light chain 1-like ENSRNOG00000031506 0.82 0.0107 1.77
Efna1 ephrin A1 ENSRNOG00000020573 0.82 0.0433 1.77
Tgfbi transforming growth factor, beta induced ENSRNOG00000012216 0.82 0.0227 1.76
Terf2ip telomeric repeat binding factor 2, interacting protein ENSRNOG00000010712 0.82 0.0459 1.76
Rufy1 RUN and FYVE domain containing 1 ENSRNOG00000003536 0.82 0.0209 1.76
Maff v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog F ENSRNOG00000012886 0.81 0.0415 1.76
Psmc6 proteasome (prosome, macropain) 26S subunit, ATPase, 6 ENSRNOG00000007203 0.81 0.0207 1.76
Igf1r insulin-like growth factor 1 receptor ENSRNOG00000014187 0.81 0.0135 1.76
Osbpl11 oxysterol binding protein-like 11 ENSRNOG00000001782 0.81 0.0467 1.76
Wsb1 WD repeat and SOCS box-containing 1 ENSRNOG00000012929 0.81 0.0223 1.75
Fhl2 four and a half LIM domains 2 ENSRNOG00000016866 0.81 0.0276 1.75
LOC691033 similar to GTPase activating protein testicular GAP1 ENSRNOG00000042535 0.80 0.0397 1.75
Pim1 Pim-1 proto-oncogene, serine/threonine kinase ENSRNOG00000000529 0.80 0.0405 1.75
Ptprb protein tyrosine phosphatase, receptor type, B ENSRNOG00000004840 0.80 0.0147 1.74
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Nubpl nucleotide binding protein-like ENSRNOG00000027444 0.80 0.0280 1.74
Slc25a2 solute carrier family 25 (mitochondrial carrier, ornithine transporter) member 2 ENSRNOG00000027359 0.80 0.0238 1.74
Ifngr1 interferon gamma receptor 1 ENSRNOG00000012074 0.80 0.0144 1.74
Capn8 calpain 8 ENSRNOG00000003468 0.80 0.0264 1.74
Myd88 myeloid differentiation primary response 88 ENSRNOG00000013634 0.80 0.0363 1.74
Notch4 notch 4 ENSRNOG00000000442 0.80 0.0100 1.74
LOC100363177 ferritin light chain 1-like ENSRNOG00000039298 0.80 0.0155 1.74
Psmc1 proteasome (prosome, macropain) 26S subunit, ATPase, 1 ENSRNOG00000003951 0.80 0.0273 1.74
Mmp8 matrix metallopeptidase 8 ENSRNOG00000009907 0.79 0.0102 1.73
Haus6 HAUS augmin-like complex, subunit 6 ENSRNOG00000024854 0.79 0.0352 1.73
Itga5 integrin, alpha 5 (fibronectin receptor, alpha polypeptide) ENSRNOG00000036832 0.79 0.0301 1.73
Ftsj3 FtsJ homolog 3 (E. coli) ENSRNOG00000009857 0.79 0.0211 1.73
Slc28a2 solute carrier family 28 (concentrative nucleoside transporter), member 2 ENSRNOG00000028668 0.79 0.0216 1.73
Naa25 N(alpha)-acetyltransferase 25, NatB auxiliary subunit ENSRNOG00000001350 0.79 0.0170 1.73
Slc2a1 solute carrier family 2 (facilitated glucose transporter), member 1 ENSRNOG00000007284 0.79 0.0102 1.72
Srfbp1 serum response factor binding protein 1 ENSRNOG00000014808 0.79 0.0175 1.72
Rbm20 RNA binding motif protein 20 ENSRNOG00000014705 0.78 0.0202 1.72
Tpsab1 tryptase alpha/beta 1 ENSRNOG00000024181 0.78 0.0446 1.72
Pi4k2b phosphatidylinositol 4-kinase type 2 beta ENSRNOG00000003924 0.78 0.0342 1.72
Vom2r11 vomeronasal 2 receptor, 11 ENSRNOG00000033775 0.78 0.0353 1.71
Ubxn4 UBX domain protein 4 ENSRNOG00000003625 0.78 0.0323 1.71
Wdr43 WD repeat domain 43 ENSRNOG00000026316 0.78 0.0105 1.71
Ankhd1 ankyrin repeat and KH domain containing 1 ENSRNOG00000030247 0.78 0.0173 1.71
Lztfl1 leucine zipper transcription factor-like 1 ENSRNOG00000006244 0.77 0.0179 1.71
Csrp2 cysteine and glycine-rich protein 2 ENSRNOG00000003772 0.77 0.0294 1.71
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ppp4r1 protein phosphatase 4, regulatory subunit 1 ENSRNOG00000013733 0.77 0.0278 1.71
Tbc1d30 TBC1 domain family, member 30 ENSRNOG00000023951 0.77 0.0284 1.71
Kctd20 potassium channel tetramerization domain containing 20 ENSRNOG00000000517 0.77 0.0398 1.71
Dmbt1 deleted in malignant brain tumors 1 ENSRNOG00000020560 0.77 0.0350 1.70
Pak1ip1 PAK1 interacting protein 1 ENSRNOG00000023799 0.77 0.0142 1.70
Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif, 1 ENSRNOG00000001607 0.76 0.0172 1.70
Efcab2 EF-hand calcium binding domain 2 ENSRNOG00000042201 0.76 0.0155 1.70
Kcne4 potassium voltage-gated channel subfamily E member 4 ENSRNOG00000015039 0.76 0.0479 1.70
Uap1 UDP-N-acteylglucosamine pyrophosphorylase 1 ENSRNOG00000002926 0.76 0.0286 1.69
Dnttip1 deoxynucleotidyltransferase, terminal, interacting protein 1 ENSRNOG00000014933 0.76 0.0225 1.69
RGD1562608 similar to KIAA1328 protein ENSRNOG00000029466 0.76 0.0180 1.69
Fmo2 flavin containing monooxygenase 2 ENSRNOG00000003510 0.76 0.0273 1.69
Lmbr1l limb region 1 like ENSRNOG00000033667 0.75 0.0249 1.69
Clec2e C-type lectin domain family 2, member E ENSRNOG00000037073 0.75 0.0209 1.68
Fbxo30 F-box protein 30 ENSRNOG00000014852 0.75 0.0109 1.68
Dhx37 DEAH (Asp-Glu-Ala-His) box polypeptide 37 ENSRNOG00000022171 0.75 0.0315 1.68
Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 ENSRNOG00000025946 0.75 0.0342 1.68
Crebrf CREB3 regulatory factor ENSRNOG00000020769 0.75 0.0463 1.68
Mybbp1a MYB binding protein (P160) 1a ENSRNOG00000015236 0.75 0.0101 1.68
Dot1l DOT1-like histone H3K79 methyltransferase ENSRNOG00000032546 0.75 0.0139 1.68
Nufip1 nuclear fragile X mental retardation protein interacting protein 1 ENSRNOG00000001033 0.75 0.0163 1.68
Eps8 epidermal growth factor receptor pathway substrate 8 ENSRNOG00000007047 0.74 0.0405 1.67
Id3 inhibitor of DNA binding 3 ENSRNOG00000026124 0.74 0.0169 1.67
Tfdp2 transcription factor Dp-2 (E2F dimerization partner 2) ENSRNOG00000011241 0.74 0.0219 1.67
Rnasel ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent) ENSRNOG00000027017 0.74 0.0101 1.67
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Nfx1 nuclear transcription factor, X-box binding 1 ENSRNOG00000009015 0.74 0.0264 1.67
Tcerg1 transcription elongation regulator 1 ENSRNOG00000018849 0.74 0.0155 1.67
Acaca acetyl-CoA carboxylase alpha ENSRNOG00000034013 0.74 0.0417 1.67
Kdm3a lysine (K)-specific demethylase 3A ENSRNOG00000007814 0.74 0.0118 1.67
Nbr1 similar to neighbor of Brca1 gene 1 ENSRNOG00000020730 0.74 0.0497 1.67
Art3 ADP-ribosyltransferase 3 ENSRNOG00000002256 0.74 0.0284 1.67
Ddrgk1 DDRGK domain containing 1 ENSRNOG00000021232 0.73 0.0101 1.66
Exosc8 exosome component 8 ENSRNOG00000013434 0.73 0.0173 1.66
RGD1565498 similar to Hypothetical protein LOC270802 ENSRNOG00000028782 0.73 0.0153 1.66
Ccdc109b coiled-coil domain containing 109B ENSRNOG00000009433 0.73 0.0445 1.66
Zfand5 zinc finger, AN1-type domain 5 ENSRNOG00000018107 0.73 0.0139 1.66
Ranbp10 RAN binding protein 10 ENSRNOG00000018000 0.73 0.0113 1.66
Lrp2bp Lrp2 binding protein ENSRNOG00000011178 0.73 0.0194 1.65
Gata6 GATA binding protein 6 ENSRNOG00000023433 0.73 0.0286 1.65
S1pr1 sphingosine-1-phosphate receptor 1 ENSRNOG00000013683 0.73 0.0184 1.65
Nploc4 nuclear protein localization 4 homolog (S. cerevisiae) ENSRNOG00000036698 0.72 0.0225 1.65
Gmeb2 glucocorticoid modulatory element binding protein 2 ENSRNOG00000013339 0.72 0.0215 1.65
Sap30 Sin3A-associated protein ENSRNOG00000013218 0.72 0.0182 1.65
Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta ENSRNOG00000031163 0.72 0.0273 1.65
Pabpc1 poly(A) binding protein, cytoplasmic 1 ENSRNOG00000008639 0.72 0.0325 1.65
Tenc1 tensin like C1 domain containing phosphatase (tensin 2) ENSRNOG00000010588 0.72 0.0123 1.64
Aup1 ancient ubiquitous protein 1 ENSRNOG00000007842 0.72 0.0123 1.64
Klf11 Kruppel-like factor 11 ENSRNOG00000000216 0.71 0.0234 1.64
Cited2 Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 ENSRNOG00000012193 0.71 0.0365 1.64
Anp32b acidic (leucine-rich) nuclear phosphoprotein 32 family, member B ENSRNOG00000009266 0.71 0.0134 1.64
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Fam91a1 family with sequence similarity 91, member A1 ENSRNOG00000008271 0.71 0.0471 1.64
Tspan14 tetraspanin 14 ENSRNOG00000010813 0.71 0.0485 1.64
Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b ENSRNOG00000016575 0.71 0.0271 1.63
Fcho2 FCH domain only 2 ENSRNOG00000015334 0.71 0.0177 1.63
Adcyap1r1 adenylate cyclase activating polypeptide 1 receptor 1 ENSRNOG00000012098 0.71 0.0315 1.63
Psmd3 proteasome (prosome, macropain) 26S subunit, non-ATPase, 3 ENSRNOG00000028103 0.71 0.0243 1.63
Medag mesenteric estrogen-dependent adipogenesis ENSRNOG00000000906 0.71 0.0473 1.63
Atl3 atlastin GTPase 3 ENSRNOG00000021203 0.70 0.0296 1.63
Sema3g sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G ENSRNOG00000018952 0.70 0.0195 1.63
LOC691960 similar to solute carrier family 28, member 2 ENSRNOG00000018204 0.70 0.0178 1.63
Tmem179 transmembrane protein 179 ENSRNOG00000013128 0.70 0.0191 1.63
Tsr1 TSR1, 20S rRNA accumulation, homolog (S. cerevisiae) ENSRNOG00000002980 0.70 0.0285 1.62
Rlf rearranged L-myc fusion ENSRNOG00000027921 0.70 0.0200 1.62
Gnai3 guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 ENSRNOG00000019465 0.70 0.0398 1.62
Dgkh diacylglycerol kinase, eta ENSRNOG00000010065 0.70 0.0146 1.62
Amotl2 angiomotin like 2 ENSRNOG00000008487 0.70 0.0134 1.62
Pcf11 PCF11 cleavage and polyadenylation factor subunit ENSRNOG00000009891 0.69 0.0165 1.62
Timp3 TIMP metallopeptidase inhibitor 3 ENSRNOG00000004303 0.69 0.0450 1.61
Fry furry homolog (Drosophila) ENSRNOG00000000894 0.69 0.0178 1.61
Avpi1 arginine vasopressin-induced 1 ENSRNOG00000014828 0.69 0.0276 1.61
Esam endothelial cell adhesion molecule ENSRNOG00000033217 0.69 0.0125 1.61
Plxna2 plexin A2 ENSRNOG00000007324 0.69 0.0155 1.61
RGD1311458 similar to cDNA sequence BC027231; hypothetical protein MGC27931 ENSRNOG00000013721 0.69 0.0142 1.61
Rybp RING1 and YY1 binding protein ENSRNOG00000005353 0.69 0.0185 1.61
Ctsd cathepsin D ENSRNOG00000020206 0.68 0.0197 1.61
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Psmd13 proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 ENSRNOG00000014109 0.68 0.0360 1.60
Tpbg trophoblast glycoprotein ENSRNOG00000010694 0.68 0.0435 1.60
Txnl1 thioredoxin-like 1 ENSRNOG00000018818 0.68 0.0352 1.60
Brpf3 bromodomain and PHD finger containing, 3 ENSRNOG00000028641 0.68 0.0329 1.60
Cnppd1 cyclin Pas1/PHO80 domain containing 1 ENSRNOG00000018325 0.68 0.0125 1.60
Map3k2 mitogen activated protein kinase kinase kinase 2 ENSRNOG00000014089 0.68 0.0197 1.60
Nucb2 nucleobindin 2 ENSRNOG00000020456 0.67 0.0471 1.60
Lrrcc1 leucine rich repeat and coiled-coil centrosomal protein 1 ENSRNOG00000010891 0.67 0.0324 1.60
Tmem214 transmembrane protein 214 ENSRNOG00000008812 0.67 0.0281 1.60
Palmd palmdelphin ENSRNOG00000016508 0.67 0.0373 1.59
Grina glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding) ENSRNOG00000029941 0.67 0.0184 1.59
Ing3 inhibitor of growth family, member 3 ENSRNOG00000005496 0.67 0.0320 1.59
Naca nascent polypeptide-associated complex alpha subunit ENSRNOG00000002632 0.67 0.0441 1.59
Vwa1 von Willebrand factor A domain containing 1 ENSRNOG00000018338 0.67 0.0327 1.59
Psma4 proteasome (prosome, macropain) subunit, alpha type 4 ENSRNOG00000013493 0.67 0.0293 1.59
Tra2b transformer 2 beta homolog (Drosophila) ENSRNOG00000001783 0.67 0.0273 1.59
Zswim4 zinc finger, SWIM-type containing 4 ENSRNOG00000007582 0.67 0.0375 1.59
Zfp110 zinc finger protein 110 ENSRNOG00000031328 0.67 0.0151 1.59
Med13l mediator complex subunit 13-like ENSRNOG00000001120 0.67 0.0350 1.59
Cnksr1 connector enhancer of kinase suppressor of Ras 1 ENSRNOG00000022838 0.67 0.0217 1.59
Med15 mediator complex subunit 15 ENSRNOG00000001877 0.67 0.0357 1.59
Myb myeloblastosis oncogene ENSRNOG00000014313 0.67 0.0360 1.59
Tmem171 transmembrane protein 171 ENSRNOG00000015449 0.66 0.0209 1.59
Lin37 lin-37 DREAM MuvB core complex component ENSRNOG00000020929 0.66 0.0433 1.59
Psmd2 proteasome (prosome, macropain) 26S subunit, non-ATPase, 2 ENSRNOG00000001719 0.66 0.0142 1.58
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Brms1 breast cancer metastasis-suppressor 1 homolog ENSRNOG00000020117 0.66 0.0372 1.58
Pgf placental growth factor ENSRNOG00000005650 0.66 0.0213 1.58
Tor1aip1 torsin A interacting protein 1 ENSRNOG00000003946 0.66 0.0177 1.58
Mast4 microtubule associated serine/threonine kinase family member 4 ENSRNOG00000010720 0.66 0.0209 1.58
Hectd1 HECT domain containing E3 ubiquitin protein ligase 1 ENSRNOG00000006905 0.66 0.0412 1.58
Hsf4 heat shock transcription factor 4 ENSRNOG00000015253 0.66 0.0238 1.58
Smad6 SMAD family member 6 ENSRNOG00000009173 0.66 0.0295 1.58
Zfp598 zinc finger protein 598 ENSRNOG00000012434 0.66 0.0160 1.58
Rad54b RAD54 homolog B (S. cerevisiae) ENSRNOG00000039949 0.66 0.0462 1.58
Atf6 activating transcription factor 6 ENSRNOG00000024632 0.66 0.0495 1.58
Pdgfrb platelet derived growth factor receptor, beta polypeptide ENSRNOG00000018461 0.66 0.0284 1.58
Lonrf3 LON peptidase N-terminal domain and ring finger 3 ENSRNOG00000013092 0.66 0.0376 1.58
Trmt6 tRNA methyltransferase 6 homolog (S. cerevisiae) ENSRNOG00000021270 0.66 0.0435 1.57
Ddx21 DEAD (Asp-Glu-Ala-Asp) box helicase 21 ENSRNOG00000043099 0.65 0.0265 1.57
Peak1 pseudopodium-enriched atypical kinase 1 ENSRNOG00000042519 0.65 0.0375 1.57
Egln3 egl-9 family hypoxia-inducible factor 3 ENSRNOG00000005053 0.65 0.0227 1.57
Rlim ring finger protein, LIM domain interacting ENSRNOG00000002824 0.65 0.0249 1.57
Lrrc32 leucine rich repeat containing 32 ENSRNOG00000015310 0.65 0.0433 1.57
Arhgap26 Rho GTPase activating protein 26 ENSRNOG00000013920 0.65 0.0166 1.57
Zrsr1 zinc finger (CCCH type), RNA binding motif and serine/arginine rich 1 ENSRNOG00000009639 0.65 0.0405 1.57
Cul4b cullin 4B ENSRNOG00000002585 0.65 0.0159 1.57
Atr ATR serine/threonine kinase ENSRNOG00000010027 0.65 0.0390 1.57
Il6st interleukin 6 signal transducer ENSRNOG00000013963 0.65 0.0273 1.57
Slc7a6os solute carrier family 7, member 6 opposite strand ENSRNOG00000020049 0.65 0.0343 1.57
Zfp868 zinc finger protein 868 ENSRNOG00000028919 0.65 0.0244 1.57
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ddx27 DEAD (Asp-Glu-Ala-Asp) box polypeptide 27 ENSRNOG00000008081 0.65 0.0160 1.57
Anapc7 anaphase promoting complex subunit 7 ENSRNOG00000001283 0.65 0.0369 1.56
Txnip thioredoxin interacting protein ENSRNOG00000021201 0.65 0.0489 1.56
Rbm28 RNA binding motif protein 28 ENSRNOG00000005468 0.64 0.0209 1.56
Slc20a2 solute carrier family 20 (phosphate transporter), member 2 ENSRNOG00000019490 0.64 0.0462 1.56
Rad17 RAD17 homolog (S. pombe) ENSRNOG00000018353 0.64 0.0215 1.56
Sec14l1 SEC14-like 1 (S. cerevisiae) ENSRNOG00000002722 0.64 0.0360 1.56
Cxcl11 chemokine (C-X-C motif) ligand 11 ENSRNOG00000022298 0.64 0.0441 1.56
Strc stereocilin ENSRNOG00000014845 0.64 0.0230 1.56
F2rl1 coagulation factor II (thrombin) receptor-like 1 ENSRNOG00000018003 0.64 0.0155 1.56
Psma3 proteasome subunit alpha type-3-like ENSRNOG00000022652 0.64 0.0225 1.56
Lamp2 lysosomal-associated membrane protein 2 ENSRNOG00000000164 0.64 0.0310 1.56
Rpl24 ribosomal protein L24 ENSRNOG00000001611 0.64 0.0152 1.55
Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 ENSRNOG00000018770 0.64 0.0256 1.55
Nap1l1 nucleosome assembly protein 1-like 1 ENSRNOG00000003890 0.64 0.0209 1.55
Arhgap27 Rho GTPase activating protein 27 ENSRNOG00000028569 0.63 0.0353 1.55
Chrna1 cholinergic receptor, nicotinic, alpha 1 (muscle) ENSRNOG00000018286 0.63 0.0178 1.55
Sfr1 SWI5-dependent recombination repair 1 ENSRNOG00000012641 0.63 0.0338 1.55
Pacsin3 protein kinase C and casein kinase substrate in neurons 3 ENSRNOG00000014204 0.63 0.0442 1.55
Hes1 hes family bHLH transcription factor 1 ENSRNOG00000001720 0.63 0.0293 1.55
Ezh1 enhancer of zeste 1 polycomb repressive complex 2 subunit ENSRNOG00000020336 0.63 0.0296 1.55
Cpsf7 cleavage and polyadenylation specific factor 7 ENSRNOG00000020668 0.63 0.0360 1.55
Uaca uveal autoantigen with coiled-coil domains and ankyrin repeats ENSRNOG00000012868 0.62 0.0159 1.54
Phka2 phosphorylase kinase, alpha 2 ENSRNOG00000003949 0.62 0.0274 1.54
Pes1 pescadillo ribosomal biogenesis factor 1 ENSRNOG00000004515 0.62 0.0212 1.54
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Npm1 nucleophosmin (nucleolar phosphoprotein B23, numatrin) ENSRNOG00000004616 0.62 0.0405 1.54
Sec23b Sec23 homolog B (S. cerevisiae) ENSRNOG00000008411 0.62 0.0498 1.54
RGD1309350 5-hydroxyisourate hydrolase-like ENSRNOG00000012744 0.62 0.0184 1.54
Cdc42se1 CDC42 small effector 1 ENSRNOG00000021112 0.62 0.0342 1.54
Brd8 bromodomain containing 8 ENSRNOG00000020340 0.62 0.0344 1.54
Clcf1 cardiotrophin-like cytokine factor 1 ENSRNOG00000018752 0.62 0.0451 1.54
Efnb2 ephrin B2 ENSRNOG00000014648 0.62 0.0230 1.53
LOC685391 LRRGT00063 ENSRNOG00000043170 0.62 0.0477 1.53
Psmd1 proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 ENSRNOG00000017730 0.62 0.0337 1.53
Psmd12 proteasome (prosome, macropain) 26S subunit, non-ATPase, 12 ENSRNOG00000003117 0.62 0.0176 1.53
Taf1b TATA box binding protein (Tbp)-associated factor, RNA polymerase I, B ENSRNOG00000004506 0.61 0.0209 1.53
Snx10 sorting nexin 10 ENSRNOG00000011944 0.61 0.0500 1.53
Slc3a2 solute carrier family 3 (amino acid transporter heavy chain), member 2 ENSRNOG00000018487 0.61 0.0183 1.53
Dyrk1a dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A ENSRNOG00000001662 0.61 0.0463 1.53
Dnajc3 DnaJ (Hsp40) homolog, subfamily C, member 3 ENSRNOG00000010352 0.61 0.0371 1.53
Btaf1 BTAF1 RNA polymerase II, B-TFIID transcription factor-associated, 170kDa ENSRNOG00000017938 0.61 0.0216 1.53
Ncl nucleolin ENSRNOG00000018273 0.61 0.0184 1.53
Rhbdd2 rhomboid domain containing 2 ENSRNOG00000001443 0.61 0.0272 1.53
Hlx H2.0-like homeobox ENSRNOG00000002309 0.61 0.0241 1.53
Fbxo4 F-box protein 4 ENSRNOG00000015622 0.61 0.0296 1.53
Amn1 antagonist of mitotic exit network 1 homolog (S. cerevisiae) ENSRNOG00000036917 0.61 0.0208 1.53
Wfdc2 WAP four-disulfide core domain 2 ENSRNOG00000014739 0.61 0.0469 1.53
Gstp1 glutathione S-transferase pi 1 ENSRNOG00000018237 0.61 0.0367 1.52
Galc galactosylceramidase ENSRNOG00000003759 0.61 0.0269 1.52
Ptpn2 protein tyrosine phosphatase, non-receptor type 2 ENSRNOG00000017453 0.61 0.0265 1.52
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Kcnmb4 potassium large conductance calcium-activated channel, subfamily M, beta member 4 ENSRNOG00000022297 0.61 0.0300 1.52
Hip1r huntingtin interacting protein 1 related ENSRNOG00000001091 0.61 0.0239 1.52
Zfp259 zinc finger protein 259 ENSRNOG00000018481 0.61 0.0209 1.52
Mpdu1 mannose-P-dolichol utilization defect 1 ENSRNOG00000012162 0.61 0.0292 1.52
Lemd3 LEM domain containing 3 ENSRNOG00000024027 0.61 0.0322 1.52
Blm Bloom syndrome, RecQ helicase-like ENSRNOG00000011213 0.60 0.0186 1.52
Hnrnpf heterogeneous nuclear ribonucleoprotein F ENSRNOG00000014562 0.60 0.0307 1.52
Pqlc2 PQ loop repeat containing 2 ENSRNOG00000017706 0.60 0.0425 1.52
Psmd14 proteasome (prosome, macropain) 26S subunit, non-ATPase, 14 ENSRNOG00000004911 0.60 0.0479 1.52
Ppm1d protein phosphatase, Mg2+/Mn2+ dependent, 1D ENSRNOG00000003329 0.60 0.0202 1.52
Psma6 proteasome (prosome, macropain) subunit, alpha type 6 ENSRNOG00000007114 0.60 0.0253 1.52
Utp14a UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast) ENSRNOG00000005012 0.60 0.0274 1.52
Mecp2 methyl CpG binding protein 2 ENSRNOG00000037262 0.60 0.0307 1.52
Pms2 postmeiotic segregation increased 2 (S. cerevisiae) ENSRNOG00000001040 0.60 0.0363 1.51
Slc25a17 solute carrier family 25 (mitochondrial carrier, peroxisomal membrane protein), member 17 ENSRNOG00000018920 0.60 0.0197 1.51
Zfp496 zinc finger protein 496 ENSRNOG00000003129 0.60 0.0373 1.51
Hbp1 HMG-box transcription factor 1 ENSRNOG00000008927 0.60 0.0172 1.51
Cmtm8 CKLF-like MARVEL transmembrane domain containing 8 ENSRNOG00000011201 0.60 0.0342 1.51
Ewsr1 EWS RNA-binding protein 1 ENSRNOG00000009437 0.60 0.0380 1.51
RGD1306353 similar to Zinc finger protein 198 ENSRNOG00000029220 0.60 0.0393 1.51
Meis3 Meis homeobox 3 ENSRNOG00000021390 0.60 0.0272 1.51
Foxk1 forkhead box K1 ENSRNOG00000001104 0.59 0.0459 1.51
Pcgf5 polycomb group ring finger 5 ENSRNOG00000018532 0.59 0.0312 1.51
Eva1c eva-1 homolog C ENSRNOG00000002072 0.59 0.0341 1.51
Ppp1r13l protein phosphatase 1, regulatory subunit 13 like ENSRNOG00000025350 0.59 0.0374 1.51
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ktn1 kinectin 1 (kinesin receptor) ENSRNOG00000012255 0.59 0.0387 1.51
Slc25a38 solute carrier family 25, member 38 ENSRNOG00000018552 0.59 0.0360 1.51
Tbc1d9 TBC1 domain family, member 9 (with GRAM domain) ENSRNOG00000003496 0.59 0.0459 1.51
Usp16 ubiquitin specific peptidase 16 ENSRNOG00000001598 0.59 0.0401 1.51
Sqstm1 sequestosome 1 ENSRNOG00000003147 0.59 0.0296 1.51
Nr2c2 nuclear receptor subfamily 2, group C, member 2 ENSRNOG00000010536 0.59 0.0405 1.51
Psmb3 proteasome (prosome, macropain) subunit, beta type 3 ENSRNOG00000012938 0.59 0.0337 1.51
Bach2 BTB and CNC homology 1, basic leucine zipper transcription factor 2 ENSRNOG00000006170 0.59 0.0398 1.51
Zscan21 zinc finger and SCAN domain containing 21 ENSRNOG00000039234 0.59 0.0253 1.50
March7 membrane-associated ring finger (C3HC4) 7, E3 ubiquitin protein ligase ENSRNOG00000006241 0.59 0.0445 1.50
Cul1 cullin 1 ENSRNOG00000005310 0.59 0.0258 1.50
Stk11ip serine/threonine kinase 11 interacting protein ENSRNOG00000020107 0.59 0.0186 1.50
Mettl9 methyltransferase like 9-like ENSRNOG00000025940 0.59 0.0294 1.50
Lphn2 latrophilin 2 ENSRNOG00000032660 0.59 0.0459 1.50
Tspan2 tetraspanin 2 ENSRNOG00000023338 0.59 0.0323 1.50
Cers4 ceramide synthase 4 ENSRNOG00000001072 -0.59 0.0475 -1.50
Lama4 laminin, alpha 4 ENSRNOG00000000599 -0.59 0.0370 -1.50
Papln papilin, proteoglycan-like sulfated glycoprotein ENSRNOG00000009448 -0.59 0.0307 -1.50
Slc16a12 solute carrier family 16, member 12 ENSRNOG00000021916 -0.59 0.0494 -1.50
Ndufb6 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6 ENSRNOG00000024539 -0.59 0.0312 -1.50
Ift27 intraflagellar transport 27 ENSRNOG00000006440 -0.59 0.0477 -1.50
Pqlc1 PQ loop repeat containing 1 ENSRNOG00000017204 -0.59 0.0225 -1.50
Wdr7 WD repeat domain 7 ENSRNOG00000018387 -0.59 0.0450 -1.50
Hook3 hook microtubule-tethering protein 3 ENSRNOG00000014275 -0.59 0.0391 -1.51
Tspan9 tetraspanin 9 ENSRNOG00000005442 -0.59 0.0255 -1.51
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Extl2 exostosin-like glycosyltransferase 2 ENSRNOG00000014323 -0.59 0.0294 -1.51
Giot1 gonadotropin inducible ovarian transcription factor 1 ENSRNOG00000008417 -0.59 0.0405 -1.51
Ndufs5 rCG31129-like ENSRNOG00000026646 -0.59 0.0251 -1.51
Pax7 paired box 7 ENSRNOG00000018739 -0.59 0.0198 -1.51
Atp5c1 ATP synthase, H+ transporting, mitochondrial F1 complex, gamma polypeptide 1 ENSRNOG00000019223 -0.59 0.0342 -1.51
Fgd1 FYVE, RhoGEF and PH domain containing 1 ENSRNOG00000038970 -0.59 0.0436 -1.51
Chst7 carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 7 ENSRNOG00000004258 -0.59 0.0363 -1.51
Zfp518b zinc finger protein 518B ENSRNOG00000028534 -0.59 0.0180 -1.51
Idh3g isocitrate dehydrogenase 3 (NAD), gamma ENSRNOG00000037284 -0.59 0.0473 -1.51
Sdhd succinate dehydrogenase complex, subunit D, integral membrane protein ENSRNOG00000022980 -0.59 0.0342 -1.51
Tulp4 tubby like protein 4 ENSRNOG00000018012 -0.60 0.0203 -1.51
Col22a1 collagen, type XXII, alpha 1 ENSRNOG00000024824 -0.60 0.0281 -1.51
Pcnxl4 pecanex-like 4 (Drosophila) ENSRNOG00000005568 -0.60 0.0390 -1.51
Gls2 glutaminase 2 (liver, mitochondrial) ENSRNOG00000031612 -0.60 0.0218 -1.51
Zfp13 zinc finger protein 13 ENSRNOG00000003455 -0.60 0.0420 -1.51
Fam69b family with sequence similarity 69, member B ENSRNOG00000004532 -0.60 0.0435 -1.51
Gemin7 gem (nuclear organelle) associated protein 7 ENSRNOG00000034168 -0.60 0.0301 -1.51
Zfp553 zinc finger protein 553 ENSRNOG00000017837 -0.60 0.0369 -1.51
Tceal8 transcription elongation factor A (SII)-like 8 ENSRNOG00000028585 -0.60 0.0471 -1.51
Ube2d1 ubiquitin-conjugating enzyme E2D 1 ENSRNOG00000000611 -0.60 0.0405 -1.51
Rimbp2 RIMS binding protein 2 ENSRNOG00000022893 -0.60 0.0203 -1.51
Grin3a glutamate receptor, ionotropic, N-methyl-D-aspartate 3A ENSRNOG00000005723 -0.60 0.0493 -1.51
Grcc10 gene rich cluster, C10 gene ENSRNOG00000025810 -0.60 0.0197 -1.52
Sh2b2 SH2B adaptor protein 2 ENSRNOG00000001425 -0.60 0.0360 -1.52
Adamts20 ADAM metallopeptidase with thrombospondin type 1 motif, 20 ENSRNOG00000033397 -0.60 0.0246 -1.52
Gene Symbol Description Ensembl ID fold change log2 p value fold change
LOC681458 similar to stearoyl-coenzyme A desaturase 3 ENSRNOG00000013279 -0.60 0.0486 -1.52
Fem1c fem-1 homolog c (C. elegans) ENSRNOG00000003578 -0.60 0.0342 -1.52
Isoc1 isochorismatase domain containing 1 ENSRNOG00000019711 -0.60 0.0352 -1.52
Srgap3 SLIT-ROBO Rho GTPase activating protein 3 ENSRNOG00000006509 -0.60 0.0271 -1.52
Lyrm2 LYR motif containing 2 ENSRNOG00000043105 -0.60 0.0407 -1.52
Lrig1 leucine-rich repeats and immunoglobulin-like domains 1 ENSRNOG00000012952 -0.60 0.0226 -1.52
Tex2 testis expressed 2 ENSRNOG00000013659 -0.60 0.0275 -1.52
Sema4d sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain ENSRNOG00000013679 -0.60 0.0212 -1.52
Mknk1 MAP kinase-interacting serine/threonine kinase 1 ENSRNOG00000010381 -0.60 0.0342 -1.52
Ndufa12 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 ENSRNOG00000007407 -0.60 0.0248 -1.52
Prex1 phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 ENSRNOG00000006952 -0.60 0.0304 -1.52
Patz1 POZ (BTB) and AT hook containing zinc finger 1 ENSRNOG00000018709 -0.61 0.0459 -1.52
C2cd2 C2 calcium-dependent domain containing 2 ENSRNOG00000001621 -0.61 0.0173 -1.52
Ndrg3 NDRG family member 3 ENSRNOG00000036813 -0.61 0.0293 -1.52
Atp6v0e2 ATPase, H+ transporting V0 subunit e2 ENSRNOG00000008218 -0.61 0.0367 -1.52
Mrpl16 mitochondrial ribosomal protein L16 ENSRNOG00000021005 -0.61 0.0459 -1.52
Fgf7 fibroblast growth factor 7 ENSRNOG00000009425 -0.61 0.0163 -1.52
Colgalt2 collagen beta(1-O)galactosyltransferase 2 ENSRNOG00000028207 -0.61 0.0346 -1.52
Sept8 septin 8 ENSRNOG00000007462 -0.61 0.0269 -1.53
Epb41l3 erythrocyte membrane protein band 4.1-like 3 ENSRNOG00000016724 -0.61 0.0164 -1.53
Mpp5 membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5) ENSRNOG00000008788 -0.61 0.0342 -1.53
Rpl3l ribosomal protein L3-like ENSRNOG00000014641 -0.61 0.0420 -1.53
Gbp2 guanylate binding protein 2, interferon-inducible ENSRNOG00000031743 -0.61 0.0212 -1.53
Scarf1 scavenger receptor class F, member 1 ENSRNOG00000037268 -0.61 0.0152 -1.53
Cpeb2 cytoplasmic polyadenylation element binding protein 2 ENSRNOG00000005043 -0.62 0.0277 -1.53
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Glrx5 glutaredoxin 5 ENSRNOG00000004206 -0.62 0.0254 -1.53
Hs6st2 heparan sulfate 6-O-sulfotransferase 2 ENSRNOG00000030880 -0.62 0.0276 -1.53
LOC691920 similar to kinesin-like motor protein C20orf23 ENSRNOG00000010050 -0.62 0.0356 -1.53
Ak2 adenylate kinase 2 ENSRNOG00000000122 -0.62 0.0363 -1.53
Map3k7cl MAP3K7 C-terminal like ENSRNOG00000001584 -0.62 0.0228 -1.53
Xrcc5 X-ray repair complementing defective repair in Chinese hamster cells 5 ENSRNOG00000016105 -0.62 0.0405 -1.53
Tlr3 toll-like receptor 3 ENSRNOG00000021726 -0.62 0.0303 -1.54
Cav3 caveolin 3 ENSRNOG00000005798 -0.62 0.0382 -1.54
Ndufa8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 ENSRNOG00000005668 -0.62 0.0371 -1.54
Dars2 aspartyl-tRNA synthetase 2 (mitochondrial) ENSRNOG00000002813 -0.62 0.0445 -1.54
Mpz myelin protein zero ENSRNOG00000003171 -0.62 0.0216 -1.54
Msh3 mutS homolog 3 ENSRNOG00000013673 -0.62 0.0341 -1.54
Naa38 N(alpha)-acetyltransferase 38, NatC auxiliary subunit ENSRNOG00000009823 -0.62 0.0175 -1.54
Gzf1 GDNF-inducible zinc finger protein 1 ENSRNOG00000004735 -0.62 0.0282 -1.54
Nmrk1 nicotinamide riboside kinase 1 ENSRNOG00000012665 -0.62 0.0236 -1.54
LOC690271 similar to mitochondrial ribosomal protein S11 ENSRNOG00000003080 -0.62 0.0314 -1.54
Sbk1 SH3 domain binding kinase 1 ENSRNOG00000019082 -0.62 0.0360 -1.54
Ecel1 endothelin converting enzyme-like 1 ENSRNOG00000019447 -0.63 0.0184 -1.54
Atp2b3 ATPase, Ca++ transporting, plasma membrane 3 ENSRNOG00000017798 -0.63 0.0445 -1.54
Smap2 small ArfGAP2 ENSRNOG00000011421 -0.63 0.0369 -1.54
Uqcrc1 ubiquinol-cytochrome c reductase core protein I ENSRNOG00000032134 -0.63 0.0244 -1.54
Dennd4b DENN/MADD domain containing 4B ENSRNOG00000022373 -0.63 0.0335 -1.54
Abcb7 ATP-binding cassette, subfamily B (MDR/TAP), member 7 ENSRNOG00000002790 -0.63 0.0479 -1.55
Ltbp3 latent transforming growth factor beta binding protein 3 ENSRNOG00000020813 -0.63 0.0370 -1.55
Jazf1 JAZF zinc finger 1 ENSRNOG00000027026 -0.63 0.0373 -1.55
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Fyb FYN binding protein ENSRNOG00000013886 -0.63 0.0327 -1.55
Pank1 pantothenate kinase 1 ENSRNOG00000018944 -0.63 0.0177 -1.55
Hmbs hydroxymethylbilane synthase ENSRNOG00000010390 -0.64 0.0414 -1.55
Ndufs5 NADH dehydrogenase (ubiquinone) Fe-S protein 5 ENSRNOG00000029339 -0.64 0.0184 -1.56
F1LUT6 Uncharacterized protein  ENSRNOG00000000014 -0.64 0.0186 -1.56
Stradb STE20-related kinase adaptor beta ENSRNOG00000010728 -0.64 0.0352 -1.56
LOC685888 hypothetical protein LOC685888 ENSRNOG00000028087 -0.64 0.0202 -1.56
Duxbl1 double homeobox B-like 1 ENSRNOG00000025408 -0.64 0.0165 -1.56
Mylk3 myosin light chain kinase 3 ENSRNOG00000017546 -0.64 0.0338 -1.56
Cpne7 copine VII ENSRNOG00000015397 -0.64 0.0477 -1.56
Mfn2 Mitofusin-2 ENSRNOG00000006904 -0.64 0.0421 -1.56
Smim19 small integral membrane protein 19 ENSRNOG00000024930 -0.64 0.0416 -1.56
Ifi47 interferon gamma inducible protein 47 ENSRNOG00000002470 -0.64 0.0342 -1.56
Lpp LIM domain containing preferred translocation partner in lipoma ENSRNOG00000031669 -0.64 0.0303 -1.56
Dusp22 dual specificity phosphatase 22 ENSRNOG00000018218 -0.64 0.0316 -1.56
Mapk10 mitogen activated protein kinase 10 ENSRNOG00000002079 -0.64 0.0473 -1.56
Prkaca protein kinase, cAMP-dependent, catalytic, alpha ENSRNOG00000005257 -0.64 0.0319 -1.56
Napepld N-acyl phosphatidylethanolamine phospholipase D ENSRNOG00000011363 -0.64 0.0316 -1.56
Hspd1 heat shock protein 1 (chaperonin) ENSRNOG00000014525 -0.64 0.0360 -1.56
Oxsm 3-oxoacyl-ACP synthase, mitochondrial ENSRNOG00000005993 -0.65 0.0285 -1.56
Fam20c family with sequence similarity 20, member C ENSRNOG00000001314 -0.65 0.0271 -1.57
Wdr37 WD repeat domain 37 ENSRNOG00000016834 -0.65 0.0190 -1.57
Slc22a17 solute carrier family 22, member 17 ENSRNOG00000016414 -0.65 0.0280 -1.57
Tmx2 thioredoxin-related transmembrane protein 2 ENSRNOG00000005308 -0.65 0.0291 -1.57
Ubqln4 ubiquilin 4 ENSRNOG00000019933 -0.65 0.0290 -1.57
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ankrd52 ankyrin repeat domain 52 ENSRNOG00000030597 -0.65 0.0323 -1.57
Tle2 transducin-like enhancer of split 2 ENSRNOG00000005874 -0.65 0.0303 -1.57
Ndn necdin, melanoma antigen (MAGE) family member ENSRNOG00000010146 -0.65 0.0236 -1.57
RGD1309540 similar to hypothetical protein MGC40841; similar to hypothetical protein MGC4707 ENSRNOG00000014798 -0.65 0.0391 -1.57
Gfra1 GDNF family receptor alpha 1 ENSRNOG00000017438 -0.66 0.0403 -1.57
Leprel2 leprecan-like 2 ENSRNOG00000016071 -0.66 0.0330 -1.58
Kcnb1 Uncharacterized protein ENSRNOG00000008204 -0.66 0.0324 -1.58
Efhc1 EF-hand domain (C-terminal) containing 1 ENSRNOG00000042729 -0.66 0.0418 -1.58
Ppat phosphoribosyl pyrophosphate amidotransferase ENSRNOG00000002128 -0.66 0.0273 -1.58
Nid2 nidogen 2 (osteonidogen) ENSRNOG00000000341 -0.66 0.0239 -1.58
Sms spermine synthase ENSRNOG00000007688 -0.66 0.0283 -1.58
Mfap3l microfibrillar-associated protein 3-like ENSRNOG00000011775 -0.66 0.0296 -1.58
Kcnj3 potassium inwardly-rectifying channel, subfamily J, member 3 ENSRNOG00000005369 -0.66 0.0159 -1.58
Pdgfa platelet-derived growth factor alpha polypeptide ENSRNOG00000001312 -0.66 0.0315 -1.58
Mtfp1 mitochondrial fission process 1 ENSRNOG00000004640 -0.66 0.0329 -1.58
Fundc1 FUN14 domain containing 1 ENSRNOG00000003470 -0.66 0.0298 -1.58
RGD1561277 RGD1561277 ENSRNOG00000023431 -0.66 0.0233 -1.58
Emc9 ER membrane protein complex subunit 9 ENSRNOG00000019162 -0.66 0.0479 -1.58
Dpep2 dipeptidase 2 ENSRNOG00000023303 -0.66 0.0486 -1.58
Acn9 ACN9 homolog (S. cerevisiae) ENSRNOG00000011283 -0.66 0.0320 -1.58
Bcl9 B-cell CLL/lymphoma 9 ENSRNOG00000017516 -0.66 0.0275 -1.58
Armc1 armadillo repeat containing 1 ENSRNOG00000013253 -0.66 0.0179 -1.58
Zfp870 zinc finger protein 870 ENSRNOG00000030416 -0.66 0.0185 -1.58
Trps1 trichorhinophalangeal syndrome I ENSRNOG00000024998 -0.66 0.0463 -1.58
Adam33 ADAM metallopeptidase domain 33 ENSRNOG00000021242 -0.66 0.0209 -1.58
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Gng7 guanine nucleotide binding protein (G protein), gamma 7 ENSRNOG00000019857 -0.66 0.0154 -1.58
Pla2g4e phospholipase A2, group IVE ENSRNOG00000024904 -0.66 0.0374 -1.58
Lrrc75a leucine rich repeat containing 75A ENSRNOG00000027286 -0.66 0.0218 -1.58
Agr2 anterior gradient 2 ENSRNOG00000005023 -0.66 0.0275 -1.58
Zfp692 zinc finger protein 692 ENSRNOG00000002682 -0.66 0.0209 -1.58
Guf1 GUF1 GTPase homolog (S. cerevisiae) ENSRNOG00000002207 -0.66 0.0346 -1.58
Zfhx4 zinc finger homeobox 4 ENSRNOG00000008765 -0.66 0.0230 -1.58
Ptpn14 protein tyrosine phosphatase, non-receptor type 14 ENSRNOG00000003407 -0.66 0.0255 -1.58
Sdpr serum deprivation response ENSRNOG00000025895 -0.66 0.0295 -1.59
Unc119 UNC-119 homolog (C. elegans) ENSRNOG00000011060 -0.67 0.0407 -1.59
Deptor DEP domain containing MTOR-interacting protein ENSRNOG00000004328 -0.67 0.0178 -1.59
Fkbp14 FK506 binding protein 14 ENSRNOG00000009886 -0.67 0.0435 -1.59
Trak1 trafficking protein, kinesin binding 1 ENSRNOG00000019262 -0.67 0.0184 -1.59
Rufy2 RUN and FYVE domain-containing protein 2-like ENSRNOG00000000390 -0.67 0.0179 -1.59
Hibch 3-hydroxyisobutyryl-CoA hydrolase ENSRNOG00000028557 -0.67 0.0332 -1.59
Ptprq protein tyrosine phosphatase, receptor type, Q ENSRNOG00000032479 -0.67 0.0500 -1.59
Nsg1 neuron specific gene family member 1 ENSRNOG00000005700 -0.67 0.0397 -1.59
Fabp3 fatty acid binding protein 3, muscle and heart ENSRNOG00000012879 -0.67 0.0341 -1.59
Irf9 interferon regulatory factor 9 ENSRNOG00000019478 -0.67 0.0480 -1.60
Trim45 tripartite motif-containing 45 ENSRNOG00000015347 -0.68 0.0209 -1.60
Reps2 RALBP1 associated Eps domain containing protein 2 ENSRNOG00000026846 -0.68 0.0290 -1.60
Cdk5 cyclin-dependent kinase 5 ENSRNOG00000008017 -0.68 0.0323 -1.60
Gga2 golgi associated, gamma adaptin ear containing, ARF binding protein 2 ENSRNOG00000018599 -0.68 0.0363 -1.60
Smarca2 SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 ENSRNOG00000011931 -0.68 0.0142 -1.60
Atf5 activating transcription factor 5 ENSRNOG00000020060 -0.68 0.0280 -1.60
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Cnnm4 cyclin M4 ENSRNOG00000015886 -0.68 0.0238 -1.60
Stard10 StAR-related lipid transfer (START) domain containing 10 ENSRNOG00000019491 -0.68 0.0486 -1.60
Scrn3 secernin 3 ENSRNOG00000018657 -0.68 0.0275 -1.60
Epn3 epsin 3 ENSRNOG00000003284 -0.68 0.0133 -1.60
Itgav integrin alpha V ENSRNOG00000004912 -0.68 0.0278 -1.60
Axin2 axin 2 ENSRNOG00000003612 -0.68 0.0134 -1.60
Akap12 A kinase (PRKA) anchor protein 12 ENSRNOG00000019549 -0.68 0.0420 -1.60
Samhd1 SAM domain and HD domain, 1 ENSRNOG00000006418 -0.68 0.0394 -1.61
Hspa2 heat shock protein 2 ENSRNOG00000006472 -0.68 0.0281 -1.61
LOC100361946 nucleotide-binding oligomerization domain containing 2-like ENSRNOG00000001872 -0.69 0.0167 -1.61
Lgals3bp lectin, galactoside-binding, soluble, 3 binding protein ENSRNOG00000003217 -0.69 0.0178 -1.61
Rimkla ribosomal modification protein rimK-like family member A ENSRNOG00000008625 -0.69 0.0177 -1.61
Afap1l1 actin filament associated protein 1-like 1 ENSRNOG00000019403 -0.69 0.0139 -1.61
Flt3lg fms-related tyrosine kinase 3 ligand-like ENSRNOG00000042254 -0.69 0.0238 -1.61
Spopl speckle-type POZ protein-like ENSRNOG00000005070 -0.69 0.0337 -1.61
RGD1304963 similar to hypothetical protein MGC38716 ENSRNOG00000008942 -0.69 0.0432 -1.61
Ano8 anoctamin 8 ENSRNOG00000017567 -0.69 0.0405 -1.61
RGD1561832 zinc finger protein 658-like ENSRNOG00000023233 -0.69 0.0416 -1.61
Fgf9 fibroblast growth factor 9 ENSRNOG00000011471 -0.69 0.0155 -1.62
Ric8b RIC8 guanine nucleotide exchange factor B ENSRNOG00000007323 -0.69 0.0275 -1.62
Ppp2r5b protein phosphatase 2, regulatory subunit B', beta ENSRNOG00000021025 -0.69 0.0333 -1.62
Ankrd9 ankyrin repeat domain 9 ENSRNOG00000008056 -0.69 0.0441 -1.62
Ndufv1 NADH dehydrogenase (ubiquinone) flavoprotein 1 ENSRNOG00000018117 -0.69 0.0218 -1.62
Adamts3 ADAM metallopeptidase with thrombospondin type 1, motif 3 ENSRNOG00000027463 -0.70 0.0498 -1.62
Smc6 structural maintenance of chromosomes 6 ENSRNOG00000004908 -0.70 0.0243 -1.62
Gene Symbol Description Ensembl ID fold change log2 p value fold change
H2afv H2A histone family, member V ENSRNOG00000007026 -0.70 0.0342 -1.62
Hyal3 hyaluronoglucosaminidase 3 ENSRNOG00000016093 -0.70 0.0212 -1.62
Cyc1 cytochrome c-1 ENSRNOG00000012457 -0.70 0.0197 -1.62
Thbs3 thrombospondin 3 ENSRNOG00000020524 -0.70 0.0151 -1.62
Hoxc5 homeo box C5 ENSRNOG00000016598 -0.70 0.0178 -1.62
LOC306766 hypothetical LOC306766 ENSRNOG00000017133 -0.70 0.0186 -1.63
Hadh hydroxyacyl-CoA dehydrogenase ENSRNOG00000010697 -0.70 0.0142 -1.63
Trpc1 transient receptor potential cation channel, subfamily C, member 1 ENSRNOG00000009601 -0.70 0.0471 -1.63
Slc25a35 solute carrier family 25, member 35 ENSRNOG00000004668 -0.70 0.0420 -1.63
Socs2 suppressor of cytokine signaling 2 ENSRNOG00000008965 -0.70 0.0433 -1.63
Stard8 StAR-related lipid transfer (START) domain containing 8 ENSRNOG00000033883 -0.70 0.0233 -1.63
Man2b2 mannosidase, alpha, class 2B, member 2 ENSRNOG00000005526 -0.71 0.0383 -1.63
Fgf11 fibroblast growth factor 11 ENSRNOG00000014882 -0.71 0.0441 -1.63
Pyurfl1 PIGY upstream reading frame-like 1 ENSRNOG00000006858 -0.71 0.0475 -1.63
Ptgfrn prostaglandin F2 receptor inhibitor ENSRNOG00000015655 -0.71 0.0202 -1.63
LOC100174910 glutaredoxin-like protein ENSRNOG00000013738 -0.71 0.0147 -1.63
Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 ENSRNOG00000043162 -0.71 0.0197 -1.63
Entpd6 ectonucleoside triphosphate diphosphohydrolase 6 ENSRNOG00000007427 -0.71 0.0341 -1.64
Ncald neurocalcin delta ENSRNOG00000042978 -0.71 0.0178 -1.64
Akr1b1 aldo-keto reductase family 1, member B1 (aldose reductase) ENSRNOG00000009513 -0.71 0.0172 -1.64
Sh3bgr SH3 domain binding glutamate-rich protein ENSRNOG00000028238 -0.71 0.0200 -1.64
Fam53b family with sequence similarity 53, member B ENSRNOG00000017125 -0.71 0.0493 -1.64
Herc1 HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 ENSRNOG00000017592 -0.71 0.0223 -1.64
Atp5g1 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C1 (subunit 9) ENSRNOG00000007235 -0.71 0.0341 -1.64
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Plekha2 pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 ENSRNOG00000038365 -0.72 0.0275 -1.64
Zswim7 zinc finger, SWIM-type containing 7 ENSRNOG00000002970 -0.72 0.0367 -1.64
Zfp827 zinc finger protein 827 ENSRNOG00000011697 -0.72 0.0342 -1.64
Ctnnal1 catenin (cadherin associated protein), alpha-like 1 ENSRNOG00000010593 -0.72 0.0296 -1.64
Ints2 integrator complex subunit 2 ENSRNOG00000003576 -0.72 0.0275 -1.64
Gria4 glutamate receptor, ionotropic, AMPA 4 ENSRNOG00000006957 -0.72 0.0163 -1.64
CAMK2A Uncharacterized protein  ENSRNOG00000018712 -0.72 0.0160 -1.65
Hddc2 HD domain containing 2 ENSRNOG00000021442 -0.72 0.0323 -1.65
Cenpp hypothetical protein LOC679342 ENSRNOG00000015545 -0.72 0.0351 -1.65
RGD1302996 hypothetical protein MGC:15854 ENSRNOG00000000812 -0.72 0.0477 -1.65
Gen1 GEN1 Holliday junction 5' flap endonuclease ENSRNOG00000004667 -0.72 0.0303 -1.65
Map6d1 MAP6 domain containing 1 ENSRNOG00000001911 -0.72 0.0133 -1.65
Bcam basal cell adhesion molecule (Lutheran blood group) ENSRNOG00000029399 -0.72 0.0197 -1.65
Abca8a ATP-binding cassette, subfamily A (ABC1), member 8a ENSRNOG00000004147 -0.72 0.0441 -1.65
Acsf3 acyl-CoA synthetase family member 3 ENSRNOG00000015077 -0.72 0.0479 -1.65
Apol9a apolipoprotein L 9a ENSRNOG00000023410 -0.72 0.0172 -1.65
Col6a1 collagen, type VI, alpha 1 ENSRNOG00000001249 -0.72 0.0220 -1.65
Nkain1 Na+/K+ transporting ATPase interacting 1 ENSRNOG00000011445 -0.72 0.0453 -1.65
Vegfb vascular endothelial growth factor B ENSRNOG00000021156 -0.73 0.0275 -1.65
Nudt15 nudix (nucleoside diphosphate linked moiety X)-type motif 15 ENSRNOG00000025239 -0.73 0.0224 -1.66
Hdhd2 haloacid dehalogenase-like hydrolase domain containing 2 ENSRNOG00000043171 -0.73 0.0342 -1.66
Ndufb5 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5 ENSRNOG00000011949 -0.73 0.0300 -1.66
Rasl10a RAS-like, family 10, member A ENSRNOG00000008951 -0.73 0.0181 -1.66
Pigq phosphatidylinositol glycan anchor biosynthesis, class Q ENSRNOG00000020140 -0.73 0.0211 -1.66
Ppil3 peptidylprolyl isomerase (cyclophilin)-like 3 ENSRNOG00000013636 -0.73 0.0435 -1.66
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Limch1 LIM and calponin homology domains 1 ENSRNOG00000002318 -0.73 0.0318 -1.66
Atp5o ATP synthase, H+ transporting, mitochondrial F1 complex, O subunit ENSRNOG00000001991 -0.73 0.0363 -1.66
RGD1564845 similar to Xlr-like ENSRNOG00000027907 -0.73 0.0187 -1.66
Smo smoothened, frizzled class receptor ENSRNOG00000008332 -0.73 0.0162 -1.66
Lsm14b LSM14B, SCD6 homolog B (S. cerevisiae) ENSRNOG00000008877 -0.73 0.0310 -1.66
Atf7ip activating transcription factor 7 interacting protein ENSRNOG00000008870 -0.73 0.0409 -1.66
Nmnat1 nicotinamide nucleotide adenylyltransferase 1 ENSRNOG00000015962 -0.73 0.0142 -1.66
Hopx HOP homeobox ENSRNOG00000024689 -0.74 0.0225 -1.66
Pip4k2b phosphatidylinositol-5-phosphate 4-kinase, type II, beta ENSRNOG00000013030 -0.74 0.0341 -1.66
Prkra protein kinase, interferon inducible double stranded RNA dependent activator ENSRNOG00000011195 -0.74 0.0323 -1.67
Ndufb3 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 3-like ENSRNOG00000011825 -0.74 0.0297 -1.67
Desi2 desumoylating isopeptidase 2 ENSRNOG00000004524 -0.74 0.0323 -1.67
Hif1an hypoxia-inducible factor 1, alpha subunit inhibitor ENSRNOG00000014234 -0.74 0.0356 -1.67
Acadm acyl-CoA dehydrogenase, C-4 to C-12 straight chain ENSRNOG00000009845 -0.74 0.0303 -1.67
Sdk2 sidekick cell adhesion molecule 2 ENSRNOG00000024711 -0.74 0.0155 -1.67
Mrps11 mitochondrial ribosomal protein S11 ENSRNOG00000018531 -0.74 0.0181 -1.67
Invs inversin ENSRNOG00000008632 -0.74 0.0374 -1.67
Ndufa2 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 ENSRNOG00000017571 -0.74 0.0309 -1.67
Stim1 stromal interaction molecule 1 ENSRNOG00000020425 -0.74 0.0216 -1.67
Phkg1 phosphorylase kinase, gamma 1 ENSRNOG00000000920 -0.75 0.0417 -1.68
Pomk protein-O-mannose kinase ENSRNOG00000014628 -0.75 0.0494 -1.68
Hlf hepatic leukemia factor ENSRNOG00000002456 -0.75 0.0159 -1.68
LOC500350 LRRGT00139 ENSRNOG00000030158 -0.75 0.0235 -1.68
Irs1 insulin receptor substrate 1 ENSRNOG00000014597 -0.75 0.0133 -1.68
Hccs holocytochrome c synthase ENSRNOG00000025910 -0.75 0.0184 -1.68
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Cacybp calcyclin binding protein ENSRNOG00000002572 -0.75 0.0258 -1.68
Slc9a2 solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 ENSRNOG00000015567 -0.75 0.0350 -1.69
Vamp1 vesicle-associated membrane protein 1 ENSRNOG00000019219 -0.75 0.0345 -1.69
RT1-T24-4 RT1 class I, locus T24, gene 4 ENSRNOG00000042905 -0.76 0.0224 -1.69
RGD1561206 similar to solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19 ENSRNOG00000016331 -0.76 0.0197 -1.69
Tstd3 thiosulfate sulfurtransferase (rhodanese)-like domain containing 3 ENSRNOG00000028185 -0.76 0.0212 -1.69
Abcd1 ATP-binding cassette, subfamily D (ALD), member 1 ENSRNOG00000018857 -0.76 0.0307 -1.69
Fmnl1 formin-like 1 ENSRNOG00000003207 -0.76 0.0166 -1.69
Klf12 Kruppel-like factor 12 ENSRNOG00000009145 -0.76 0.0249 -1.69
Atp5i ATP synthase, H+ transporting, mitochondrial Fo complex, subunit E ENSRNOG00000000064 -0.76 0.0163 -1.69
Psme2 proteasome (prosome, macropain) activator subunit 2 ENSRNOG00000019246 -0.76 0.0301 -1.69
Adtrp androgen-dependent TFPI-regulating protein ENSRNOG00000014481 -0.76 0.0342 -1.69
Lrsam1 leucine rich repeat and sterile alpha motif containing 1 ENSRNOG00000022312 -0.76 0.0223 -1.70
Cacna2d1 calcium channel, voltage-dependent, alpha2/delta subunit 1 ENSRNOG00000033531 -0.76 0.0307 -1.70
Slc37a4 solute carrier family 37 (glucose-6-phosphate transporter), member 4 ENSRNOG00000011361 -0.76 0.0327 -1.70
Pcyox1 prenylcysteine oxidase 1 ENSRNOG00000016704 -0.76 0.0244 -1.70
Parp14 poly (ADP-ribose) polymerase family, member 14 ENSRNOG00000023334 -0.77 0.0290 -1.70
Cacna2d3 calcium channel, voltage-dependent, alpha2/delta subunit 3 ENSRNOG00000031287 -0.77 0.0133 -1.70
Rassf3 Ras association (RalGDS/AF-6) domain family member 3 ENSRNOG00000005388 -0.77 0.0360 -1.70
Cars2 cysteinyl-tRNA synthetase 2, mitochondrial ENSRNOG00000014526 -0.77 0.0230 -1.70
Fastk Fas-activated serine/threonine kinase ENSRNOG00000011667 -0.77 0.0261 -1.70
Copg1 coatomer protein complex, subunit gamma 1 ENSRNOG00000010474 -0.77 0.0170 -1.70
Entpd2 ectonucleoside triphosphate diphosphohydrolase 2 ENSRNOG00000013102 -0.77 0.0354 -1.70
Lrrc55 leucine rich repeat containing 55 ENSRNOG00000028266 -0.77 0.0269 -1.70
Ndufs8 NADH dehydrogenase (ubiquinone) Fe-S protein 8 ENSRNOG00000017446 -0.77 0.0300 -1.70
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Mlkl mixed lineage kinase domain-like ENSRNOG00000042353 -0.77 0.0199 -1.71
Mlec malectin ENSRNOG00000021725 -0.77 0.0253 -1.71
Coa5 cytochrome C oxidase assembly factor 5 ENSRNOG00000018102 -0.77 0.0449 -1.71
Maged2 melanoma antigen, family D, 2 ENSRNOG00000002449 -0.77 0.0409 -1.71
Rnf128 ring finger protein 128, E3 ubiquitin protein ligase ENSRNOG00000043123 -0.77 0.0147 -1.71
Inppl1 inositol polyphosphate phosphatase-like 1 ENSRNOG00000019730 -0.77 0.0113 -1.71
Cdk6 cyclin-dependent kinase 6 ENSRNOG00000009258 -0.78 0.0142 -1.71
Igsf10 immunoglobulin superfamily, member 10 ENSRNOG00000013917 -0.78 0.0246 -1.71
Mrpl48 mitochondrial ribosomal protein L48 ENSRNOG00000018042 -0.78 0.0414 -1.71
Siae sialic acid acetylesterase ENSRNOG00000031266 -0.78 0.0307 -1.72
Endod1 endonuclease domain containing 1 ENSRNOG00000024757 -0.78 0.0236 -1.72
Isoc2b isochorismatase domain containing 2b ENSRNOG00000016829 -0.78 0.0142 -1.72
Tnfaip2 tumor necrosis factor, alpha-induced protein 2 ENSRNOG00000010165 -0.78 0.0136 -1.72
Adck1 aarF domain containing kinase 1 ENSRNOG00000012685 -0.78 0.0342 -1.72
Nudt7 nudix (nucleoside diphosphate linked moiety X)-type motif 7 ENSRNOG00000011976 -0.78 0.0229 -1.72
Bola3 bolA family member 3 ENSRNOG00000021866 -0.78 0.0212 -1.72
Inpp5f inositol polyphosphate-5-phosphatase F ENSRNOG00000020388 -0.79 0.0223 -1.72
Mki67 marker of proliferation Ki-67 ENSRNOG00000028137 -0.79 0.0370 -1.72
Phlda3 pleckstrin homology-like domain, family A, member 3 ENSRNOG00000009068 -0.79 0.0374 -1.72
Sufu suppressor of fused homolog (Drosophila) ENSRNOG00000019807 -0.79 0.0202 -1.73
Timm21 translocase of inner mitochondrial membrane 21 homolog (yeast) ENSRNOG00000015142 -0.79 0.0341 -1.73
Sema5a Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A ENSRNOG00000011977 -0.79 0.0385 -1.73
Hspg2 perlecan (heparan sulfate proteoglycan 2) ENSRNOG00000021437 -0.79 0.0101 -1.73
Aadacl3 arylacetamide deacetylase-like 3 ENSRNOG00000026613 -0.79 0.0238 -1.73
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Pkhd1l1 polycystic kidney and hepatic disease 1-like 1 ENSRNOG00000004398 -0.79 0.0437 -1.73
Atp5g3 ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C3 (subunit 9) ENSRNOG00000001596 -0.79 0.0216 -1.73
Rab11fip3 RAB11 family interacting protein 3 (class II) ENSRNOG00000032152 -0.79 0.0420 -1.73
Zfp949 zinc finger protein 949 ENSRNOG00000043223 -0.79 0.0473 -1.73
Flad1 flavin adenine dinucleotide synthetase 1 ENSRNOG00000020642 -0.79 0.0283 -1.73
Mdp1 magnesium-dependent phosphatase 1 ENSRNOG00000019840 -0.79 0.0075 -1.73
Ngfrap1 nerve growth factor receptor (TNFRSF16) associated protein 1 ENSRNOG00000028822 -0.80 0.0477 -1.74
Extl1 exostosin-like glycosyltransferase 1 ENSRNOG00000016776 -0.80 0.0460 -1.74
Mbd4 methyl-CpG binding domain protein 4 ENSRNOG00000010919 -0.80 0.0421 -1.74
Eci1 enoyl-CoA delta isomerase 1 ENSRNOG00000008843 -0.80 0.0374 -1.74
Sema6a sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A ENSRNOG00000004033 -0.80 0.0304 -1.74
Fam212b family with sequence similarity 212, member B ENSRNOG00000015691 -0.80 0.0129 -1.74
Slc35b4 solute carrier family 35 (UDP-xylose/UDP-N-acetylglucosamine transporter), member B4 ENSRNOG00000008851 -0.80 0.0279 -1.74
Dgkb diacylglycerol kinase, beta ENSRNOG00000030771 -0.80 0.0223 -1.74
RGD1309104 similar to RIKEN cDNA 1700025G04 gene ENSRNOG00000028236 -0.80 0.0375 -1.74
Dnajc27 DnaJ (Hsp40) homolog, subfamily C, member 27 ENSRNOG00000003988 -0.80 0.0441 -1.74
Zfp879 zinc finger protein 879 ENSRNOG00000030517 -0.80 0.0136 -1.75
Rtn4ip1 reticulon 4 interacting protein 1 ENSRNOG00000000279 -0.80 0.0356 -1.75
Raph1 Ras association (RalGDS/AF-6) and pleckstrin homology domains 1 ENSRNOG00000014722 -0.81 0.0165 -1.75
Grm8 glutamate receptor, metabotropic 8 ENSRNOG00000021468 -0.81 0.0389 -1.75
Wrn Werner syndrome, RecQ helicase-like ENSRNOG00000015440 -0.81 0.0318 -1.75
RGD1309362 similar to interferon-inducible GTPase ENSRNOG00000038960 -0.81 0.0212 -1.75
Ccdc141 coiled-coil domain containing 141 ENSRNOG00000012580 -0.81 0.0068 -1.75
RGD1304978 similar to RIKEN cDNA 0610027B03 ENSRNOG00000004926 -0.81 0.0187 -1.76
Gene Symbol Description Ensembl ID fold change log2 p value fold change
RT1-M6-1 RT1 class Ib, locus M4 ENSRNOG00000022107 -0.81 0.0187 -1.76
Wee1 WEE1 G2 checkpoint kinase ENSRNOG00000010017 -0.81 0.0118 -1.76
B3galnt2 beta-1,3-N-acetylgalactosaminyltransferase 2 ENSRNOG00000016855 -0.81 0.0476 -1.76
LOC297568 alpha-1-inhibitor III ENSRNOG00000042228 -0.82 0.0476 -1.76
Oasl2 2'-5' oligoadenylate synthetase-like 2 ENSRNOG00000028814 -0.82 0.0213 -1.76
Zfand1 zinc finger, AN1-type domain 1 ENSRNOG00000010342 -0.82 0.0177 -1.76
Dpf3 D4, zinc and double PHD fingers, family 3 ENSRNOG00000008086 -0.82 0.0177 -1.76
Mrm1 mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae) ENSRNOG00000027901 -0.82 0.0179 -1.76
Atpaf1 ATP synthase mitochondrial F1 complex assembly factor 1 ENSRNOG00000010169 -0.82 0.0498 -1.76
Mmp16 matrix metallopeptidase 16 ENSRNOG00000005708 -0.82 0.0323 -1.77
Lpar6 lysophosphatidic acid receptor 6 ENSRNOG00000015577 -0.82 0.0102 -1.77
Tln2 talin 2 ENSRNOG00000018373 -0.82 0.0149 -1.77
Tmem50b transmembrane protein 50B ENSRNOG00000002028 -0.82 0.0267 -1.77
Myocd myocardin ENSRNOG00000003669 -0.82 0.0484 -1.77
Crem cAMP responsive element modulator ENSRNOG00000014900 -0.83 0.0107 -1.77
Cda cytidine deaminase-like ENSRNOG00000015677 -0.83 0.0398 -1.77
Lurap1l leucine rich adaptor protein 1-like ENSRNOG00000033740 -0.83 0.0101 -1.77
Cmpk2 cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial ENSRNOG00000007690 -0.83 0.0142 -1.78
Fam189b family with sequence similarity 189, member B ENSRNOG00000020518 -0.83 0.0327 -1.78
Cyp2t1 cytochrome P450, family 2, subfamily t, polypeptide 1 ENSRNOG00000028891 -0.83 0.0187 -1.78
Gria3 glutamate receptor, ionotropic, AMPA 3 ENSRNOG00000007682 -0.83 0.0298 -1.78
Elk1 ELK1, member of ETS oncogene family ENSRNOG00000010171 -0.83 0.0142 -1.78
Slc46a3 solute carrier family 46, member 3 ENSRNOG00000000937 -0.83 0.0195 -1.78
Nr3c2 nuclear receptor subfamily 3, group C, member 2 ENSRNOG00000034007 -0.84 0.0181 -1.78
LOC100912012 tetranectin-like ENSRNOG00000004540 -0.84 0.0159 -1.79
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Itga8 integrin, alpha 8 ENSRNOG00000016538 -0.84 0.0206 -1.79
Gdf11 growth differentiation factor 11 ENSRNOG00000007610 -0.84 0.0238 -1.79
Tenm4 teneurin transmembrane protein 4 ENSRNOG00000011151 -0.84 0.0148 -1.79
Acad10 acyl-CoA dehydrogenase family, member 10 ENSRNOG00000037815 -0.84 0.0436 -1.79
Cdc26 cell division cycle 26 ENSRNOG00000029785 -0.84 0.0186 -1.79
Rasgrp3 RAS guanyl releasing protein 3 (calcium and DAG-regulated) ENSRNOG00000032703 -0.84 0.0441 -1.79
Emx2 empty spiracles homeobox 2 ENSRNOG00000009482 -0.84 0.0186 -1.79
Casq2 calsequestrin 2 (cardiac muscle) ENSRNOG00000016243 -0.84 0.0345 -1.79
Trim5 tripartite motif-containing 5 ENSRNOG00000017191 -0.84 0.0314 -1.79
Slc39a13 solute carrier family 39 (zinc transporter), member 13 ENSRNOG00000011981 -0.84 0.0142 -1.79
St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 ENSRNOG00000019128 -0.84 0.0177 -1.80
Pcsk6 proprotein convertase subtilisin/kexin type 6 ENSRNOG00000011526 -0.84 0.0189 -1.80
Casp12 caspase 12 ENSRNOG00000033434 -0.85 0.0374 -1.80
Shc3 SHC (Src homology 2 domain containing) transforming protein 3 ENSRNOG00000014366 -0.85 0.0320 -1.80
Sim1 single-minded family bHLH transcription factor 1 ENSRNOG00000037600 -0.85 0.0246 -1.80
Col6a2 collagen, type VI, alpha 2 ENSRNOG00000001254 -0.85 0.0108 -1.80
Ccbl1 cysteine conjugate-beta lyase, cytoplasmic ENSRNOG00000016097 -0.85 0.0466 -1.80
Mstn myostatin ENSRNOG00000021294 -0.86 0.0201 -1.81
Slc36a2 solute carrier family 36 (proton/amino acid symporter), member 2 ENSRNOG00000011892 -0.86 0.0219 -1.81
Alox5 arachidonate 5-lipoxygenase ENSRNOG00000012972 -0.86 0.0253 -1.81
C1qtnf6 C1q and tumor necrosis factor related protein 6 ENSRNOG00000007300 -0.86 0.0306 -1.81
Tmem143 transmembrane protein 143 ENSRNOG00000021096 -0.86 0.0155 -1.81
Atxn1 ataxin 1 ENSRNOG00000016998 -0.86 0.0129 -1.81
Filip1l filamin A interacting protein 1-like ENSRNOG00000001645 -0.86 0.0343 -1.81
Ccdc146 coiled-coil domain containing 146 ENSRNOG00000012932 -0.86 0.0191 -1.81
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Ubac1 UBA domain containing 1 ENSRNOG00000017983 -0.86 0.0329 -1.82
Ltbp4 latent transforming growth factor beta binding protein 4 ENSRNOG00000020871 -0.86 0.0182 -1.82
Ppip5k2 diphosphoinositol pentakisphosphate kinase 2 ENSRNOG00000011613 -0.86 0.0437 -1.82
Tefm transcription elongation factor, mitochondrial ENSRNOG00000004000 -0.86 0.0498 -1.82
Slc2a12 solute carrier family 2 (facilitated glucose transporter), member 12 ENSRNOG00000011161 -0.86 0.0178 -1.82
Leprel1 leprecan-like 1 ENSRNOG00000001925 -0.86 0.0230 -1.82
Nudt5 nudix (nucleoside diphosphate linked moiety X)-type motif 5 ENSRNOG00000017741 -0.87 0.0405 -1.82
Stxbp6 syntaxin binding protein 6 (amisyn) ENSRNOG00000004198 -0.87 0.0125 -1.82
Casq1 calsequestrin 1 (fast-twitch, skeletal muscle) ENSRNOG00000006930 -0.87 0.0369 -1.82
Smyd1 SET and MYND domain containing 1 ENSRNOG00000006776 -0.87 0.0310 -1.82
Kdelc2 KDEL (Lys-Asp-Glu-Leu) containing 2 ENSRNOG00000007177 -0.87 0.0322 -1.83
Dnm1l dynamin 1-like ENSRNOG00000001813 -0.87 0.0307 -1.83
Dkk2 dickkopf WNT signaling pathway inhibitor 2 ENSRNOG00000011360 -0.87 0.0360 -1.83
Wdr92 WD repeat domain 92 ENSRNOG00000022857 -0.87 0.0305 -1.83
LOC100365881 glutathione S-transferase alpha-4-like ENSRNOG00000000217 -0.87 0.0244 -1.83
Slc25a40 solute carrier family 25, member 40 ENSRNOG00000022837 -0.87 0.0323 -1.83
Mpdz multiple PDZ domain protein ENSRNOG00000007894 -0.87 0.0125 -1.83
Perm1 PPARGC1 and ESRR induced regulator, muscle 1 ENSRNOG00000020244 -0.87 0.0494 -1.83
Phf11 PHD finger protein 11 ENSRNOG00000011580 -0.88 0.0178 -1.84
Dock10 dedicator of cytokinesis 10 ENSRNOG00000016165 -0.88 0.0238 -1.84
Kcnt2 potassium channel, subfamily T, member 2 ENSRNOG00000013312 -0.88 0.0374 -1.84
Trim35 tripartite motif-containing 35 ENSRNOG00000009449 -0.88 0.0218 -1.84
Ndufs3 NADH dehydrogenase (ubiquinone) Fe-S protein 3 ENSRNOG00000009155 -0.88 0.0261 -1.85
Cd28 Cd28 molecule ENSRNOG00000010283 -0.89 0.0453 -1.85
Mpc2 mitochondrial pyruvate carrier 2 ENSRNOG00000003150 -0.89 0.0147 -1.85
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Gcgr glucagon receptor ENSRNOG00000036692 -0.89 0.0281 -1.85
Leprel4 leprecan-like 4 ENSRNOG00000015787 -0.89 0.0184 -1.85
Dach1 dachshund family transcription factor 1 ENSRNOG00000008834 -0.89 0.0113 -1.85
RGD1559731 similar to RIKEN cDNA 4930578C19 ENSRNOG00000004265 -0.89 0.0068 -1.85
Tex9 testis expressed 9 ENSRNOG00000024291 -0.89 0.0417 -1.85
Col6a6 collagen, type VI, alpha 6 ENSRNOG00000023007 -0.89 0.0123 -1.85
Cradd CASP2 and RIPK1 domain containing adaptor with death domain ENSRNOG00000008507 -0.89 0.0131 -1.86
Aspa aspartoacylase ENSRNOG00000019659 -0.89 0.0180 -1.86
Ccdc92 coiled-coil domain containing 92 ENSRNOG00000021691 -0.89 0.0101 -1.86
Lbx1 ladybird homeobox 1 ENSRNOG00000025520 -0.89 0.0094 -1.86
Frk fyn-related Src family tyrosine kinase ENSRNOG00000000543 -0.89 0.0212 -1.86
Zfp763 zinc finger protein 763 ENSRNOG00000004557 -0.90 0.0209 -1.86
Rnaseh2a ribonuclease H2, subunit A ENSRNOG00000003504 -0.90 0.0202 -1.86
Mppe1 metallophosphoesterase 1 ENSRNOG00000018648 -0.90 0.0156 -1.87
Kcnma1 potassium large conductance calcium-activated channel, subfamily M, alpha member 1 ENSRNOG00000005985 -0.90 0.0315 -1.87
Slc38a3 solute carrier family 38, member 3 ENSRNOG00000016827 -0.90 0.0360 -1.87
Vldlr very low density lipoprotein receptor ENSRNOG00000027491 -0.90 0.0453 -1.87
Ints3 integrator complex subunit 3 ENSRNOG00000015153 -0.90 0.0180 -1.87
Cxadr coxsackie virus and adenovirus receptor ENSRNOG00000001557 -0.90 0.0218 -1.87
Zfp606 zinc finger protein 606 ENSRNOG00000019127 -0.90 0.0177 -1.87
Trmt1l tRNA methyltransferase 1-like ENSRNOG00000002580 -0.91 0.0343 -1.87
Calcr calcitonin receptor ENSRNOG00000010053 -0.91 0.0133 -1.87
Mdh1 malate dehydrogenase 1, NAD (soluble) ENSRNOG00000008103 -0.91 0.0307 -1.87
Ndufb7 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7 ENSRNOG00000028717 -0.91 0.0131 -1.88
Slco3a1 solute carrier organic anion transporter family, member 3a1 ENSRNOG00000032798 -0.91 0.0177 -1.88
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Mrpl12 mitochondrial ribosomal protein L12 ENSRNOG00000036695 -0.91 0.0212 -1.88
Rfesd Rieske (Fe-S) domain containing ENSRNOG00000012810 -0.92 0.0348 -1.89
Clasp1 cytoplasmic linker associated protein 1 ENSRNOG00000002376 -0.92 0.0177 -1.89
Fam118b family with sequence similarity 118, member B ENSRNOG00000011543 -0.92 0.0258 -1.89
Ppapdc3 phosphatidic acid phosphatase type 2 domain containing 3 ENSRNOG00000010068 -0.92 0.0100 -1.89
Chordc1 cysteine and histidine-rich domain (CHORD)-containing 1 ENSRNOG00000026643 -0.92 0.0197 -1.89
Vom1r93 vomeronasal 1 receptor 93 ENSRNOG00000017735 -0.92 0.0202 -1.89
Elovl7 ELOVL fatty acid elongase 7 ENSRNOG00000010450 -0.92 0.0136 -1.90
Kcnh2 potassium voltage-gated channel, subfamily H (eag-related), member 2 ENSRNOG00000009872 -0.92 0.0090 -1.90
Aknad1 AKNA domain containing 1 ENSRNOG00000028025 -0.92 0.0073 -1.90
Acyp1 acylphosphatase 1, erythrocyte (common) type ENSRNOG00000006744 -0.92 0.0163 -1.90
Lmod3 leiomodin 3 (fetal) ENSRNOG00000032443 -0.92 0.0238 -1.90
C1qtnf2 C1q and tumor necrosis factor related protein 2 ENSRNOG00000003870 -0.92 0.0102 -1.90
Sirt3 sirtuin 3 ENSRNOG00000013828 -0.93 0.0066 -1.90
Gcnt4 glucosaminyl (N-acetyl) transferase 4, core 2 ENSRNOG00000016500 -0.93 0.0067 -1.90
Doc2g double C2-like domains, gamma ENSRNOG00000018029 -0.93 0.0342 -1.90
Ramp1 receptor (G protein-coupled) activity modifying protein 1 ENSRNOG00000019926 -0.93 0.0134 -1.90
Ddx60 DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 ENSRNOG00000014541 -0.93 0.0318 -1.90
Pfn2 profilin 2 ENSRNOG00000017427 -0.93 0.0445 -1.91
Fam149a family with sequence similarity 149, member A ENSRNOG00000021693 -0.93 0.0275 -1.91
Cntn2 contactin 2 (axonal) ENSRNOG00000009033 -0.93 0.0133 -1.91
Asah2 N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2 ENSRNOG00000012196 -0.93 0.0150 -1.91
Dyrk1b dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b ENSRNOG00000019254 -0.93 0.0396 -1.91
Ptpn3 protein tyrosine phosphatase, non-receptor type 3 ENSRNOG00000011425 -0.93 0.0397 -1.91
Pde7b phosphodiesterase 7B ENSRNOG00000013436 -0.93 0.0276 -1.91
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Arhgef6 Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 ENSRNOG00000000869 -0.94 0.0346 -1.91
Pgm5 phosphoglucomutase 5 ENSRNOG00000015406 -0.94 0.0101 -1.91
Adamts19 ADAM metallopeptidase with thrombospondin type 1 motif, 19 ENSRNOG00000019577 -0.94 0.0159 -1.92
Gbp5 guanylate binding protein 5 ENSRNOG00000032240 -0.95 0.0223 -1.93
Mx2 myxovirus (influenza virus) resistance 2 ENSRNOG00000001963 -0.95 0.0398 -1.93
Amy2a3 amylase 2a3 ENSRNOG00000016168 -0.95 0.0479 -1.93
C2cd5 C2 calcium-dependent domain containing 5 ENSRNOG00000014382 -0.95 0.0125 -1.93
Cacng6 calcium channel, voltage-dependent, gamma subunit 6 ENSRNOG00000014326 -0.95 0.0365 -1.93
Zkscan4 zinc finger with KRAB and SCAN domains 4 ENSRNOG00000038818 -0.95 0.0476 -1.93
Dnmt3a DNA (cytosine-5-)-methyltransferase 3 alpha ENSRNOG00000026649 -0.95 0.0176 -1.93
Tm6sf1 transmembrane 6 superfamily member 1 ENSRNOG00000019662 -0.95 0.0142 -1.93
Sugct succinylCoA:glutarate-CoA transferase ENSRNOG00000014028 -0.95 0.0139 -1.93
Cacnb4 calcium channel, voltage-dependent, beta 4 subunit ENSRNOG00000007666 -0.95 0.0257 -1.94
Lyrm5 LYR motif containing 5 ENSRNOG00000015848 -0.96 0.0317 -1.94
Sh3kbp1 SH3-domain kinase binding protein 1 ENSRNOG00000004322 -0.96 0.0246 -1.94
Ablim2 actin binding LIM protein family, member 2 ENSRNOG00000007882 -0.96 0.0370 -1.94
Abcd3 ATP-binding cassette, subfamily D (ALD), member 3 ENSRNOG00000011929 -0.96 0.0072 -1.94
Slc25a20 solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 ENSRNOG00000020288 -0.96 0.0179 -1.94
Popdc2 popeye domain containing 2 ENSRNOG00000002994 -0.96 0.0264 -1.95
mrpl24 mitochondrial ribosomal protein L24 ENSRNOG00000022234 -0.96 0.0136 -1.95
Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide ENSRNOG00000002934 -0.96 0.0227 -1.95
Nudt14 nudix (nucleoside diphosphate linked moiety X)-type motif 14 ENSRNOG00000014362 -0.96 0.0301 -1.95
Ank2 ankyrin 2, neuronal ENSRNOG00000011076 -0.96 0.0164 -1.95
Ccnd2 cyclin D2 ENSRNOG00000019939 -0.96 0.0177 -1.95
Fam126b family with sequence similarity 126, member B ENSRNOG00000025079 -0.97 0.0055 -1.95
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Coq7 coenzyme Q7 homolog, ubiquinone (yeast) ENSRNOG00000017012 -0.97 0.0298 -1.95
Chdh choline dehydrogenase ENSRNOG00000015859 -0.97 0.0476 -1.95
Ano5 anoctamin 5 ENSRNOG00000015972 -0.97 0.0457 -1.96
Bmp1 bone morphogenetic protein 1 ENSRNOG00000010890 -0.97 0.0051 -1.96
Uba7 ubiquitin-like modifier activating enzyme 7 ENSRNOG00000029195 -0.97 0.0159 -1.96
Angptl1 angiopoietin-like 1 ENSRNOG00000004712 -0.97 0.0277 -1.96
Map7d3 MAP7 domain containing 3 ENSRNOG00000027831 -0.97 0.0391 -1.96
Sec14l5 SEC14-like 5 (S. cerevisiae) ENSRNOG00000002917 -0.97 0.0133 -1.96
Fuom fucose mutarotase ENSRNOG00000018476 -0.97 0.0205 -1.97
RGD1307461 similar to RIKEN cDNA 6430571L13 gene; similar to g20 protein ENSRNOG00000015718 -0.98 0.0209 -1.97
Car4 carbonic anhydrase 4 ENSRNOG00000002916 -0.98 0.0176 -1.97
Sec16b SEC16 homolog B (S. cerevisiae) ENSRNOG00000005229 -0.98 0.0123 -1.97
Tle1 transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila) ENSRNOG00000005882 -0.98 0.0201 -1.98
Sorl1 sortilin-related receptor, LDLR class A repeats-containing ENSRNOG00000024374 -0.98 0.0113 -1.98
Ppm1j protein phosphatase, Mg2+/Mn2+ dependent, 1J ENSRNOG00000012481 -0.98 0.0061 -1.98
Ankh ANKH inorganic pyrophosphate transport regulator ENSRNOG00000010960 -0.98 0.0209 -1.98
Paqr7 progestin and adipoQ receptor family member VII ENSRNOG00000022054 -0.98 0.0066 -1.98
Gpsm2 G-protein signaling modulator 2 ENSRNOG00000012149 -0.99 0.0090 -1.98
Aldh1a2 aldehyde dehydrogenase 1 family, member A2 ENSRNOG00000016042 -0.99 0.0155 -1.98
Dusp10 dual specificity phosphatase 10 ENSRNOG00000004003 -0.99 0.0257 -1.98
Itgb6 integrin, beta 6 ENSRNOG00000008346 -0.99 0.0104 -1.98
Fkbp4 FK506 binding protein 4 ENSRNOG00000006444 -0.99 0.0316 -1.99
Ptgr2 prostaglandin reductase 2 ENSRNOG00000038166 -0.99 0.0198 -1.99
Cep70 centrosomal protein 70 ENSRNOG00000022845 -0.99 0.0222 -1.99
RGD1561161 similar to BC067074 protein ENSRNOG00000039582 -0.99 0.0073 -1.99
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Tmem132a transmembrane protein 132A ENSRNOG00000021338 -1.00 0.0178 -1.99
Per3 period circadian clock 3 ENSRNOG00000018413 -1.00 0.0107 -1.99
Prepl prolyl endopeptidase-like ENSRNOG00000007326 -1.00 0.0136 -2.00
Fxyd6 FXYD domain-containing ion transport regulator 6 ENSRNOG00000016412 -1.00 0.0043 -2.00
Lrrc17 leucine rich repeat containing 17 ENSRNOG00000012817 -1.00 0.0142 -2.00
Frem1 Fras1 related extracellular matrix 1 ENSRNOG00000022309 -1.01 0.0155 -2.01
Bpnt1 3'(2'), 5'-bisphosphate nucleotidase 1 ENSRNOG00000002378 -1.01 0.0322 -2.01
Cdon cell adhesion associated, oncogene regulated ENSRNOG00000011789 -1.01 0.0092 -2.01
Stac3 cell adhesion associated, oncogene regulated ENSRNOG00000008050 -1.01 0.0096 -2.01
Fndc3c1 fibronectin type III domain containing 3C1 ENSRNOG00000002451 -1.01 0.0187 -2.01
MAMDC2 Uncharacterized protein  ENSRNOG00000024620 -1.01 0.0094 -2.02
Rab15 RAB15, member RAS oncogene family ENSRNOG00000007364 -1.01 0.0051 -2.02
Tfrc transferrin receptor ENSRNOG00000001766 -1.01 0.0179 -2.02
Rerg RAS-like, estrogen-regulated, growth-inhibitor ENSRNOG00000027592 -1.01 0.0318 -2.02
Ptprz1 protein tyrosine phosphatase, receptor-type, Z polypeptide 1 ENSRNOG00000006030 -1.02 0.0047 -2.02
Fitm2 fat storage-inducing transmembrane protein 2 ENSRNOG00000027434 -1.02 0.0222 -2.02
Dock2 dedicator of cytokinesis 2 ENSRNOG00000006932 -1.02 0.0233 -2.03
Pgpep1 pyroglutamyl-peptidase I ENSRNOG00000019639 -1.02 0.0153 -2.03
Nudt12 nudix (nucleoside diphosphate linked moiety X)-type motif 12 ENSRNOG00000022576 -1.02 0.0398 -2.03
Zfp426 zinc finger protein 266 ENSRNOG00000033624 -1.03 0.0178 -2.04
Jph2 junctophilin 2 ENSRNOG00000008170 -1.03 0.0249 -2.04
Trak2 trafficking protein, kinesin binding 2 ENSRNOG00000010881 -1.03 0.0146 -2.04
Fgf6 fibroblast growth factor 6 ENSRNOG00000019836 -1.03 0.0257 -2.04
Pkia protein kinase (cAMP-dependent, catalytic) inhibitor alpha ENSRNOG00000012095 -1.03 0.0246 -2.04
Klhl31 kelch-like family member 31 ENSRNOG00000006224 -1.03 0.0382 -2.05
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Tbc1d31 TBC1 domain family, member 31 ENSRNOG00000006103 -1.03 0.0441 -2.05
Dpp4 dipeptidylpeptidase 4 ENSRNOG00000030763 -1.03 0.0236 -2.05
Fras1 Fraser extracellular matrix complex subunit 1 ENSRNOG00000002053 -1.04 0.0323 -2.05
Nceh1 neutral cholesterol ester hydrolase 1 ENSRNOG00000013313 -1.04 0.0095 -2.06
Nfam1 NFAT activating protein with ITAM motif 1 ENSRNOG00000022975 -1.04 0.0044 -2.06
Tmem150c transmembrane protein 150C ENSRNOG00000002258 -1.04 0.0257 -2.06
Ghr growth hormone receptor ENSRNOG00000015654 -1.05 0.0155 -2.07
Tpmt thiopurine S-methyltransferase ENSRNOG00000016468 -1.05 0.0142 -2.07
MGC108823 similar to interferon-inducible GTPase ENSRNOG00000019542 -1.05 0.0280 -2.07
Col6a3 collagen, type VI, alpha 3 ENSRNOG00000019648 -1.05 0.0142 -2.07
Ccna1 cyclin A1 ENSRNOG00000014052 -1.06 0.0108 -2.08
Cxxc5 CXXC finger protein 5 ENSRNOG00000032878 -1.06 0.0037 -2.08
Ppic peptidylprolyl isomerase C ENSRNOG00000017416 -1.06 0.0332 -2.08
Rtn4 reticulon 4 ENSRNOG00000004621 -1.06 0.0312 -2.08
Nkiras1 NFKB inhibitor interacting Ras-like 1 ENSRNOG00000008565 -1.06 0.0043 -2.08
Hmcn2 hemicentin 2 ENSRNOG00000008820 -1.06 0.0042 -2.09
Dmrt2 doublesex and mab-3 related transcription factor 2 ENSRNOG00000016301 -1.06 0.0131 -2.09
Nr0b2 nuclear receptor subfamily 0, group B, member 2 ENSRNOG00000007229 -1.07 0.0177 -2.09
P2rx6 purinergic receptor P2X, ligand-gated ion channel, 6 ENSRNOG00000001873 -1.07 0.0167 -2.09
Mchr1 melanin-concentrating hormone receptor 1 ENSRNOG00000018895 -1.07 0.0092 -2.10
Entpd5 ectonucleoside triphosphate diphosphohydrolase 5 ENSRNOG00000033206 -1.07 0.0303 -2.10
Fam13a family with sequence similarity 13, member A ENSRNOG00000007947 -1.07 0.0224 -2.10
D2hgdh D-2-hydroxyglutarate dehydrogenase ENSRNOG00000019012 -1.07 0.0291 -2.10
Fgf2 fibroblast growth factor 2 ENSRNOG00000017392 -1.07 0.0187 -2.10
Tmc7 transmembrane channel-like 7 ENSRNOG00000016679 -1.07 0.0066 -2.11
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Wnt5a wingless-type MMTV integration site family, member 5A ENSRNOG00000015618 -1.08 0.0053 -2.11
Rcan2 regulator of calcineurin 2 ENSRNOG00000010350 -1.08 0.0043 -2.11
Serpinf1 serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 ENSRNOG00000003172 -1.08 0.0494 -2.11
Actr3b ARP3 actin-related protein 3 homolog B (yeast) ENSRNOG00000031855 -1.08 0.0172 -2.12
Calm1 calmodulin 1 ENSRNOG00000016770 -1.08 0.0323 -2.12
Dzip1 DAZ interacting zinc finger protein 1 ENSRNOG00000010311 -1.08 0.0282 -2.12
Coq3 coenzyme Q3 methyltransferase ENSRNOG00000009974 -1.08 0.0178 -2.12
Rhobtb3 Rho-related BTB domain containing 3 ENSRNOG00000012414 -1.10 0.0050 -2.14
Hyal1 hyaluronoglucosaminidase 1 ENSRNOG00000015858 -1.10 0.0153 -2.15
Clec11a C-type lectin domain family 11, member A ENSRNOG00000019138 -1.11 0.0201 -2.16
Zim1 zinc finger, imprinted 1 ENSRNOG00000015071 -1.11 0.0248 -2.16
Epdr1 ependymin related 1 ENSRNOG00000018989 -1.11 0.0272 -2.16
Oplah 5-oxoprolinase (ATP-hydrolysing) ENSRNOG00000011781 -1.11 0.0342 -2.16
Kcnq1 potassium voltage-gated channel, KQT-like subfamily, member 1 ENSRNOG00000020532 -1.12 0.0179 -2.17
Wls wntless Wnt ligand secretion mediator ENSRNOG00000036816 -1.12 0.0249 -2.17
Kif24 kinesin family member 24 ENSRNOG00000012735 -1.12 0.0055 -2.17
Cyp2j4 cytochrome P450, family 2, subfamily j, polypeptide 4 ENSRNOG00000031004 -1.12 0.0192 -2.18
Tesk2 testis-specific kinase 2 ENSRNOG00000017282 -1.13 0.0054 -2.18
Acsl6 acyl-CoA synthetase long-chain family member 6 ENSRNOG00000026745 -1.13 0.0462 -2.18
Fbxw7 F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase ENSRNOG00000010889 -1.13 0.0042 -2.19
Mamstr MEF2 activating motif and SAP domain containing transcriptional regulator ENSRNOG00000024580 -1.13 0.0483 -2.19
Bcs1l BC1 (ubiquinol-cytochrome c reductase) synthesis-like ENSRNOG00000016754 -1.13 0.0203 -2.19
Sobp sine oculis-binding protein homolog (Drosophila) ENSRNOG00000000316 -1.13 0.0164 -2.19
Armcx3 armadillo repeat containing, X-linked 3 ENSRNOG00000025730 -1.13 0.0314 -2.19
RGD1560334 similar to Myosin light chain 1 slow a ENSRNOG00000003860 -1.13 0.0037 -2.19
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Fn1 fibronectin 1 ENSRNOG00000014288 -1.13 0.0223 -2.19
Cc2d2a coiled-coil and C2 domain containing 2A ENSRNOG00000005106 -1.14 0.0067 -2.20
Rps6ka2 ribosomal protein S6 kinase polypeptide 2 ENSRNOG00000013194 -1.14 0.0342 -2.20
C1qtnf3 C1q and tumor necrosis factor related protein 3 ENSRNOG00000018570 -1.14 0.0133 -2.21
Ddah2 dimethylarginine dimethylaminohydrolase 2 ENSRNOG00000000842 -1.14 0.0155 -2.21
Ccnd1 cyclin D1 ENSRNOG00000020918 -1.14 0.0233 -2.21
Ndufs1 NADH dehydrogenase (ubiquinone) Fe-S protein 1 ENSRNOG00000011849 -1.14 0.0151 -2.21
Tmtc4 transmembrane and tetratricopeptide repeat containing 4 ENSRNOG00000014310 -1.14 0.0044 -2.21
Klhl13 kelch-like family member 13 ENSRNOG00000014029 -1.15 0.0131 -2.21
Sv2b synaptic vesicle glycoprotein 2b ENSRNOG00000011160 -1.15 0.0118 -2.22
Rilp Rab interacting lysosomal protein ENSRNOG00000003784 -1.15 0.0146 -2.23
Klhl23 kelch-like family member 23 ENSRNOG00000007981 -1.16 0.0133 -2.23
Taco1 translational activator of mitochondrially encoded cytochrome c oxidase I ENSRNOG00000008405 -1.16 0.0129 -2.24
Tppp tubulin polymerization promoting protein ENSRNOG00000028261 -1.17 0.0459 -2.25
Akr1e2 aldo-keto reductase family 1, member E2 ENSRNOG00000017165 -1.17 0.0266 -2.25
Pcolce procollagen C-endopeptidase enhancer ENSRNOG00000025001 -1.17 0.0117 -2.25
Pde4a phosphodiesterase 4A, cAMP-specific ENSRNOG00000020828 -1.17 0.0398 -2.26
Plekha6 pleckstrin homology domain containing, family A member 6 ENSRNOG00000002907 -1.18 0.0063 -2.26
Fstl1 follistatin-like 1 ENSRNOG00000002746 -1.18 0.0241 -2.26
Lgi2 leucine-rich repeat LGI family, member 2 ENSRNOG00000003887 -1.18 0.0085 -2.27
RGD1311744 similar to RIKEN cDNA 5830475I06 ENSRNOG00000005960 -1.18 0.0092 -2.27
Schip1 schwannomin interacting protein 1 ENSRNOG00000009276 -1.18 0.0223 -2.27
Fam161b family with sequence similarity 161, member B ENSRNOG00000011112 -1.19 0.0089 -2.28
Dnajc28 DnaJ (Hsp40) homolog, subfamily C, member 28 ENSRNOG00000002026 -1.19 0.0342 -2.28
Tbck TBC1 domain containing kinase ENSRNOG00000011454 -1.19 0.0469 -2.28
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Atp1b4 ATPase, (Na+)/K+ transporting, beta 4 polypeptide ENSRNOG00000007059 -1.19 0.0178 -2.28
Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 ENSRNOG00000013269 -1.19 0.0125 -2.28
Cit citron rho-interacting serine/threonine kinase ENSRNOG00000001143 -1.19 0.0066 -2.29
Scube2 signal peptide, CUB domain, EGF-like 2 ENSRNOG00000013123 -1.20 0.0131 -2.30
Tp53inp2 tumor protein p53 inducible nuclear protein 2 ENSRNOG00000018225 -1.20 0.0166 -2.30
Smoc2 SPARC related modular calcium binding 2 ENSRNOG00000014166 -1.20 0.0136 -2.31
Opcml opioid binding protein/cell adhesion molecule-like ENSRNOG00000023809 -1.21 0.0149 -2.31
Dhrs11 dehydrogenase/reductase (SDR family) member 11 ENSRNOG00000027891 -1.22 0.0183 -2.33
Slc25a30 solute carrier family 25, member 30 ENSRNOG00000001052 -1.23 0.0142 -2.34
Palld palladin, cytoskeletal associated protein ENSRNOG00000010107 -1.23 0.0217 -2.34
Lgals1 lectin, galactoside-binding, soluble, 1 ENSRNOG00000009884 -1.23 0.0042 -2.35
Reep1 receptor accessory protein 1 ENSRNOG00000008481 -1.23 0.0113 -2.35
Abi3bp ABI family, member 3 (NESH) binding protein ENSRNOG00000001627 -1.24 0.0307 -2.36
Mkks McKusick-Kaufman syndrome ENSRNOG00000006705 -1.24 0.0341 -2.36
Armcx6 armadillo repeat containing, X-linked 6 ENSRNOG00000037707 -1.25 0.0073 -2.37
Col11a1 collagen, type XI, alpha 1 ENSRNOG00000023148 -1.25 0.0225 -2.38
Osgin2 oxidative stress induced growth inhibitor family member 2 ENSRNOG00000009358 -1.25 0.0119 -2.38
Grb14 growth factor receptor bound protein 14 ENSRNOG00000031396 -1.25 0.0104 -2.39
Cd248 CD248 molecule, endosialin ENSRNOG00000020197 -1.26 0.0066 -2.39
Fsd1l fibronectin type III and SPRY domain containing 1-like ENSRNOG00000017823 -1.26 0.0210 -2.39
Prkg1 protein kinase, cGMP-dependent, type 1 ENSRNOG00000033641 -1.27 0.0172 -2.40
Myh7b myosin, heavy chain 7B, cardiac muscle, beta ENSRNOG00000018997 -1.27 0.0241 -2.41
Ncf1 neutrophil cytosolic factor 1 ENSRNOG00000001480 -1.27 0.0178 -2.42
RGD1311863 similar to RIKEN cDNA 2410127L17 ENSRNOG00000012872 -1.27 0.0229 -2.42
Oxnad1 oxidoreductase NAD-binding domain containing 1 ENSRNOG00000019760 -1.28 0.0138 -2.42
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Wfdc1 WAP four-disulfide core domain 1 ENSRNOG00000015904 -1.28 0.0068 -2.43
Pi16 peptidase inhibitor 16 ENSRNOG00000000525 -1.28 0.0209 -2.43
Aqp7 aquaporin 7 ENSRNOG00000009686 -1.28 0.0317 -2.43
Sspn sarcospan ENSRNOG00000001807 -1.28 0.0194 -2.43
Tppp3 tubulin polymerization-promoting protein family member 3 ENSRNOG00000016890 -1.29 0.0163 -2.44
Pecr peroxisomal trans-2-enoyl-CoA reductase ENSRNOG00000015809 -1.29 0.0390 -2.44
Acot13 acyl-CoA thioesterase 13 ENSRNOG00000018415 -1.29 0.0445 -2.45
Pstk phosphoseryl-tRNA kinase ENSRNOG00000020605 -1.30 0.0459 -2.46
Efr3b EFR3 homolog B (S. cerevisiae) ENSRNOG00000012950 -1.30 0.0159 -2.46
Dusp19 dual specificity phosphatase 19 ENSRNOG00000008868 -1.30 0.0118 -2.47
Smtn smoothelin ENSRNOG00000019451 -1.31 0.0026 -2.47
Dffa DNA fragmentation factor, alpha subunit ENSRNOG00000013603 -1.31 0.0172 -2.48
Lynx1 Ly6/neurotoxin 1 ENSRNOG00000006086 -1.31 0.0216 -2.48
Fam216b family with sequence similarity 216, member B ENSRNOG00000021943 -1.31 0.0063 -2.48
Slc47a1 solute carrier family 47 (multidrug and toxin extrusion), member 1 ENSRNOG00000002355 -1.32 0.0213 -2.49
Nudt8 nudix (nucleoside diphosphate linked moiety X)-type motif 8 ENSRNOG00000017955 -1.32 0.0115 -2.49
Capn6 calpain 6 ENSRNOG00000004882 -1.32 0.0101 -2.49
Actc1 actin, alpha, cardiac muscle 1 ENSRNOG00000008536 -1.32 0.0131 -2.50
Ssc5d scavenger receptor cysteine rich family, 5 domains ENSRNOG00000016687 -1.32 0.0023 -2.50
Bgn biglycan ENSRNOG00000017440 -1.33 0.0371 -2.51
Abcd2 ATP-binding cassette, subfamily D (ALD), member 2 ENSRNOG00000015538 -1.34 0.0355 -2.53
Igdcc4 immunoglobulin superfamily, DCC subclass, member 4 ENSRNOG00000033496 -1.35 0.0123 -2.54
Cilp cartilage intermediate layer protein, nucleotide pyrophosphohydrolase ENSRNOG00000029911 -1.35 0.0133 -2.55
Scn1a sodium channel, voltage-gated, type I, alpha subunit ENSRNOG00000005989 -1.35 0.0275 -2.55
Dynll1 dynein light chain LC8-type 1 ENSRNOG00000011222 -1.36 0.0229 -2.56
Gene Symbol Description Ensembl ID fold change log2 p value fold change
RragB Ras-related GTP binding B ENSRNOG00000003160 -1.37 0.0320 -2.58
Ebpl emopamil binding protein-like ENSRNOG00000014659 -1.37 0.0023 -2.59
Slc16a3 solute carrier family 16 (monocarboxylate transporter), member 3 ENSRNOG00000036677 -1.38 0.0095 -2.59
Inpp5j inositol polyphosphate-5-phosphatase J ENSRNOG00000019361 -1.38 0.0023 -2.60
Tmem25 transmembrane protein 25 ENSRNOG00000014218 -1.38 0.0030 -2.60
Pik3ap1 phosphoinositide-3-kinase adaptor protein 1 ENSRNOG00000013309 -1.38 0.0296 -2.60
Carns1 carnosine synthase 1 ENSRNOG00000018603 -1.39 0.0066 -2.62
Bub1 BUB1 mitotic checkpoint serine/threonine kinase ENSRNOG00000032778 -1.39 0.0208 -2.63
Nt5c1a 5'-nucleotidase, cytosolic IA ENSRNOG00000015283 -1.40 0.0279 -2.63
Ppara peroxisome proliferator activated receptor alpha ENSRNOG00000021463 -1.40 0.0133 -2.64
Clcn4 chloride channel, voltage-sensitive 4 ENSRNOG00000003533 -1.40 0.0407 -2.64
Mmp15 matrix metallopeptidase 15 ENSRNOG00000012622 -1.41 0.0071 -2.67
Plekhh3 pleckstrin homology domain containing, family H (with MyTH4 domain) member 3 ENSRNOG00000020238 -1.42 0.0021 -2.68
Fndc1 fibronectin type III domain containing 1 ENSRNOG00000030210 -1.44 0.0241 -2.72
Zfp385a zinc finger protein 385A ENSRNOG00000036833 -1.46 0.0223 -2.75
Myo3b myosin IIIB ENSRNOG00000030022 -1.48 0.0310 -2.78
Ccdc80 coiled-coil domain containing 80 ENSRNOG00000002052 -1.48 0.0225 -2.79
Cnst consortin, connexin sorting protein ENSRNOG00000002710 -1.48 0.0142 -2.79
Postn periostin, osteoblast specific factor ENSRNOG00000012660 -1.54 0.0129 -2.91
Mum1l1 melanoma associated antigen (mutated) 1-like 1 ENSRNOG00000030475 -1.54 0.0035 -2.91
Asb15 ankyrin repeat and SOCS box containing 15 ENSRNOG00000006365 -1.55 0.0378 -2.93
Dbp D site of albumin promoter (albumin D-box) binding protein ENSRNOG00000021027 -1.56 0.0096 -2.94
Sfrp2 secreted frizzled-related protein 2 ENSRNOG00000009465 -1.56 0.0023 -2.95
Scd1 stearoyl-Coenzyme A desaturase 1 ENSRNOG00000013552 -1.57 0.0324 -2.96
Esr1 estrogen receptor 1 ENSRNOG00000019358 -1.57 0.0056 -2.96
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Sesn3 sestrin 3 ENSRNOG00000008173 -1.57 0.0043 -2.97
Sema6c sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6C ENSRNOG00000021101 -1.60 0.0225 -3.04
Rcor2 REST corepressor 2 ENSRNOG00000021183 -1.60 0.0023 -3.04
Slco5a1 solute carrier organic anion transporter family, member 5A1 ENSRNOG00000008966 -1.61 0.0112 -3.05
Agbl1 ATP/GTP binding protein-like 1 ENSRNOG00000022610 -1.61 0.0327 -3.06
G0s2 G0/G1switch 2 ENSRNOG00000006019 -1.62 0.0018 -3.08
Abhd1 abhydrolase domain containing 1 ENSRNOG00000025689 -1.63 0.0072 -3.10
Ppargc1b peroxisome proliferator-activated receptor gamma, coactivator 1 beta ENSRNOG00000017503 -1.63 0.0023 -3.10
Sypl2 synaptophysin-like 2 ENSRNOG00000019780 -1.65 0.0365 -3.14
Stat1 signal transducer and activator of transcription 1 ENSRNOG00000014079 -1.65 0.0085 -3.14
Arhgef9 Cdc42 guanine nucleotide exchange factor (GEF) 9 ENSRNOG00000007733 -1.65 0.0039 -3.14
Gpd1 glycerol-3-phosphate dehydrogenase 1 (soluble) ENSRNOG00000019213 -1.66 0.0068 -3.16
Col14a1 collagen, type XIV, alpha 1 ENSRNOG00000026415 -1.66 0.0240 -3.17
Rasgrf1 RAS protein-specific guanine nucleotide-releasing factor 1 ENSRNOG00000014025 -1.69 0.0017 -3.22
Crabp1 cellular retinoic acid binding protein 1 ENSRNOG00000023633 -1.71 0.0133 -3.26
Cdc42ep2 CDC42 effector protein (Rho GTPase binding) 2 ENSRNOG00000020904 -1.71 0.0101 -3.27
Hpdl 4-hydroxyphenylpyruvate dioxygenase-like ENSRNOG00000018143 -1.71 0.0131 -3.27
Angptl2 angiopoietin-like 2 ENSRNOG00000016678 -1.73 0.0057 -3.32
Sacs sacsin molecular chaperone ENSRNOG00000014509 -1.73 0.0017 -3.32
Akr1b10 aldo-keto reductase family 1, member B10 (aldose reductase) ENSRNOG00000027433 -1.74 0.0039 -3.35
Otub2 OTU deubiquitinase, ubiquitin aldehyde binding 2 ENSRNOG00000009117 -1.75 0.0077 -3.35
Pdp1 pyruvate dehyrogenase phosphatase catalytic subunit 1 ENSRNOG00000016180 -1.75 0.0023 -3.37
Nqo2 NAD(P)H dehydrogenase, quinone 2 ENSRNOG00000017820 -1.77 0.0125 -3.42
Adamts8 ADAM metallopeptidase with thrombospondin type 1 motif, 8 ENSRNOG00000005574 -1.80 0.0342 -3.47
Trim7 tripartite motif-containing 7 ENSRNOG00000002469 -1.80 0.0019 -3.48
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Fsd2 fibronectin type III and SPRY domain containing 2 ENSRNOG00000019278 -1.80 0.0202 -3.49
Plcd4 phospholipase C, delta 4 ENSRNOG00000016361 -1.83 0.0142 -3.55
Cdh23 cadherin-related 23 ENSRNOG00000033087 -1.86 0.0447 -3.62
Myl6b myosin, light chain 6B, alkali, smooth muscle and non-muscle ENSRNOG00000028837 -1.89 0.0017 -3.71
Itgb1bp2 integrin beta 1 binding protein 2 ENSRNOG00000003596 -1.90 0.0115 -3.72
Sel1l3 sel-1 suppressor of lin-12-like 3 (C. elegans) ENSRNOG00000004932 -1.90 0.0078 -3.73
Gamt guanidinoacetate N-methyltransferase ENSRNOG00000024577 -1.91 0.0035 -3.76
Col1a2 collagen, type I, alpha 2 ENSRNOG00000011292 -1.96 0.0066 -3.88
Scn4b sodium channel, voltage-gated, type IV, beta subunit ENSRNOG00000026679 -1.96 0.0246 -3.89
Chodl chondrolectin ENSRNOG00000001915 -1.98 0.0055 -3.96
Pfkfb1 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 ENSRNOG00000000165 -2.01 0.0321 -4.04
Lum lumican ENSRNOG00000004610 -2.13 0.0039 -4.38
Gadl1 glutamate decarboxylase-like 1 ENSRNOG00000013221 -2.13 0.0088 -4.39
Itm2a integral membrane protein 2A ENSRNOG00000002365 -2.14 0.0032 -4.40
Grm4 glutamate receptor, metabotropic 4 ENSRNOG00000000487 -2.15 0.0017 -4.45
Clcn1 chloride channel, voltage-sensitive 1 ENSRNOG00000016917 -2.17 0.0323 -4.50
P2ry1 purinergic receptor P2Y, G-protein coupled, 1 ENSRNOG00000014232 -2.28 0.0146 -4.85
Col5a1 collagen, type V, alpha 1 ENSRNOG00000008749 -2.28 0.0049 -4.85
Smco1 single-pass membrane protein with coiled-coil domains 1 ENSRNOG00000024960 -2.30 0.0142 -4.91
Tet1 tet methylcytosine dioxygenase 1 ENSRNOG00000000277 -2.30 0.0023 -4.92
Ky kyphoscoliosis peptidase ENSRNOG00000008210 -2.32 0.0088 -5.00
Igfbp5 insulin-like growth factor binding protein 5 ENSRNOG00000017206 -2.33 0.0023 -5.04
Dok5 docking protein 5 ENSRNOG00000013196 -2.35 0.0223 -5.08
Cpa1 carboxypeptidase A1 (pancreatic) ENSRNOG00000010725 -2.38 0.0016 -5.22
Kcnj13 potassium inwardly-rectifying channel, subfamily J, member 13 ENSRNOG00000016057 -2.41 0.0420 -5.30
Gene Symbol Description Ensembl ID fold change log2 p value fold change
Kera keratocan ENSRNOG00000004635 -2.46 0.0471 -5.51
Col1a1 collagen, type I, alpha 1 ENSRNOG00000003897 -2.53 0.0035 -5.77
Sfrp4 secreted frizzled-related protein 4 ENSRNOG00000018893 -2.58 0.0163 -5.98
Mfap4 microfibril-associated glycoprotein 4-like ENSRNOG00000002382 -2.58 0.0030 -5.98
Rab3a RAB3A, member RAS oncogene family ENSRNOG00000019433 -2.60 0.0023 -6.08
Map2k6 mitogen-activated protein kinase kinase 6 ENSRNOG00000004437 -2.64 0.0017 -6.24
Mlf1 myeloid leukemia factor 1 ENSRNOG00000012827 -2.77 0.0063 -6.83
Pik3c2g phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit type 2 gamma ENSRNOG00000034228 -2.80 0.0100 -6.97
Col3a1 collagen, type III, alpha 1 ENSRNOG00000003357 -3.09 0.0035 -8.53
Nrep neuronal regeneration related protein ENSRNOG00000020467 -3.25 0.0017 -9.52
RGD1565323 similar to OTTMUSP00000000621 ENSRNOG00000021789 -3.84 0.0201 -14.33
Table Supplementary 2 Functional classification of genes differentially expressed in cardiac cachexia
Go Module GOTERM GO database GOID p value term
Collagen biosynthesis REACTOME 5417884 3.5 E-4
Regulation of myotube differentiation GO: BiologicalProcess 10830 2.2 E-2
Extracellular matrix organization REACTOME 5417076 6.0 E-7
Muscle contraction GO: BiologicalProcess 6936 4.3 E-2
Regulation of lipid storage GO: BiologicalProcess 10883 6.8 E-3
The citric acid cycle and respiratory electron transport REACTOME 5416705 6.0 E-4
Metabolism of amino acids and derivatives REACTOME 5416707 1.9 E-4
Glycerolipid metabolic process GO: BiologicalProcess 46486 4.4 E-4
ATP metabolic process GO: BiologicalProcess 46034 3.6 E-2
Carbohydrate metabolic process GO: BiologicalProcess 5975 4.4 E-6
Ubiquitin-Proteasome KEGG 3050 3.7 E-8
p53 signaling pathway KEGG 4115 5.7 E-3
Senescence and Autophagy WikiPathways 1267 2.9 E-2
Apoptosis REACTOME 5416750 5.5 E-7
Positive regulation of cell death GO: BiologicalProcess 10942 1.5 E-6
Positive regulation of peptidase activity GO: BiologicalProcess 10952 1.3 E-4
IGF signaling pathway GO: BiologicalProcess 48009 3.1 E-3
TGF beta signaling pathway GO: BiologicalProcess 7179 7.9 E-3
PI3K-Akt signaling pathway KEGG 4151 4.0 E-9
Positive regulation of cell adhesion GO: BiologicalProcess 45785 2.6 E-2
Negative regulation of cell migration GO: BiologicalProcess 30336 1.7 E-2
Signaling by Wnt REACTOME 5417230 4.2 E-2
MAPK signaling pathway KEGG 4010 3.0 E-3
Negative regulation of cell proliferation GO: BiologicalProcess 8285 2.7 E-6
Negative regulation of chemokine production GO: BiologicalProcess 32682 1.6 E-2
Regulation of I-kappaB kinase/NF-kappaB signaling GO: BiologicalProcess 43122 3.6 E-2
Positive regulation of ion transport GO: BiologicalProcess 43270 2.4 E-2
Cellular calcium ion homeostasis GO: BiologicalProcess 6874 3.0 E-3
positive regulation of angiogenesis GO: BiologicalProcess 45766 1.7 E-2
protein kinase B signaling GO: BiologicalProcess 43491 1.9 E-2Others
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Functional classification of genes differentially expressed in cardiac cachexia
% associated genes Nr.genes Associated genes found
24.074074 13 [Bmp1, Col11a1, Col14a1, Col1a1, Col1a2, Col3a1, Col5a1, Col6a1, Col6a2, Colgalt2
18.965517 11 [Cav3, Cdon, Hif1an, Id3, Igfbp3, Mamstr, Myocd, Naca, Ppapdc3, Sik1, Smyd1]
14.230769 37 [Bgn, Bmp1, Col11a1, Col14a1, Col1a1, Col1a2, Col3a1, Col5a1, Col6a1, Col6a2,
10.900474 23 [Actc1, Ank2, Casq1, Casq2, Cav3, Chrna1, Edn1, Ednrb, Kcnh2, Kcnma1, Kcnq1,
26.470589 9 [Fitm2, Itgav, Nfkbia, Osbpl11, Osbpl8, Pnpla2, Ppara, Ptpn2, Zc3h12a]
13.953488 24 [Atp5c1, Atp5g1, Atp5k, Atp5o, Cyc1, Idh3g, Mpc2, Ndufa12, Ndufa2, Ndufa8,
13.705584 27 [Ccbl1, Cdo1, Fah, Gamt, Gls2, Hibch, Hpd, Psma3, Psma4, Psma6, Psmb3, 
12.345679 30 [Acsl4, Acsl6, Bpnt1, Cav3, Chka, Cyp2e1, Dgkh, Fabp3, Fgf2, Fgf7, Fitm2, Gpd1,
10.810811 24 [Abcb7, Abcd1, Abcd3, Actc1, Ak2, Atf7ip, Atp1b1, Atp5c1, Atp5g1, Atp5g3, Atp5k,
10.032362 62 [Acadm, Acer2, Adcyap1r1, Akr1b3, Art3, Atp1b1, B3galnt2, C1qtnf2, C1qtnf3, Cds2, 
35.555557 16 [Psma3, Psma4, Psma6, Psmb3, Psmc1, Psmc4, Psmc6, Psmd1, Psmd11,
18.84058 13 [Atr, Bid, Ccnd1, Ccnd2, Cdk6, Cdkn1a, Gadd45b, Igfbp3, Pmaip1, Ppm1d, Serpine1,
18.333334 11 [Cdkn1a, Col1a1, Creg1, Fn1, Igf1r, Igfbp5, Il6st, Lamp2, Plat, Rnasel, Serpine1]
17.058823 29 [Arhgap10, Bcl2l1, Bcl2l11, Bid, Bmx, Dapk1, Dffa, Dnm1l, Dynll1, Kpna1, Pmaip1,
11.898734 47 [Acer2, Adm, Aldh1a2, Axin2, Bcl2l1, Bcl2l11, Bid, Brms1, Casp12, Cd248, Cd24a, 
16.17647 22 [Acer2, Adrm1, Anp32b, Bcl2l11, Bid, Casp12, Cradd, Cyr61, Fn1, Hspd1, Ift57, 
29.032259 9 [Atxn1, Cilp, Ghr, Igf1r, Igfbp3, Igfbp5, Inppl1, Irs1, Phip]
14.285714 18 [Cav3, Ccl2, Cited2, Col1a2, Col3a1, Dusp22, Fos, Furin, Gcnt2, Itga8, Lemd3,
13.802817 49 [Angpt2, Bcl2l1, Bcl2l11, Ccnd1, Ccnd2, Cdk6, Cdkn1a, Col11a1, Col1a1, Col1a2,
12.582782 19 [Abi3bp, Ccdc80, Cd24a, Cd63, Cdk6, Cited2, Cyr61, Gcnt2, Gpr56, Hyal1, Itga5,
12.578616 20 [Abhd2, Adarb1, Angpt2, Cd63, Cited2, Col3a1, Dach1, Dll4, Fgf2, Gnrh1, Gpr56,
11.167513 22 [Calm1, Cul1, Gng7, Ppp2r5b, Psma3, Psma4, Psma6, Psmb3, Psmc1, Psmc4,
11.417323 29 [Cacna2d1, Cacna2d3, Cacnb4, Cacng6, Dusp10, Elk1, Fgf11, Fgf2, Fgf6, Fgf7,
10.575139 57 [Adarb1, Adm, Aldh1a2, Axin2, Btg2, Cblb, Cd24a, Cdk6, Cdkn1a, Ctsl, Cxadr,
50 5 [C1qtnf3, F2rl1, Gstp1, Klf4, Slc37a4]
11.904762 20 [C1qtnf3, Cxxc5, Esr1, F2rl1, Gstp1, Hmox1, Il18, Lgals1, Lgals9, Litaf, Myd88, Nfkbia,
12.269938 20 [Acsl6, Adcyap1r1, Ank2, Creb3, Hbp1, Kcnh2, Kcnq1, Lgals3, Map2k6, Mchr1,
10.847458 32 [Adcyap1r1, Adm, Ank2, Cacnb4, Calcr, Casq1, Casq2, Cav3, Ccdc109b, Ccl2,
14.545455 16 [Adm, Angpt2, Chil1, Fgf2, Gata6, Hmox1, Hyal1, Mir23a, Mir23b, Mir27a, Pgf,
13.333333 18 [C1qtnf3, Cav3, Chil1, Clcf1, Fgf2, Gcnt2, Igf1r, Igfbp5, Inpp5f, Irs1, Klf4, Meis3,
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Associated genes found
 Leprel1, Leprel2, Pcolce]
 Colgalt2, Ctsd, Ctsl, Fgf2, Fn1, Furin, Hspg2, Itga5, Itga8, Itgav, Itgb6, Lama4, Leprel1, Leprel2, Lox, Ltbp3, Ltbp4, Lum,
 Map2k6, Mkks, Myh7b, Myl6b, Myocd, Ncf1, Nos1, Ppp1r13l, Prkg1, Scn4b, Smad7, Vegfb]
 Ndufb3, Ndufb5, Ndufb6, Ndufb7, Ndufs1, Ndufs3, Ndufs5, Ndufs8, Ndufv1, Pdk4, Pdp1, Sdhd, Slc16a3, Uqcrc1]
Psmc1, Psmc4, Psmc6, Psmd1, Psmd11, Psmd12, Psmd13, Psmd14, Psmd2, Psmd3, Psmd8, Psme2, Sat1, Slc25a2,
 H6pd, Il6st, Inpp5f, Inpp5j, Inppl1, Mecp2, Mppe1, Pdgfa, Pdgfrb, Pi4k2a, Pigq, Pik3c2a, Pik3c2g, Pip4k2b, Plcd4, Pnpla2,
 Atp5o, Blm, Carns1, Entpd5, Msh3, Myc, Myh7b, Ndufs1, Pcyox1, Pms2, Rad54b, Rhobtb3, Wrn]
Chil1, Chst7, Colgalt2, Coq3, Entpd5, Extl1, Foxo1, Fuom, Galc, Gcgr, Gcnt2, Gfpt2, Gpd1, H6pd, Hyal1, Hyal3, Igfbp3,
 Psmd12, Psmd13, Psmd14, Psmd2, Psmd3, Psmd8, Psme2]
 Sesn1, Sesn3]
 Psma3, Psma4, Psma6, Psmb3, Psmc1, Psmc4, Psmc6, Psmd1, Psmd11, Psmd12, Psmd13, Psmd14, Psmd2, Psmd3,
Cdk5, Cdkn1a, Cyr61, Dffa, Dnm1l, Efhc1, Elk1, Fndc1, Gadd45b, Gata6, Hspd1, Id3, Igfbp3, Il18, Ing3, Kcnma1, Klf11, Map2k6,
Mmp14, Myc, Pcolce, Pmaip1, Psmd14, Psme2, S100a9, Sfrp2, Stat1, Tnfsf10, Uaca]
 Ltbp3, Ltbp4, Mstn, Myocd, Nrep, Smad6, Smad7]
 Col3a1, Col5a1, Col6a1, Col6a2, Col6a3, Col6a6, Creb3, Efna1, Eif4ebp1, Fgf11, Fgf2, Fgf6, Fgf7, Fgf9, Fn1, Ghr, Gng7,
 Itgav, Lgals1, Plekha2, Prex1, Sdc4, Smad7, Smoc2, Wnt5a]
 Gtpbp4, Igfbp3, Igfbp5, Klf4, Osbpl8, Pfn2, Prkg1, Serpine1, Sfrp2]
 Psmc6, Psmd1, Psmd11, Psmd12, Psmd13, Psmd14, Psmd2, Psmd3, Psmd8, Psme2, Wls, Wnt5a]
 Fgf9, Fos, Gadd45b, Hspa2, Map2k6, Map3k2, Map3k6, Mapk10, Mecom, Mknk1, Myc, Nr4a1, Pdgfa, Pdgfrb, Pla2g4e,
 Dach1, Dll4, Efnb2, Fgf2, Gdf11, Gpr56, Gstp1, Gtpbp4, Hes1, Hmox1, Hyal1, Ift57, Igfbp3, Igfbp5, Inppl1, Klf11, Klf4, Lbx1,
 Pik3ap1, Sqstm1, Stat1, Terf2ip, Tle1, Tlr3, Uaca, Ube2v1]
 Nos1, P2ry1, Pdgfrb, Rtn4, Scn4b, Serpine1, Sgk1, Slc36a2, Tmem132a, Trpc1]
 Cd24a, Cdh23, Edn1, Ednrb, Efhc1, Esr1, F2rl1, Fgf2, Il6st, Itgav, Jph2, Mchr1, Ndn, Nos1, Nucb2, P2ry1, Prkg1, S1pr1,
 Runx1, Sema5a, Serpine1, Sfrp2, Wnt5a]
 Osbpl8, Pdgfa, Phlda3, Sema5a, Sesn1, Sesn3]
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Associated genes found
 Mfap4, Mmp14, Mmp15, Mmp16, Mmp8, Nid2, Pcolce, Pdgfa, Sdc4]
 Sms, Sqrdl]
 Sik1, Slc37a4]
 Igfbp5, Il6st, Inppl1, Irs1, Man2b2, Mdh1, Mecp2, Mlec, Mpdu1, Myc, P2ry1, Pak1ip1, Pdk4, Pfkfb1, Pgm5, Phka2, Phkg1, Pigq,
 Psmd8, Psme2, Tnfsf10, Unc5b]
 Myc, Nos1, Nr4a1, Nupr1, Phlda1, Phlda3, Pmaip1, Rps6ka2, Sfrp2, Sfrp4, Sik1, Tnfrsf12a, Tnfsf10, Trim35, Txnip, Uaca,
 Igf1r, Il4ra, Irs1, Itga5, Itga8, Itgav, Itgb6, Lama4,
 Prkaca, Rasgrf1, Rasgrp3, Rps6ka2]
 Leprel1, Leprel2, Lrrc32, Mbd4, Mfn2, Mtss1, Myc, Myocd, Nos1, Npm1, Nupr1, Pmaip1, Ptpn14, Ptpn2, Rerg, Rnf139,
 Slc37a4, Stc1, Sypl2, Trpc1]
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Associated genes found
 Pmm1, Pomk, Ppara, Prkg1, Ptpn2, Ramp1, Rorc, Siae, Sik1, Slc35b4, Slc37a4, Slc3a2, Sorbs1, St8sia4, Tet1, Trak2, Vegfb]
 Utp11l, Wnt5a]
 Rps6ka2, Serpinf1, Sfrp2, Sfrp4, Smad6, Smarca2, Stat1, Tenc1, Tgif1, Trim35, Wfdc1, Wnt5a]
   Table Supplementary S3 Top upregulated genes in cardiac cachexia. Ranked by a combination of p-value < 0.05 and fold change ≥ 5. a GO terms determined by Uniprot and AmiGO 2 databases. 
Gene Symbol Description Ensembl ID GO Biological Processa Fold Change p Value 
Cyp2e1 Cytochrome P450, family 2, subfamily e, polypeptide 1  ENSRNOG00000012458 Metabolic and oxi-reduction process 49.57 0.0010 
Mt1m Metallothionein 1M ENSRNOG00000028841 Metabolic process 8.18 0.0082 
Fah Fumarylacetoacetate hydrolase  ENSRNOG00000013223 Metabolic process 7.74 0.0023 
Mt1 Metallothionein 1  ENSRNOG00000025764 Negative regulation of growth 7.42 0.0042 
Pbld1 Phenazine biosynthesis-like protein domain containing 1  ENSRNOG00000000386 Biosynthetic process 6.99 0.0061 
Cdkn1a Cyclin-dependent kinase inhibitor 1A  ENSRNOG00000000521 Negative regulation of cell growth  6.29 0.0131 
Serpine1 Serpin peptidase inhibitor, clade E, member 1  ENSRNOG00000001414 Response to hyperoxia 5.51 0.0172 
Mt2A Metallothionein 2A  ENSRNOG00000043098 Negative regulation of growth 5.31 0.0067 
Table Supplementary S4 Top downregulated genes in cardiac cachexia 
Gene Symbol Description Ensembl ID GO Biological Process a Fold Change p Value 
Ky Kyphoscoliosis peptidase ENSRNOG00000008210 Neuromuscular junction development -5.00 0.0088 
Igfbp5 Insulin-like growth factor binding protein 5  ENSRNOG00000017206 Skeletal muscle tissue growth -5.04 0.0023 
Dok5 Docking protein 5  ENSRNOG00000013196 Nervous system development -5.08 0.0223 
Cpa1 Carboxypeptidase A1 (pancreatic)  ENSRNOG00000010725 Proteolysis involved in cellular protein catabolic 
process 
-5.22 0.0016 
Kcnj13 Potassium inwardly-rectifying channel, subfamily J, member 13  ENSRNOG00000016057 Ion transport -5.30 0.0420 
Kera Keratocan  ENSRNOG00000004635  -5.51 0.0471 Col1a1 Collagen, type I, alpha 1  ENSRNOG00000003897 Collagen biosynthetic process and skeletal 
system development  
-5.77 0.0035 
Sfrp4 Secreted frizzled-related protein 4  ENSRNOG00000018893 Cell differentiation -5.98 0.0163 
Mfap4 Microfibril-associated glycoprotein 4-like  ENSRNOG00000002382 Signal transduction -5.98 0.0030 
Rab3a RAB3A, member RAS oncogene family  ENSRNOG00000019433  Mitochondrion organization -6.08 0.0023 
Map2k6 Mitogen-activated protein kinase kinase 6  ENSRNOG00000004437 Positive regulation of apoptosis  -6.24 0.0017 
Mlf1 Myeloid leukemia factor 1  ENSRNOG00000012827 Cell cycle arrest -6.83 0.0063 
Pik3c2g Phosphatidylinositol-4-phosphate 3-kinase, catalytic subunit 
type 2 gamma  
ENSRNOG00000034228 Phosphatidylinositol phosphorylation -6.97 0.0100 
Col3a1 Collagen, type III, alpha 1  ENSRNOG00000003357 Collagen biosynthetic process -8.53 0.0035 
Nrep Neuronal regeneration related protein  ENSRNOG00000020467 Regulation of transforming growth factor beta 
receptor signaling pathway 
-9.52 0.0017 
RGD1565323 Similar to OTTMUSP00000000621  ENSRNOG00000021789 Protein phosphorylation -14.33 0.0201 
 Ranked by a combination of p-value < 0.05 and fold change ≤ -5. a GO terms determined by Uniprot and AmiGO 2 databases. 
Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-29b-4373288 33.492 7.691 2.554 0.020 0.183
mmu-miR-132-4373143 29.414 3.612 2.261 0.032 0.133
hsa-miR-27a#-002445 30.662 5.971 2.218 0.018 0.118
mmu-miR-337-5p-4395645 31.056 5.255 1.975 0.030 0.115
mmu-miR-434-3p-4395734 27.236 1.435 1.936 0.001 0.142
mmu-miR-539-4378103 26.400 0.598 1.906 0.001 0.303
mmu-miR-136-4395641 29.777 3.976 1.877 0.024 0.152
mmu-miR-210-4373089 28.264 2.462 1.722 0.022 0.060
mmu-miR-322-4378107 29.039 3.238 1.705 0.008 0.177
mmu-miR-331-3p-4373046 27.517 1.716 1.583 0.012 0.109
mmu-miR-376c-4395580 30.819 5.018 1.575 0.006 0.222
mmu-miR-29a-4395223 24.473 -1.328 1.520 0.000 0.249
mmu-miR-204-4373094 30.342 4.541 1.504 0.009 0.160
hsa-miR-30d#-002305 31.446 6.756 0.625 0.040 0.043
rno-miR-146B-002755 28.542 3.852 0.585 0.016 0.160
hsa-miR-214-000517 28.545 3.854 0.583 0.005 0.124
rno-miR-632-241110_mat 32.333 7.642 0.515 0.005 0.133
rno-miR-489-001353 30.567 5.877 0.472 0.003 0.115
mmu-miR-682-4381081 35.118 9.530 25.931 0.133
mmu-miR-31#-002495 35.550 10.924 14.821 0.059
mmu-miR-125b-3p-4395489 32.111 6.588 12.800 0.044
mmu-miR-147-4395373 35.149 9.626 12.148 0.138
mmu-miR-10b#-002572 33.285 8.527 7.604 0.043
mmu-miR-200b-4395362 34.463 9.466 7.529 0.046
mmu-miR-467H-002809 34.143 9.455 6.890 0.042
mmu-miR-342-5p-4395657 35.210 9.621 5.309 0.106
mmu-miR-217-4395686 34.866 9.343 4.628 0.112
mmu-miR-7a-4378130 34.021 8.465 4.440 0.196 0.069
mmu-miR-540-5p-4395691 33.816 8.819 4.300 0.096
mmu-miR-449a-4373207 33.726 7.924 3.486 0.220 0.141
mmu-miR-669D-002808 34.944 10.318 3.289 0.041
rno-miR-379#-002081 33.507 8.873 2.936 0.041
mmu-miR-503#-002536 34.884 10.193 2.771 0.064 0.102
mmu-miR-380-5p-4395731 32.942 7.141 2.722 0.196 0.107
mmu-miR-187-4373307 33.347 7.673 2.522 0.582 0.125
mmu-miR-434-5p-4395711 34.294 8.485 2.483 0.109
hsa-miR-29a#-002447 32.166 7.476 2.460 0.048
mmu-miR-200c-4395411 32.594 6.923 2.341 0.092 0.061
Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
hsa-miR-299-5p-000600 31.462 6.771 2.328 0.136 0.114
mmu-miR-125a-3p-4395310 34.638 8.757 2.292 0.156 0.111
mmu-miR-181c-4373115 34.829 9.157 2.108 0.674 0.041
mmu-miR-542-5p-4395693 33.274 7.473 2.086 0.081 0.067
mmu-miR-1928-121164_mat 34.617 9.927 2.016 0.289 0.115
mmu-miR-331-5p-4395344 33.375 7.711 1.984 0.146
mmu-miR-98-4373009 32.945 7.143 1.848 0.240 0.066
mmu-miR-382-4373019 31.617 5.816 1.840 0.597 0.059
mmu-miR-685-4386748 32.566 6.902 1.803 0.122 0.065
mmu-miR-544-4395680 34.522 8.691 1.776 0.115
mmu-miR-34a-4395168 29.837 4.165 1.756 0.257 0.044
hsa-miR-27b#-002174 31.962 7.272 1.716 0.175 0.073
mmu-miR-345-5p-4395658 33.106 7.305 1.694 0.097
rno-miR-450a-4381124 31.653 5.851 1.679 0.046 0.177
mmu-miR-184-4373113 32.954 7.153 1.617 0.128
mmu-miR-376b#-002451 30.629 5.939 1.586 0.134 0.172
mmu-miR-217-001133 35.522 10.834 1.566 0.069
hsa-miR-340-000550 33.369 8.712 1.564 0.551 0.136
rno-miR-17-3p-4395779 34.111 8.428 1.547 0.925 0.149
rno-miR-351-4395764 32.020 6.219 1.509 0.197 0.084
mmu-miR-410-4378093 31.998 6.197 1.492 0.193 0.102
mmu-miR-23b-4373073 30.722 4.921 1.491 0.074 0.134
mmu-miR-221-4373077 32.599 6.743 1.469 0.044
hsa-miR-136#-002100 30.499 5.809 1.465 0.208 0.130
mmu-miR-155-4395701 30.452 4.650 1.460 0.150 0.288
hsa-miR-376a#-001287 34.614 9.756 1.458 0.124
hsa-miR-338-5P-002658 30.652 5.962 1.457 0.265 0.068
mmu-miR-212-002551 30.138 5.448 1.454 0.367 0.098
mmu-miR-337-000193 31.695 7.004 1.442 0.100 0.146
mmu-miR-345-001137 33.053 8.395 1.420 0.581 0.095
hsa-miR-26b#-002444 33.646 8.955 1.417 0.164 0.075
mmu-miR-411-4381013 28.173 2.371 1.415 0.176 0.166
mmu-miR-487b-001306 30.634 5.944 1.409 0.290 0.144
mmu-miR-675-3p-4386762 31.710 5.908 1.391 0.529 0.068
mmu-miR-21-4373090 29.643 3.842 1.377 0.274 0.096
mmu-miR-672-4395438 32.323 6.659 1.374 0.884 0.124
mmu-let-7g#-002492 34.619 10.000 1.362 0.614 0.119
mmu-miR-322#-002506 29.126 4.436 1.361 0.042 0.171
Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-362-5p-002614 33.366 8.895 1.360 0.953 0.114
mmu-miR-199b-001131 34.154 9.496 1.349 0.627 0.056
mmu-miR-10b-4395329 31.828 6.027 1.347 0.258 0.190
mmu-miR-19b-4373098 26.358 0.557 1.333 0.090 0.148
mmu-miR-1939-121180_mat 33.137 8.447 1.324 0.185 0.084
mmu-miR-194-4373106 32.716 7.052 1.323 0.271 0.232
rno-miR-29c#-001818 33.415 8.725 1.313 0.861 0.078
mmu-miR-379-4373349 30.737 4.935 1.296 0.272 0.135
mmu-miR-92a-4373013 29.991 4.189 1.283 0.161 0.253
mmu-miR-487b-4378102 31.689 5.887 1.272 0.172 0.163
mmu-miR-19a-4373099 30.326 4.525 1.270 0.192 0.146
mmu-miR-1954-121137_mat 32.448 7.758 1.259 0.258 0.048
mmu-miR-191-4395410 22.609 -3.193 1.252 0.165 0.155
rno-miR-381-4381102 32.278 6.607 1.249 0.315 0.066
mmu-let-7c-1#-002479 33.463 9.210 1.242 0.083
mmu-miR-451-4373360 33.303 7.502 1.239 0.524 0.047
mmu-miR-30c-4373060 23.386 -2.416 1.234 0.048 0.187
mmu-miR-133a-4395357 17.328 -8.473 1.234 0.147 0.110
mmu-miR-18a-4395533 35.276 9.567 1.234 0.146
mmu-miR-323-3p-4395338 32.688 6.887 1.232 0.781 0.083
mmu-let-7g-4395393 28.179 2.377 1.230 0.058 0.189
mmu-miR-384-5p-4395732 31.856 6.055 1.229 0.345 0.256
rno-miR-1-4395765 20.039 -5.763 1.223 0.006 0.159
mmu-miR-328-4373049 30.624 4.823 1.208 0.280 0.112
mmu-miR-127-4373147 30.550 4.748 1.200 0.345 0.173
mmu-miR-223-4395406 26.782 0.980 1.185 0.114 0.181
mmu-miR-30a-4373061 26.347 0.546 1.184 0.009 0.188
hsa-miR-183#-002270 33.472 8.673 1.181 0.073
mmu-miR-186-4395396 27.499 1.697 1.180 0.167 0.272
mmu-miR-130a-4373145 32.508 6.706 1.173 0.357 0.115
hsa-miR-744#-002325 35.139 10.449 1.158 0.069
mmu-miR-17-4395419 27.641 1.840 1.153 0.210 0.240
mmu-miR-126-3p-4395339 21.444 -4.357 1.148 0.203 0.140
mmu-miR-30b-4373290 24.723 -1.078 1.142 0.027 0.146
mmu-miR-26a-4395166 24.391 -1.410 1.138 0.119 0.110
mmu-miR-20a-4373286 29.095 3.294 1.134 0.360 0.192
mmu-miR-133b-4395358 21.383 -4.419 1.133 0.186 0.076
mmu-let-7d-4395394 29.358 3.556 1.132 0.358 0.158
Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-148a-4373130 32.391 6.590 1.131 0.405 0.084
mmu-miR-433-4373205 32.036 6.372 1.130 0.288 0.082
hsa-miR-106b#-002380 32.412 7.722 1.129 0.862 0.097
rno-miR-7a#-002062 28.260 3.570 1.128 0.164 0.144
rno-miR-196c-4395750 30.479 4.678 1.124 0.570 0.189
hsa-miR-151-5P-002642 30.628 5.938 1.118 0.361 0.095
mmu-miR-26b-4395167 27.075 1.273 1.117 0.418 0.151
mmu-miR-101b-002531 28.939 4.249 1.115 0.220 0.240
mmu-miR-1937b-241023_mat 19.200 -5.490 1.113 0.476 0.182
mmu-miR-218-4373081 31.195 5.394 1.113 0.502 0.145
mmu-miR-30d-4373059 27.330 1.528 1.111 0.109 0.126
mmu-miR-365-4373194 30.746 4.945 1.107 0.458 0.113
mmu-miR-30e-4395334 25.376 -0.426 1.100 0.202 0.241
mmu-miR-16-4373121 23.358 -2.443 1.098 0.312 0.195
mmu-miR-128a-4395327 31.325 5.524 1.085 0.739 0.121
mmu-miR-150-4373127 24.490 -1.312 1.083 0.444 0.191
mmu-let-7e-4395517 27.258 1.457 1.072 0.553 0.124
mmu-miR-139-5p-4395400 28.439 2.637 1.070 0.470 0.159
mmu-miR-467F-002886 26.340 1.650 1.067 0.559 0.053
mmu-miR-720-001629 23.603 -1.087 1.067 0.668 0.176
mmu-miR-101a-4395364 32.396 6.595 1.067 0.779 0.152
hsa-miR-30e-3p-000422 24.077 -0.613 1.066 0.500 0.171
mmu-miR-24-4373072 21.359 -4.442 1.065 0.434 0.113
hsa-miR-30a-3p-000416 23.548 -1.142 1.065 0.539 0.218
mmu-miR-106a-4395589 28.885 3.084 1.065 0.543 0.188
mmu-miR-342-3p-4395371 28.323 2.522 1.063 0.471 0.098
mmu-miR-126-5p-4373269 27.248 1.447 1.062 0.447 0.190
mmu-miR-1937c-241011_mat 21.840 -2.850 1.057 0.495 0.152
rno-miR-7#-001338 29.745 5.055 1.057 0.537 0.185
mmu-miR-574-3p-4395460 28.240 2.438 1.054 0.561 0.149
hsa-miR-411#-002238 33.355 8.665 1.054 0.753 0.102
mmu-miR-484-4381032 29.321 3.520 1.047 0.547 0.144
mmu-miR-1186-002825 35.173 10.524 1.043 0.060
mmu-miR-103-4373158 31.129 5.328 1.041 0.800 0.062
mmu-miR-1193-002794 32.049 7.392 1.035 0.944 0.068
mmu-miR-29c-4395171 31.131 5.330 1.024 0.699 0.226
mmu-miR-1-4395333 22.408 -3.393 1.023 0.912 0.069
mmu-miR-140-4373374 28.042 2.241 1.021 0.826 0.237
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Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-190-4373110 33.477 7.675 1.020 0.615 0.045
mmu-miR-143-4395360 28.090 2.288 1.019 0.795 0.206
mmu-miR-107-4373154 34.296 8.560 1.018 0.092
mmu-miR-383-4381093 35.911 9.987 1.018 0.106
mmu-miR-203-4373095 32.742 6.940 1.013 0.908 0.148
hsa-miR-223-000526 23.888 -0.803 1.009 0.902 0.201
rno-miR-664-001323 27.942 3.252 1.004 0.883 0.197
mmu-miR-188-5p-4395431 33.791 7.989 1.003 0.450 0.075
mmu-miR-27b-4373068 29.981 4.180 1.000 0.964 0.168
rno-miR-190b-4395749 33.842 8.040 0.991 0.594 0.209
mmu-miR-450a-5p-4395414 32.584 6.913 0.984 0.655 0.067
mmu-miR-381-4373020 33.985 8.606 0.984 0.811 0.052
mmu-miR-145-4395389 25.458 -0.343 0.982 0.898 0.113
mmu-let-7c-4373167 27.642 1.841 0.979 0.864 0.147
mmu-miR-100-4373160 28.951 3.149 0.974 0.969 0.098
mmu-miR-125b-5p-4373148 27.867 2.066 0.973 0.974 0.136
mmu-miR-99b-4373007 30.183 4.382 0.972 0.830 0.055
mmu-miR-28-4373067 31.340 5.539 0.972 0.935 0.149
rno-miR-339-3p-4395760 29.827 4.026 0.967 0.852 0.082
hsa-miR-206-000510 17.884 -6.806 0.965 0.698 0.207
mmu-miR-466k-240990_mat 32.718 8.028 0.965 0.971 0.069
mmu-miR-494-4395476 32.534 6.732 0.964 0.466 0.082
mmu-miR-1839-5p-121135_mat 33.235 8.544 0.960 0.746 0.110
rno-miR-350-001337 33.981 9.008 0.957 0.061
mmu-miR-541-002562 33.598 8.820 0.955 0.845 0.083
mmu-miR-322-001059 30.588 5.898 0.954 0.926 0.076
mmu-miR-195-4373105 26.140 0.338 0.953 0.468 0.194
mmu-miR-337-3p-4395662 33.904 8.102 0.953 0.806 0.117
mmu-miR-694-001681 27.641 2.951 0.947 0.820 0.049
mmu-miR-208b-4395401 32.996 7.195 0.942 0.861 0.186
hsa-miR-22-000398 26.359 1.669 0.942 0.983 0.057
rno-miR-504-007334 33.664 8.985 0.939 0.074
mmu-let-7f-4373164 31.013 5.211 0.934 0.692 0.045
mmu-miR-222-4395387 28.512 2.710 0.929 0.437 0.259
mmu-miR-486-4378096 24.911 -0.890 0.928 0.318 0.147
mmu-miR-10a-4373153 31.268 5.466 0.927 0.850 0.115
mmu-miR-351-4373345 32.447 6.645 0.926 0.952 0.045
mmu-miR-15b-4373122 31.970 6.169 0.917 0.934 0.137
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Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-27a-4373287 28.760 2.959 0.916 0.484 0.251
mmu-miR-34c#-002584 31.754 7.063 0.916 0.700 0.094
hsa-miR-423-3P-002626 29.796 5.106 0.914 0.734 0.127
mmu-miR-152-4395170 30.132 4.331 0.909 0.732 0.222
mmu-miR-2134-241120_mat 26.673 1.983 0.903 0.941 0.220
mmu-let-7i-4395332 28.702 2.901 0.902 0.275 0.178
hsa-miR-143-000466 31.768 7.077 0.902 0.915 0.127
mmu-miR-125a-5p-4395309 28.171 2.369 0.896 0.973 0.157
mmu-miR-148b-4373129 35.517 9.769 0.885 0.087
mmu-let-7a-4373169 29.992 4.190 0.884 0.822 0.076
mmu-miR-744-4395435 32.545 6.743 0.883 0.674 0.187
mmu-miR-872#-002542 29.561 4.871 0.881 0.307 0.102
hsa-miR-455-001280 33.301 8.611 0.880 0.084
mmu-miR-138-4395395 30.071 4.270 0.876 0.265 0.249
mmu-miR-99a-4373008 28.923 3.122 0.876 0.524 0.072
rno-miR-532-5p-4395752 30.795 4.994 0.876 0.657 0.174
mmu-miR-500-4395736 33.350 7.901 0.873 0.075
mmu-miR-181a-4373117 32.040 6.239 0.869 0.642 0.062
mmu-miR-532-3p-4395466 31.467 5.666 0.862 0.396 0.161
mmu-miR-196b-4395326 28.456 2.655 0.861 0.392 0.168
mmu-miR-15a-4373123 31.436 5.635 0.856 0.542 0.109
mmu-miR-499-4381047 30.896 5.094 0.854 0.593 0.224
mmu-miR-93-4373302 31.333 5.531 0.854 0.605 0.205
mmu-miR-146b-4373178 27.424 1.622 0.853 0.229 0.168
hsa-miR-200c-000505 33.184 8.494 0.851 0.444 0.115
rno-miR-352-001339 30.498 5.808 0.851 0.521 0.061
mmu-miR-592-002017 33.428 8.749 0.851 0.556 0.083
hsa-miR-196a-241070_mat 24.755 0.064 0.849 0.295 0.151
mmu-miR-24-2#-002494 27.432 2.742 0.843 0.309 0.129
mmu-miR-191#-002576 34.894 10.424 0.842 0.643 0.118
rno-miR-409-3P-002679 31.124 6.434 0.841 0.414 0.145
rno-miR-99a#-002073 32.963 8.273 0.833 0.981 0.059
mmu-miR-199a-3p-4395415 27.869 2.068 0.831 0.061 0.193
rno-miR-125b#-002074 30.901 6.210 0.826 0.055 0.137
hsa-miR-421-002700 31.761 7.071 0.825 0.544 0.201
mmu-miR-339-5p-4395368 31.886 6.085 0.824 0.583 0.064
mmu-miR-495-4381078 32.034 6.233 0.822 0.993 0.052
mmu-miR-320-4395388 27.293 1.492 0.820 0.301 0.193
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Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-1274a-121150_mat 23.175 -1.516 0.820 0.484 0.137
hsa-miR-22#-002301 30.789 6.098 0.819 0.326 0.067
hsa-miR-29b-2#-002166 35.103 10.131 0.814 0.191
mmu-miR-193b-4395597 27.476 1.675 0.809 0.079 0.183
mmu-miR-706-001641 31.401 6.711 0.809 0.347 0.050
hsa-miR-140-3p-002234 29.366 4.676 0.799 0.061 0.076
hsa-miR-378-000567 28.736 4.046 0.796 0.521 0.247
mmu-miR-374-5p-001319 26.901 2.211 0.793 0.084 0.109
hsa-miR-28-3p-002446 27.929 3.239 0.785 0.004 0.195
mmu-miR-10b-001181 32.210 7.519 0.780 0.480 0.101
mmu-miR-877#-002548 30.433 5.743 0.778 0.103 0.079
mmu-miR-497-4381046 31.003 5.202 0.778 0.136 0.178
mmu-miR-376a-4373347 34.858 9.057 0.777 0.086
mmu-miR-340-3p-4395370 34.619 8.775 0.776 0.650 0.147
mmu-miR-543-4395487 34.138 9.140 0.772 0.096
mmu-miR-350-4395660 34.552 8.895 0.767 0.070
hsa-miR-93#-002139 30.584 5.893 0.765 0.222 0.186
mmu-miR-2135-241140_mat 28.826 4.135 0.765 0.249 0.103
hsa-miR-149-002255 25.894 1.204 0.763 0.010 0.140
mmu-miR-872-4395375 33.760 7.958 0.760 0.150 0.272
mmu-miR-28#-002545 28.802 4.112 0.754 0.119 0.071
mmu-miR-25-4373071 33.237 7.435 0.753 0.207
mmu-miR-409-3p-4395443 32.122 6.321 0.751 0.369 0.238
mmu-miR-146a-4373132 25.815 0.014 0.748 0.026 0.194
mmu-miR-431-4395173 31.518 5.717 0.748 0.296 0.087
mmu-miR-214-4395417 29.331 3.530 0.747 0.083 0.122
mmu-miR-423-5p-4395451 33.770 8.121 0.744 0.059
mmu-miR-503-4395586 32.747 6.946 0.738 0.504 0.090
mmu-miR-466g-241015_mat 33.924 9.234 0.738 0.782 0.050
mmu-miR-652-4395463 32.696 6.894 0.737 0.479 0.126
mmu-miR-543-001298 34.757 9.979 0.732 0.141
mmu-miR-1961-197391_mat 31.963 7.273 0.730 0.264 0.050
mmu-miR-106b-4373155 32.079 6.278 0.724 0.217 0.202
mmu-miR-193#-002577 32.892 8.202 0.717 0.204 0.157
hsa-miR-213-000516 34.395 9.737 0.708 0.614 0.045
mmu-miR-2138-241080_mat 27.902 3.212 0.706 0.929 0.047
mmu-miR-134-4373299 31.548 5.747 0.700 0.217 0.084
mmu-let-7b-4373168 29.392 3.590 0.692 0.067 0.138
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Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-324-5p-4373052 33.674 8.010 0.690 0.796 0.065
mmu-miR-369-5p-4373195 34.560 8.920 0.689 0.313 0.044
mmu-miR-29b#-002497 34.030 9.301 0.689 0.152
mmu-miR-1896-121128_mat 31.420 6.729 0.680 0.110 0.057
mmu-miR-2146-241082_mat 23.582 -1.108 0.680 0.027 0.087
mmu-miR-34b-3p-4395748 33.293 7.825 0.679 0.827 0.072
mmu-let-7a#-002478 32.490 7.800 0.678 0.081 0.101
hsa-miR-214#-002293 31.932 7.241 0.674 0.024 0.151
mmu-miR-202-3p-4373311 32.281 6.479 0.662 0.090 0.052
mmu-miR-142-3p-4373136 32.328 6.526 0.660 0.433 0.158
mmu-miR-182-4395729 31.939 6.138 0.647 0.610 0.117
mmu-miR-1839-3p-121203_mat 32.599 7.908 0.645 0.224 0.056
mmu-miR-326-001061 33.519 8.862 0.633 0.278 0.046
mmu-miR-467b-001684 33.037 8.347 0.630 0.520 0.040
mmu-miR-1897-5p-121199_mat 31.190 6.500 0.627 0.236 0.066
hsa-miR-33a#-002136 33.753 9.062 0.624 0.273 0.048
mmu-miR-1894-3p-241002_mat 34.044 9.354 0.623 0.156 0.114
mmu-miR-335-5p-4373045 32.789 6.988 0.613 0.330 0.113
hsa-miR-324-3p-000579 30.077 5.387 0.611 0.204 0.082
mmu-miR-361-4373035 34.096 8.252 0.611 0.603 0.080
mmu-miR-708-4395452 33.560 7.896 0.599 0.238
mmu-miR-335-3p-4395296 34.718 9.027 0.597 0.546 0.097
mmu-miR-130b-4373144 30.881 5.080 0.594 0.097 0.057
mmu-miR-192-4373108 33.184 7.383 0.583 0.758 0.196
mmu-miR-671-3p-4395433 35.120 9.411 0.581 0.137
mmu-miR-485-3p-001943 33.299 8.665 0.576 0.222 0.056
mmu-miR-674#-001956 31.662 6.971 0.570 0.313 0.077
mmu-miR-301a-4373064 33.191 7.520 0.534 0.307 0.107
mmu-miR-301b-4395730 33.778 7.977 0.526 0.212 0.117
mmu-miR-205-4373093 34.758 9.049 0.506 0.103 0.080
hsa-miR-189-000488 34.515 9.916 0.505 0.786 0.040
rno-miR-224-4373187 35.145 9.884 0.498 0.073
mmu-miR-340-5p-4395369 33.847 8.046 0.496 0.054 0.121
hsa-miR-425-001104 33.898 9.208 0.477 0.311 0.061
mmu-miR-31-4373331 36.162 9.987 0.474 0.643 0.161
mmu-miR-193-4395361 34.487 9.038 0.466 0.111
hsa-miR-99b#-002196 32.909 8.219 0.463 0.266 0.057
rno-miR-345-3p-4395762 33.537 7.735 0.443 0.160 0.043
Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
mmu-miR-185-4395382 33.476 7.675 0.430 0.061 0.066
rno-miR-505-4381097 34.223 8.930 0.416 0.060
mmu-miR-690-001677 28.987 4.297 0.375 0.120 0.115
mmu-miR-384-3p-4395733 37.260 11.704 0.374 0.070
mmu-miR-9-4373285 34.199 8.732 0.337 0.079
hsa-let-7i#-002172 35.529 10.903 0.328 0.114
hsa-miR-412-001023 35.118 10.146 0.311 0.063
mmu-miR-409-5p-4395442 36.468 10.719 0.286 0.051
mmu-miR-338-3p-4395363 36.708 10.972 0.265 0.140
mmu-miR-704-001639 37.417 12.894 0.262 0.046
hsa-miR-10a#-002288 34.918 10.665 0.239 0.055
hsa-miR-338-000548 37.182 12.556 0.173 0.064
mmu-miR-296-5p-4373066 37.185 11.477 0.166 0.041
mmu-miR-183-4395380 36.849 11.207 0.146 0.051
mmu-miR-196a#-002477 36.743 11.984 0.116 0.502 0.040
mmu-miR-15a#-002488 38.270 13.831 0.086 0.085 0.046
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mmu-miR-122-4395356 35.046 9.522 0.064
mmu-miR-124-4373295 0.040
mmu-miR-125b#-002508 0.040
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mmu-miR-2136-241133_mat 34.845 9.872 0.060
mmu-miR-2139-241130_mat 0.200
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mmu-miR-412-002575 35.472 10.779 0.074
mmu-miR-425-4380926 0.040
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mmu-miR-494-001293 34.975 10.173 0.176
mmu-miR-496-4386771 0.200
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Table Supplementary 5 Results of miRNA expression analysis using TaqMan Low Density Arrays
Target Name (ID LifeTech) Cт Mean ΔCт Mean RQ P-Value Threshold
Y1-001727 27.253 0.052
Y1-4386739 29.178 0.057
Table Suplementary S6 Target genes deregulated by differentially expressed miRNAs
GOTERM GOID GO Database P-value % Genes (n) miRNAs Associated (n) Target Genes Deregulated miRNAS
Extracellular matrix 
organization 6016202 REACTOME 9.2 E-5 8.08 21 11
[Adamts3, Col1a1, Col1a2, 
Col22a1, Col3a1, Col5a1, 
Col6a2, Itga8, Lum, Mmp15, 
Mmp16, Pdgfa, Serpine1, Pgf, 








protein degradation 3050 KEGG 3.0 E-5 17.24 5 4




Citric acid cycle and 
respiratory electron 
transport




 JNK cascade 7254 GO Biological Process 3.4 E-4 3.03 8 9
[Cdc42se1, Dusp10, Mecom, 




5p, miR-450a-5p, miR-489-3p, 
miR-539-5p, miR-632]
Cellular response to TGF 
beta 71560 GO Biological Process 7.8 E-3 5.38 12 9
[Col1a1, Col1a2, Col3a1, 
Dusp22, Gcnt2, Itga8, Klf10, 




3p, miR-376c-3p, miR-489-3p, 
miR-539-5p, miR-632]
miRNA Predicted Validated Total
miR-204-5p 24 0 24
miR-29b-3p 18 6 24
miR-136-5p 8 14 22
miR-322-3p 21 0 21
miR-539-5p 21 0 21
miR-29a-3p 15 5 20
miR-30d-3p 16 0 16
miR-132-3p 15 0 15
miR-214-3p 13 0 13
miR-632 10 0 10
miR-331-3p 7 0 7
miR-146b-5p 6 0 6
miR-434-3p 6 0 6
miR-376c-3p 5 0 5
miR-489-3p 5 0 5
miR-210-3p 2 0 2
miR-27a-5p 2 0 2
miR-337-5p 1 0 1
n: number of targets mRNAs
mRNA targets (n)
Table Supplementary 7 Number of targets mRNAs per differentially expressed 
microRNAs in cardiac cachexia.
Table Supplementary 8 mRNAs co-deregulated by 3 or more miRNAs in cardiac cachexia. 
mRNA miRNA (n) List of miRNAs
Fbxw7 5 miR-136-5p*, miR-204-5p, miR-29a-3p,miR-29b-3p, miR-322-3p
Dnmt3a 3 miR-29b-3p*, miR-29a-3p*, miR-204-5p
Ppic 3 miR-29b-3p,miR-29a-3p, miR-204-5p
* validated interaction, n: n: number of miRNAs
































Mus musculus R: ACTCGAACGGGAATCCATCGGTCAT
Col3a1 F: TCCTGGTGGTCCTGGTACTG
Mus musculus R: AGGAGAACCACTGTTGCCTG
Myh2 F: AGGCGGCTGAGGAGCACGTA




















mRNA RefSeq Sequence (5′ – 3′)
MyH7 F: GGAGCGCAAGTTTGTCATAAGT
Mus musculus R: CTCAAGCTGCTCAGCAATCTATTT
Ppia F: TGCCTTCTTTCACCTTCCCAA
Mus musculus R: TGGCAAATGCTGGACCAAAC
Ppib F: TCTCGGAGCGCAATATGAAGG
Mus musculus R: AGCAAAAGGAAGACGACGGA
NM_011149.2
NM_080728.2
NM_008907.1
